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Patients with burn injuries suffer from pain and an inflammatory response;
however, treatment methods are still not satisfactory and remain challenging. Due
to the long stage of burn wound rehabilitation, which contributes to the long-term
sensory problems, an effective treatment must begin at the outset of burn wound
care. The functionalized wound dressing is expected to be a great treatment strategy
over the commercialization wound dressing products and engineered skin substi-
tutes nowadays. Some studies revealed the use of calcium alginate polysaccharide
(CAPS) as an “active” dressing due to its calcium richness for wound healing and
scar tissue formation. The outstanding outcome of CAPS dressing for severe burn
injuries was indicated by natural wound healing and less scarring formation, mini-
mum bacterial infection, cytokine enhancement regulation, and appropriate
inflammatory response and pain regulation. These advantages affirmed the phyto-
polysaccharide dressing as the next generation of wound dressing materials with
highly desirable properties.
Keywords: severe burn injuries, wound dressing, wound management, calcium
alginate polysaccharide, inflammatory response
1. Introduction
Burns are the most traumatic injuries and physically harmful because of long
hospitalization and rehabilitation, which lead to significant morbidity and mortality
[1, 2]. The development of effective treatment associated with burn injury is a
major unmet medical problem. Current burn wound treatment methods, such as
eschar excision, split-thickness skin autograft, and cell-based skin constructs, are
still not satisfactory and remain challenging. Not only causing painful and relative
costly treatment, but those methods are also very difficult to perform in patients
due to poor availability of healthy tissue [3–5].
Despite any advances in burn management, how to treat wound properly at the
outset of burn injury is the important key of an effective treatment. Most patients
with burn injuries suffer from long-term pain and posttraumatic situation; there-
fore, an appropriate burn wound handling with a good dressing initially is expected




Dressing as an Accelerated




Patients with burn injuries suffer from pain and an inflammatory response;
however, treatment methods are still not satisfactory and remain challenging. Due
to the long stage of burn wound rehabilitation, which contributes to the long-term
sensory problems, an effective treatment must begin at the outset of burn wound
care. The functionalized wound dressing is expected to be a great treatment strategy
over the commercialization wound dressing products and engineered skin substi-
tutes nowadays. Some studies revealed the use of calcium alginate polysaccharide
(CAPS) as an “active” dressing due to its calcium richness for wound healing and
scar tissue formation. The outstanding outcome of CAPS dressing for severe burn
injuries was indicated by natural wound healing and less scarring formation, mini-
mum bacterial infection, cytokine enhancement regulation, and appropriate
inflammatory response and pain regulation. These advantages affirmed the phyto-
polysaccharide dressing as the next generation of wound dressing materials with
highly desirable properties.
Keywords: severe burn injuries, wound dressing, wound management, calcium
alginate polysaccharide, inflammatory response
1. Introduction
Burns are the most traumatic injuries and physically harmful because of long
hospitalization and rehabilitation, which lead to significant morbidity and mortality
[1, 2]. The development of effective treatment associated with burn injury is a
major unmet medical problem. Current burn wound treatment methods, such as
eschar excision, split-thickness skin autograft, and cell-based skin constructs, are
still not satisfactory and remain challenging. Not only causing painful and relative
costly treatment, but those methods are also very difficult to perform in patients
due to poor availability of healthy tissue [3–5].
Despite any advances in burn management, how to treat wound properly at the
outset of burn injury is the important key of an effective treatment. Most patients
with burn injuries suffer from long-term pain and posttraumatic situation; there-
fore, an appropriate burn wound handling with a good dressing initially is expected
to be a great way to minimize scar formation and accelerate burn wound healing.
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A good clinical dressing must be easy to handle, avoids infection and inflammation,
has no toxicity, causes no allergic reactions, and permits easy and early mobilization
[6, 7].
Bioactive wound dressing, or functionalized wound dressing, is expected to
overcome the limitations of the current treatment in burn wound management.
This dressing delivers either bioactive compounds or dressing that is constructed
from a material having endogenous activity in wound healing, which contribute not
only a matrix for repair but also growth factors and cytokines to enhance the
healing process [8]. Various types of bioactive wound dressings are available on the
market and are used clinically. However, bioactive wound dressings have advan-
tages and disadvantages, so choosing the suitable wound dressing as needed is
advised.
Alginate, commonly derived from seaweed, has been widely investigated by
many researchers for possible new alternative in wound management field. Algi-
nate, a rich natural polysaccharide, which contains glycosaminoglycan (GAG), has
several major properties such as biocompatibility, gelling, and swelling that keep
the wound site moist enough for proper healing and then able to reduce healing
times of wounds [9, 10]. When attached with wound, an ion-exchange reaction
occurs between the calcium in the alginate and the sodium in the exudate, thus
producing a soluble gel that help maintain a moist wound environment and also
hold bacterial infection in absorbed wound fluid at the same time. This is why
alginate is recommended for the treatment of moderate to highly exuding
wounds [11].
Calcium alginate polysaccharide (CAPS) has been found suitable for use in
pharmaceutical drugs, as a bioactive food ingredient, and for cell encapsulation or
tissue regeneration [12]. Numerous studies revealed that CAPS-containing dressing
for severe burn injuries has outstanding outcomes such as rapid wound closure with
less scarring formation, minimum bacterial infection, cytokine enhancement regu-
lation, and appropriate inflammatory response and pain regulation. In addition, this
material becomes substantial to be considered as optimal burn wound dressing
treatment because it maintains a great moist microenvironment at the wound site.
Therefore, the detail mechanisms and involvement of CAPS dressing in accelerating
burn wound healing will be further discussed in this chapter.
2. Medical dressing for the treatment of burn injury
Generally, the treatment of burn injury depends on both depth and surface area
of burn wounds, which reepithelialization is the most important stage of burn
wound repair. For the severe burn injury such as deep partial-thickness or full-
thickness burn, there is a need of special treatment to prevent delayed reepithelia-
lization due to the destruction of epithelial regenerative elements in the basal layer
of the epidermis and in the dermis. To date, eschar excision and split-thickness skin
autograft taken from a healthy skin of the same patient are medical standard
treatments for severe burn injury [3, 4]. However, the grafts are causing pain and
very difficult to perform in patients due to poor availability of healthy tissue. In
addition, many types of cell-based skin constructs have been developed for full-
thickness burn injury, but poor survival rate of the keratinocytes in cell sheets has
been a major concern in these discoveries [5].
On the other hand, for the first or superficial second-degree injury, the
reepithelialization remains possible by the migration of keratinocytes from the
edges of the wound, followed by their proliferation, stratification, and dedifferen-
tiation to form an intact epithelium [3]. But still, an optimal reepithelialization
4
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requires a supportive microenvironment to avoid infection. Bacterial infection was
well known as a common cause of death after burns [13]. Commonly, antimicrobial
creams and occlusive dressings are applied on the wound to avoid infection, to limit
wound progression, and to improve epithelialization progression [14].
Despite any advances in burn management, how to treat wound properly at the
outset of burn injury is the important key of an effective treatment. The proper
burn wound handling in the beginning with the functionalized wound dressing may
enhance reepithelialization progress and accelerate an intact epithelium formation
with minimal scar appearance. Not only should achieve rapid healing at reasonable
cost with less inconvenience to the patient, but the use of clinical dressing also must
be easy to handle, avoids infection and inflammation, has no toxicity, causes no
allergic reactions, and permits easy and early mobilization [6, 7].
Based on its natural action, wound dressings are normally classified as passive
products, interactive products, and bioactive products [9]. Passive products consist
of traditional dressings like gauze and tulle dressings which account for the largest
market segment. Interactive products consist of polymeric films and forms, which
are recommended for low exuding wounds due to its characteristics. Bioactive
products are which deliver either bioactive compounds or dressings are constructed
from a material having endogenous activity in wound healing. These materials
include proteoglycans, collagen, non-collagenous protein, chitosan, or alginate.
They are considered to contribute not only a matrix for repair but also growth
factors and cytokines to enhance the healing process [8]. Commercially, various
types of those bioactive wound dressings are currently used in the clinical setting
with their advantages and disadvantages for some types of wounds. In the case of
burn wound, the dressing with rich glycosaminoglycan (GAG) is expected to
encourage the efficient and rapid healing process. GAG has a significant role in
wound healing phases which acts as a regulator of early inflammation to modulate
inflammatory cell and fibroblast cell migration, pro-inflammatory cytokine synthe-
sis, and the phagocytosis of invading microbes [15].
Alginate, commonly derived from seaweed, is a rich natural anionic phytol
polysaccharide (APS) that consists of mainly differing ratios of D-mannuronic and
L-guluronic acid, which are covalently bound through 1,4-glycosidic linkages.
Polysaccharides and proteins are the most common natural polymers used in the
tissue engineering field for the regeneration of full-thickness wounds because of
their biocompatibility, biodegradability, and similarity with ECM [16, 17].
Containing glycosaminoglycan (GAG), they play a key role in wound healing due to
their ability to encourage activation of the immune system that cleans up the wound
site after injury and reduces the pain simultaneously. It provides a moist environ-
ment around the wound site that leads to rapid granulation and reepithelialization.
Alginate-based wound dressings have also been demonstrated for their hemostatic
properties in exudation/bleeding wounds and burns [9]. Alginate can easily form
gels by binding with divalent cations, especially calcium ions [18]. The gelling
property of alginate helps in the dressing removal without much trauma [19].
Alginate dressings were originally presented as formed from calcium alginate
fibers and have been technically fabricated with fibers woven to form a more solid
and strengthen structure to obtain an applicable wound dressing. As wound dress-
ing, treatment with calcium alginate polysaccharide (CAPS) dressings had shown
great wound recovery outcome in various types of skin wounds [20–23]. They
promoted healing via a direct modulatory effect on wound macrophage activation
that secretes pro-inflammatory cytokines within the chronic wound bed which may
initiate a delayed inflammatory phase [24]. Additionally, numerous studies
revealed that CAPS-containing dressing for severe burn injuries has outstanding
outcomes such as rapid wound closure with less scarring formation, minimum
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creams and occlusive dressings are applied on the wound to avoid infection, to limit
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bacterial infection, cytokine enhancement regulation, and appropriate inflamma-
tory response and pain regulation. Hence, this material becomes substantial to be
considered as an optimal burn wound dressing.
3. The problem and historical perspective of burn wound healing
The proper treatment of wound has attracted the human attention over several
decades. Among the various types of wound, severe burn injuries are the most
traumatic and physically harmful, which lead to significant morbidity and mortality
[1, 2]. Burn injuries can lead to multifarious uncontrolled effects after the accident,
and they may have a major impact to the body functions of burn-injured patients.
Historically, they were accounted for an estimate of 180,000 deaths every year,
which are related to burn injury worldwide, and the vast majority occurs in low-
and middle-income countries [25]. Most burn victims face up a long-term hospital-
ization and suffer major burns covering 25% of their body surface.
The healing process of burn wound, both small burn and large severe burn
injuries, occurs through several biological processes, such as hemostasis, inflamma-
tion, proliferation, and maturation. Without the right handling, a hypertrophic scar
caused by fibroblastic proliferation will be formed during the healing process,
which is confined to the wound site [26]. In addition to local wound repair, severe
large burns also can stimulate a persistent pathophysiological stress response [27].
Most patients with burn injuries suffer pain during burn wound debridement in the
clinic, which they describe as severe to excruciating despite the use of powerful
opioid analgesics [28]. Based on local and systemic pathophysiologic responses,
burn wound recovery is generally divided into three phases: acute phase, healing
phase, and rehabilitation phase. The acute phase may be completely bypassed in
smaller injuries, which specifically lasts 2–3 days [29, 30]; the healing phase may be
weeks or more, whereas the rehabilitation phase most often takes at least 1 year and
sometimes much longer, depending on patient participation in the treatment plan,
patient age, and specification of burn [31]. These long phases of recovery often lead
burn-injured patients to survive from long-term pain and encounter a
posttraumatic situation.
In order to reduce the lifelong burn wound recovery phases which usually con-
tributes to the further problems, an effective treatment must begin at the outset of
burn wound care. An appropriate burn wound handling in the beginning is expected
to be a great way to minimize scar formation and accelerate burn wound healing.
4. Application of CAPS dressing for accelerating burn injury treatment
Since burns have a heterogeneous nature, a variety of animal burn models have
been developed as valuable tools to observe the pathophysiology of burns. Animal
models continue to be explored to uncover the molecular and cellular aspects that
characterize human burn trauma [32]. Better understanding of the burn wound
healing in animal models and their relation to human wounds will significantly
overcome the limited translation of research into practical treatments for burn-
injured patients.
Wang et al. [33] treated a severe burn injury in swine model with calcium
alginate polysaccharide (CAPS) dressing to observe wound repair and scar forma-
tion comparing to the use of carboxymethyl cellulose (CMC) as a commonly used
wound dressing for many years [34, 35]. These animals were also used to assess the
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secondary outcomes of the depth of scar formation at postburn, determined by the
Vancouver Scar Scale (VSS) which consists of four variables: vascularity, height
(thickness), pliability, and pigmentation. The total score ranges from 0 to 14,
whereby a score of 0 reflects normal skin. The results showed that wounds dressed
with CAPS exhibit a rapid reepithelialization and less scar formation, which
appeared with a smooth wound. Based on VSS scores, there was less scar formation
in the wounds dressed with CAPS, shown by significantly lower scores up to
6 weeks of observation. Scarring, or fibrosis, is known as an abnormal tissue
remodeling. The management of scar formation is one of major complications
encountered during the wound healing process. Without the right handling, a
hypertrophic scar caused by fibroblastic proliferation will be formed during the
healing process [26]. Moreover, healing by fibrosis instead of regeneration often
causes lifelong disability that has a significant economic impact [36].
In line, an obvious wound closure and relative complete reepithelialization were
observed to occur on wound dressed with the CAPS dressing in rat group model [37].
Their histological analysis revealed that the new dermis tissue on dressing treated
wound area was composed of reorganized and stratified epithelial layer, with fully
developed connective tissue, hair follicle, sebaceous glands, and aligned collagen.
Another study reported that CAPS dressing treatment accelerated wound closure rate
and exhibited a faster epithelialization [38]. They found that the expression of skin
tissue collagen I was elevated by CAPS dressing application, and this dressing pro-
vides a moist environment and a faster collagen I-related epithelialization.
The ability of CAPS dressing reduces scar formation in burn injury is attribut-
able to its rich contain of glycosaminoglycan (GAG), which was known to promote
wound healing, lead to rapid granulation and reepithelialization, and thus yield a
minimum scar formation certainly. Moreover, when attached to the wound, an ion-
exchange reaction occurs between the calcium in the alginate and the sodium in the
exudate, producing a soluble gel that turns to help maintain a moist wound envi-
ronment [39]. CAPS dressings also have their inherent ability to augment hemosta-
sis, as release of calcium ions leads to platelet activation [40, 41]. Additionally,
calcium ions also speed up the wound healing process by modulating cell prolifera-
tion, maturation, and the creation of epidermal lipid barriers [42–44].
As another major challenge in burn injury management, bacterial infection
becomes the most common cause of mortality and morbidity [13, 45, 46]. Infection
is defined as the presence of high concentrations (>105 organisms/g of tissue) of
bacteria in the burn wound and usually progresses to invasion of subjacent tissue
within 5 days. Infection can delay wound healing process due to the development of
a pronounced immune response, accompanied by sepsis or septic shock, which
causes hypotension and impaired perfusion of end organs including the skin. To
prevent this condition, wound dressing for burn injury treatment should create an
optimal environment, which provides barrier against chronic wound infection.
Some studies have demonstrated that CAPS dressings have hemostatic [47] and
some bacteriostatic [48] properties. CAPS dressing for burn wound treatment
demonstrated a remarkable inhibition of bacterial growth than CMC dressing treat-
ment, which significantly reduced the amount of bacteria at 3 weeks postburn
injury [33]. This reduction was maintained until 6 weeks postburn injury. The
infection control functioned by CAPS dressing might be related to its bacterial
infection holding in absorbed wound fluid. As they swell, they trap wound debris
and bacteria, thereby reducing overall bacterial load within the wound during
dressing changes [19]. In addition, the advantages of a new technology conferring a
bactericidal effect on CAPS gels for wound dressing have been explored. Poor et al.
[49] developed nonthermal-plasma-treated alginate gel wound dressing, and the
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bacterial infection, cytokine enhancement regulation, and appropriate inflamma-
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results showed that this treatment has better wound decontamination and wound
healing capabilities, as well as broad-spectrum antibacterial activity and negligible
cytotoxicity.
CAPS dressing reduced the bacterial growth through the release of calcium,
which has been recommended as an antimicrobial agent [50–55], resulting in supe-
rior bactericidal and bacteriolytic effects compared with other antimicrobial agents
[52–55]. Moreover, the use of alginate derivatives such as antibacterial, antiviral,
and antifungal agents has been revealed by numerous data [56, 57]. Negatively
charged alginates were found to interact with the outer bacterial cellular surface,
which causes disruption and leakage of intracellular substances [58, 59]. Addition-
ally, the ability of alginate modulating the production of toxins, microbial growth,
and factors crucial for microorganism’s stability could be the reasons for its
antibacterial efficacy characteristic. Some varieties of bacteria such as Pseudomonas,
Escherichia, Proteus, and Acinetobacter have been proven to be detained by bacterio-
static activity of alginate [60, 61].
Further, the CAPS dressing treatment has also demonstrated its critical role in
inflammation. Inflammation is a crucial stage to successful burn wound healing.
The release of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, IL-8,
interferon (INF)-γ, and tumor necrosis factor (TNF)-α, after thermal injury is one
of the important systemic inflammatory responses in burn-induced skin damages
[62, 63]. Pro-/anti-inflammatory cytokines act as important modulators of immune
cell proliferation, differentiation, and clonal growth of lymphocyte subpopulations
and also attract immune cells to the site of burn injuries [64], which are substantial
in the process of burn wound recovery.
The involvement of IL-4, IL-6, TNF-α, and MCP-1 was found in the early stages
of the rat’s response to burn injury treated with CAPS dressing [33]. Immune cells
were attracted by these cytokines to the site of injuries to initiate an immune
response right away after burning. The ratio of IL-6 to TNF-α can be used to predict
mortality from sepsis following burn injury [65]. IL-4 and IL-8 may serve as pre-
dictive biomarkers of mortality from sepsis and/or multiple organ failure (MOF)
[66]. In addition, MCP-1, an initiator of typ. 2 T-cell generation and an indicator of
bacterial infection, is essential for optimal microbial elimination [52]. The involve-
ment of MCP-1 in Gram-positive bacterial infections has been demonstrated in the
control of Listeria monocytogenes infections [53]. Chan et al. [67] and Thomas et al.
[24] have also revealed the similar results both in vitro and in vivo. Particularly,
aside from the other chemokines and cytokines, at least fivefold more of IL-1β
secretion was found from CAPS gel treatment compared to agarose and collagen gel
treatment [67]. IL-1β is known as a critical mediator of inflammation which has
substantial roles in neutrophil mobilization, cellular adhesion to the endothelium,
and white blood cell infiltration [68, 69].
Furthermore, the pain is related with the modulation of transforming growth
factor (TGF-β), an important inflammatory cytokine and anti-inflammatory factor
[70–72], that implicated in the pathogenesis of keloids and hypertrophic scarring.
TGF-β also participates in the mechanism of pain signals including peripheral and
central processing [71]. CAPS dressing for burn wound treatment demonstrated
high levels of TGF-β1, TGF-β2, and TGF-β3, suggesting that it might contribute to
reduced pain perception [33]. TGF-β1 is responsible for the fibrotic scarring
response, whereas TGF-β2 and TGF-β3 are responsible for the scarless wound
healing [70]. Another study confirmed that alginate-containing dressings can aug-
ment natural wound healing with inhibition of cytokines associated with fibrosis,
resulting in decreased wound size and increasing epithelial proliferation [73].
Those data correlated very well with the use of CAPS dressing for human skin
wound in the clinical setting recently. CAPS dressings were applied after perianal
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abscess surgery, which was known as an acute suppurative infectious disease that
occurs around the anus, anal canal, and rectum. The results showed that the
expression of a variety of proliferative cytokines increases in the wound treated
with CAPS dressing and helps promote wound healing [74]. The CAPS dressing
treatment also was found to increase the synthesis of collagen and, on the other
hand, inhibit the apoptosis of mitochondrial pathway and death receptor pathway.
Some literatures revealed that calcium ions from Ca-alginate systems [62] and
oligosaccharides derived from polysaccharides (β-glucan, xyloglucan, chitin, pectin,
D-mannuronic, and L-guluronic) can stimulate human cells to produce cytokines
[75, 76]. Especially, enhancement of IL-1β secretion was expected due to the con-
nection between calcium ion-induced mitochondrial damage and activation of the
NLRP3 inflammasome, an important molecular platform expressed by myeloid cells
in innate immune defense [77–79]. Besides, alginate-containing dressings have the
potential to activate macrophages and have the ability to generate a pro-
inflammatory signal which promotes granulation tissue formation [24]. However,
another factor that may be important in cytokine induction not only relates to the
proportions of guluronic to mannuronic acid residues but also their polymeric
arrangement [80].
In summary, because of these properties, CAPS dressings are considered as a
bioactive wound dressing and expected to accelerate the treatment for burn wound
healing. There were few products made from CAPS related to surgery and wound
management previously but, due to the small amount of these fibers used in total
product with high-cost manufacture, it seems not profitable to continue the pro-
duction. With the improved technology lately, CAPS has been developed into
spinning fine dressing as an applicable wound dressing. Together with the increased
understanding of CAPS beneficials in accelerating burn injury treatment, it is
expected that CAPS dressing will give potential value for medical and business field
simultaneously.
5. Conclusion
As the glycosaminoglycan (GAG) has influential roles in the stimulation of rapid
wound healing, calcium alginate polysaccharide (CAPS), which contains a rich
amount of GAG, can be regarded as a remarkable material-based wound dressing
option. Since this material had technically actualized into spinning fibers woven or
non-woven, it is expected that CAPS-containing wound dressing not only gives an
optimal burn injury treatment alternative in medical field but also can rise up the
textile industry value from the business perspective. Owing the significant benefits
as an “active” dressing for burn wound recovery, such as rapid wound closure with
less scarring formation, minimum bacterial infection, cytokine enhancement regu-
lation, and appropriate inflammatory response and pain regulation, which have
been demonstrated in several studies and clinical trials, therefore, the CAPS dress-
ing holds a promising potential as the advisable preference of burn injury treatment
strategies with highly desirable properties.
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Abstract
The work is devoted to the use of collagen materials produced on the basis of 
connective tissues of hydrobionts. Their characteristics as potential means of per-
sonal hygiene and wound healing are investigated. The results of studies of physical 
and chemical characteristics of collagen materials from freshwater fish with a 
modified structure obtained in this paper indicate the prospects of their use as an 
absorbent layer of personal hygiene products, due to the high moisture absorp-
tion capacity, which is an order of magnitude higher than the moisture capacity 
of untreated collagen and higher moisture capacity of superadsorbing polymers 
required for use in personal hygiene products. The resulting material meets the 
requirements of sanitary and epidemiological safety, allergenic action on the skin, 
as can be concluded from the results of tests on animals, it does not. This material 
accelerates reparative processes to the same extent as collagen used in standard 
hemostatic sponges with the simplicity of its production technology, low cost, and 
availability of raw materials.
Keywords: hygiene, human, safety, hydration, moisture capacity, sorption capacity, 
deodorization, collagen, substances, fish raw materials
1. Introduction
Absorbing and deodorizing properties are especially important when improving 
and creating new medical means and materials, including those for individual use 
(personal hygiene).
Presently, the improvement of, for example, the napkins is focused primarily 
on the modification of their shape and design [1–3]; however, less attention is paid 
to a selection of moisture-absorbing layer materials for personal hygiene means, 
and their domestic production (in Russia) is absent. These materials can be divided 
now into three categories, i.e., the synthetics—for example, polyvinyl alcohols, 
polyethylene oxides, cross-linked polyacrylic esters [2]; natural materials—cel-
lulose, guaric or xanthan gum; and modified natural materials—the cross-linked 
starches, sulphitic cellulose, Kraft cellulose [1]. The mixes of polymers of either 
synthetic or natural origin can be used. Particles of these polymers (they are called 
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and chemical characteristics of collagen materials from freshwater fish with a 
modified structure obtained in this paper indicate the prospects of their use as an 
absorbent layer of personal hygiene products, due to the high moisture absorp-
tion capacity, which is an order of magnitude higher than the moisture capacity 
of untreated collagen and higher moisture capacity of superadsorbing polymers 
required for use in personal hygiene products. The resulting material meets the 
requirements of sanitary and epidemiological safety, allergenic action on the skin, 
as can be concluded from the results of tests on animals, it does not. This material 
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1. Introduction
Absorbing and deodorizing properties are especially important when improving 
and creating new medical means and materials, including those for individual use 
(personal hygiene).
Presently, the improvement of, for example, the napkins is focused primarily 
on the modification of their shape and design [1–3]; however, less attention is paid 
to a selection of moisture-absorbing layer materials for personal hygiene means, 
and their domestic production (in Russia) is absent. These materials can be divided 
now into three categories, i.e., the synthetics—for example, polyvinyl alcohols, 
polyethylene oxides, cross-linked polyacrylic esters [2]; natural materials—cel-
lulose, guaric or xanthan gum; and modified natural materials—the cross-linked 
starches, sulphitic cellulose, Kraft cellulose [1]. The mixes of polymers of either 
synthetic or natural origin can be used. Particles of these polymers (they are called 
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the superadsorbing polymers too) may have the form of powder, grains, granules, 
or fibers. Their use in the form of fibers is met more often because in this case the 
extensive capillary network is formed capable of binding a significant amount of 
moisture in macrocapillaries.
In case of choice of materials for functional layer, the preference, as we think, 
should be given to natural or modified natural materials. They do not, as a rule, 
cause allergy; they are environmentally friendly; and in general, they are perfectly 
recognized by the human body. Of all, collagen, particularly, the protein connecting 
tissues of animals, fish, and birds in whose organisms its content is the highest [4], 
belongs to natural materials, which could be used in personal hygiene.
At the same time, collagen is concentrated in the by-products and waste of the 
processing industries of agro-industrial complex [5] that are based on processing 
poultry, meat, and fish. In this regard, the sources of collagen can be considered as 
easily available and inexpensive, and their use for receiving collagenic substances 
decreases environmental pollution. The wide range of technological processing 
and a variety of sources [6–8] give the chance to use collagen not only as a part of 
the absorbing layers but also in other layers of personal hygiene. Collagen plays an 
important role in the implementation of reparative function of connecting tissue 
[9], it is fully compatible with human skin [10]; therefore, effects of irritation, 
discomfort, and other negative effects on skin may be expected as the system will be 
minimized.
Collagen is the fibrillary protein that forms fibrous materials [11–13], i.e., similar 
to cellulose, its fibers can form locks and gaps where water pours and remains 
entrapped. Moreover, like cellulose, collagen can swell and bulk up in water due 
to penetration of water into a structure of the material due to a large number of 
functional groups and their increased hydration ability [14, 15]. This property cre-
ates the prerequisites for use of collagen in the absorbing layers of personal hygiene 
means as the best material capable to compete with cellulose presently in use as well 
as other known materials.
Fish collagen in this regard is of the greatest interest, due to its special rheologi-
cal characteristics facilitating the technological processing (its structure is low 
molecular in comparison with collagen of animals, it does not require obligatory 
hydrolysis when processing raw materials, and the final materials made of fish 
collagen are more elastic) [16]. However, the question of methods of its processing 
is open yet for saving and increasing its water-absorbing ability, and the question 
of sorption ability, especially to aromatic substances, and also its wound healing 
activity are not properly investigated yet.
The wide use of collagen in the cosmetic, medical, and food industries is inter-
fered by its possible allergenicity. Thus, when holding mesotherapeutic procedures 
with collagen injections, allergic reaction develops in ~6% of women [17]. However, 
in this case, it must be taken into consideration that allergic effects are, as a rule, 
found in collagen of animal or sea fish origin. At the same time, for example in  
[18, 19], separate data are given that collagen of fresh-water fish shows minimum 
allergenicity or its total absence in comparison with collagen of sea fish. Yet, the 
results of both fresh-water fish collagen allergenicity research and its processing 
to increase its water-absorbing ability are unknown to the authors of this article. 
Moreover, there are but a few researches of microbiological and toxicological 
indicators of collagen of fish of internal natural reservoirs.
One more very interesting scope of collagen use is the creation of antidecubi-
tal bandages and sheets for people with limited mobility. High requirements of 
water-absorbing ability are obvious in this case. The hemostatic collagenic sponges 
are rather popular [20] having both styptic and aseptic effects and stimulating 
the processes of tissue regeneration. However, they are manufactured by way of 
19
A Study of the Use of Modified Collagen of Freshwater Fish as a Material for Personal Care…
DOI: http://dx.doi.org/10.5772/intechopen.88363
hydrolysis of the collagen extracted by splitting cattle skin. The process of hydro-
lysis is extremely prolonged, and it demands the use of expensive reactants, which 
makes such sponges a very costly product. These shortcomings are eliminated in the 
products from fish collagen but the question of whether they will be able to compete 
with standard sponges’ wound-healing properties requires a separate research.
The purpose of this work is to study the water-absorbing and sorption ability of 
collagen of fresh-water fish, search for opportunities of its increase, and assess the 
effect of a wound-healing, sanitary, and epidemiologic safety and allergenicity of 
the material received through collagen from fresh-water fish from internal natural 
basins of Russia.
2. Materials and methods
The objects of research were the collagenic product received by special process-
ing of skins of pond fish using the author’s technology (cf. the Russian Federation 
Patent No. 2614273). Skins of the silver carp were used, which is a valuable source 
of proteins among which the prevailing fraction is collagen [21]. Skins of fish were 
processed in weak solutions of alkalis and organic acids, and the received prepara-
tions were dried up with lyophilic process, in the course of which the material got a 
sponge form.
For the research of swelling capacity of the received material, the preset amount 
of water was used, and in our case, it was 20 ml, previously weighing the cup for 
processing and the studied material, measured the change of mass of water without 
sponge was measured when the constant volume of free liquid was eached, then the 
change of mass of a sponge was recalculated.
The research on the effect of a wound-healing property was made by histo-
logic and histochemical methods [22] on animals of the same age received from a 
vivarium and the laboratories of the Voronezh State Medical University of N. N. 
Burdenko.
The first stage of research was carried out on animals and then on the human 
patient. All animals passed the quarantine, and they had no symptoms of diseases 
and received a standard diet. The average mass of an animal was 300 ± 25 g, and the 
dispersion of initial weight did not exceed 15%.
The research was made on 168 laboratory white rats divided into three groups: 
two of them are control and one is the main (see Table 1).
Wound modeling was carried out with the modified Sychennikov’s technique 
(1974). Under ester anesthesia in aseptic conditions on the skin spot shaved from 
wool, after processing of skin with antiseptic solution, using the disposable medi-
cal scalpel a linear section of skin 1 cm long was made on the external surface of 
an average one-third of a hip, a fastion and the muscles. Soft tissues were clipped 
to extend the cut and warmed up. The area of wounds before an initiation of 
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between the groups. The treatment of the second control group and the main group 
was applied right after the modeling of wounds.
In the first control group, the treatment was not used. In the second control 
group, the treatment of wound was made by washing it directly after modeling 
with 5 ml of 0.9% solution of sodium chloride and introduction into a wound of a 
standard collagenic sponge, which was cut out to fit the area of wound for its full 
closing. In the main group unlike the second control group used an analog of a 
standard sponge made of fish raw materials was used.
The dynamics of wound process arresting was estimated on the basis of the 
research methods listed below:
1. Clinical methods: the general condition of animals, indicators of a course of 
wound process (defect closing speed, exudation, presence of necrotic masses, 
emergence of granulations, epithelization, etc.).
2. Planimetric methods: the control of the area of a wound by the technique 
of Popova/the tsellofanografic method/and its dynamics. For calculation of 
percent of a daily change of the wound area, the following formula was used: 
% S = (S–Sn/S)*100%, where S is the area of a wound at the previous meas-
urement; Sn is the area of a wound at the current measurement.
3. Histologic methods: to study the dynamics of histologic changes, the excision of 
tissue was made on the first, third, seventh, and eleventh day after the initiation 
of treatment with capture of an intact skin, a bottom and edge of a wound to a 
size 1.0 × 1.0 × 0.5 cm. The received material was fixed in the 10% solution of 
neutral formalin, dehydrated, further the 6 microns thick paraffin cuts were made 
and painted with hematoxylin-eosin and studied in a light microscope according 
to Van-Gizona. The images were obtained using the cross view of several fields 
of vision and analyzed in the image analysis system LeicaQwinStandartV2.6 
(Leica, Germany), consisting of LeicaDRM microscope equipped with the 
“LeicaDC 300F” digital camera and a computer with the LeicaQ 550W software. 
Micrographs were processed using the Microsoft applications.
3. Histochemical methods
For histochemical research, the painted cuts of collagen samples were photo-
graphed at four hundredfold increase, and then contrasting of the reaction product 
was made equivalent to the histogram using the Threshold function filter allocation. 
For the allocated areas, the area in pixels was determined, which was recalculated 
in micrometers by the photograph with the same device with which the image was 
obtained, and the final object with an area of 1 micron was recalculated into pixels.
Investigation of the content of ribonucleic acid (RNA) with the technique with 
Azur V by Shea was made, which provided the selective identification of nucleatic 
and cytoplasmic RNA and made it possible to carry out the quantitative research of 
RNA content within the Malpighi sprout layer of epidermis.
Processing of cuts in 100% acetic anhydride at room temperature allowed to 
block the potentially reactive amino groups of protein, and the differentiation in 
tertiary butyl alcohol provided the removal of the molecules of Azur V that were 
not connected with RNA.
The content of sulph-hydrylic groups of proteins (SH group) was studied by 
Chevremont and Frederick’s method. This reaction represents the biochemical cys-
teine test at which the insoluble deposit of the Berlin azure is formed. Quantitative 
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assessment of maintenance of SH-group within a Malpighi layer allowed to define 
the extent of maturing and the differentiation of epidermis at various methods of 
wound treatment.
Research of sanitary and epidemiologic safety was made at “The Center 
of Hygiene and Epidemiology in the Voronezh Region” Federal establishment 
(see the Test report No. 9627p of 09.02.2017). Determination of the content of 
heavy metals—arsenic, mercury, and lead—was made by GOST 26927-86, GOST 
30178-96, and GOST 29188.2-9, and hydrogen indicator was measured according 
to GOST 26930-86. The skin-irritant effect of collagenic substances and its impact 
on mucous membranes were determined by the instruction 1.1.11-1352004, and 
the general toxic effect was determined by the alternative in vitro methods accord-
ing to the document No. 29FTs1394 of January 29, 2002. Microbiological indica-
tors were determined by the state standard specifications: (GOSTs) as follows: 
the total of mesophilic aerobic and facultative and aerobic microorganisms—by 
GOST ISO 21149-2013; Candida albicans—by GOST ISO 18416-2013; Escherichia 
coli—in accordance with GOST ISO 21150-2013; Staphylococcus aureus—in accor-
dance with GOST ISO 22718-2013; and Pseudomonas aeruginosa—in accordance 
with GOST ISO 22717-2013.
The research of allergenicity was made in the same conditions (The Protocol on 
technical and toxicological research within the preclinical tests of porous medical 
materials from fish raw materials of July 01, 2014). Allergenic properties of colla-
genic substance of fish origin were studied on guinea pigs with skin applications.
Provocative skin tests were made as follows: before the applications, the sen-
sitization of animals was made by repeated drawing of collagenic dispersion on 
skin. Daily applications were made on three guinea pigs with water dispersions of 
the modified collagen in cultivations on the cut-off site of skin, 1:1; 1:10 and 1:100, 
within 14 days (which corresponds to the duration of the incubatory period).
During the entire period of the experiment, the observed guinea pigs underwent 
measurement of body temperature, thickness of a skin fold on the place of applica-
tion, and temperature on the place of introduction.
4. Results
The graphic dependences reflecting the kinetics of swelling capacity of collagen 
made of fish skin are presented in Figure 1 (curve 1). The swelling capacity, i.e., the 
amount of water, absorbed by the unit of mass at hydration, is the characteristic 
that most adequately reflects the water-absorbing properties of the absorbing layer 
material of personal hygiene means.
In Figure 1, it is clear that the established value of swelling capacity of fish 
skin is approximately 3 g of moisture per 1 g of solid. After fish skin processing 
and receiving the material, its swelling capacity and, respectively, the moisture 
capacity increase approximately by 10 times (Figure 1, curve 2). At the same time, 
the amount of moisture bound with the sample is equal to 30 g per 1 g of solid. 
According to the data [2], the required value of this indicator for the superadsorb-
ing polymer used in personal hygiene means is equal to 10 g of water per 1 g of 
solid. The processing we offered here allows to receive the material comparable or 
surpassing in moisture capacity of the polymers that are traditionally used in the 
absorbing layers of personal hygiene. Producing the collagenic materials from skin 
of fresh-water fish by modification is expedient because it allows to increase a mate-
rial’s moisture capacity.
The results of histologic analysis of experimental animals in the wound healing 
research are the following:
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Chevremont and Frederick’s method. This reaction represents the biochemical cys-
teine test at which the insoluble deposit of the Berlin azure is formed. Quantitative 
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assessment of maintenance of SH-group within a Malpighi layer allowed to define 
the extent of maturing and the differentiation of epidermis at various methods of 
wound treatment.
Research of sanitary and epidemiologic safety was made at “The Center 
of Hygiene and Epidemiology in the Voronezh Region” Federal establishment 
(see the Test report No. 9627p of 09.02.2017). Determination of the content of 
heavy metals—arsenic, mercury, and lead—was made by GOST 26927-86, GOST 
30178-96, and GOST 29188.2-9, and hydrogen indicator was measured according 
to GOST 26930-86. The skin-irritant effect of collagenic substances and its impact 
on mucous membranes were determined by the instruction 1.1.11-1352004, and 
the general toxic effect was determined by the alternative in vitro methods accord-
ing to the document No. 29FTs1394 of January 29, 2002. Microbiological indica-
tors were determined by the state standard specifications: (GOSTs) as follows: 
the total of mesophilic aerobic and facultative and aerobic microorganisms—by 
GOST ISO 21149-2013; Candida albicans—by GOST ISO 18416-2013; Escherichia 
coli—in accordance with GOST ISO 21150-2013; Staphylococcus aureus—in accor-
dance with GOST ISO 22718-2013; and Pseudomonas aeruginosa—in accordance 
with GOST ISO 22717-2013.
The research of allergenicity was made in the same conditions (The Protocol on 
technical and toxicological research within the preclinical tests of porous medical 
materials from fish raw materials of July 01, 2014). Allergenic properties of colla-
genic substance of fish origin were studied on guinea pigs with skin applications.
Provocative skin tests were made as follows: before the applications, the sen-
sitization of animals was made by repeated drawing of collagenic dispersion on 
skin. Daily applications were made on three guinea pigs with water dispersions of 
the modified collagen in cultivations on the cut-off site of skin, 1:1; 1:10 and 1:100, 
within 14 days (which corresponds to the duration of the incubatory period).
During the entire period of the experiment, the observed guinea pigs underwent 
measurement of body temperature, thickness of a skin fold on the place of applica-
tion, and temperature on the place of introduction.
4. Results
The graphic dependences reflecting the kinetics of swelling capacity of collagen 
made of fish skin are presented in Figure 1 (curve 1). The swelling capacity, i.e., the 
amount of water, absorbed by the unit of mass at hydration, is the characteristic 
that most adequately reflects the water-absorbing properties of the absorbing layer 
material of personal hygiene means.
In Figure 1, it is clear that the established value of swelling capacity of fish 
skin is approximately 3 g of moisture per 1 g of solid. After fish skin processing 
and receiving the material, its swelling capacity and, respectively, the moisture 
capacity increase approximately by 10 times (Figure 1, curve 2). At the same time, 
the amount of moisture bound with the sample is equal to 30 g per 1 g of solid. 
According to the data [2], the required value of this indicator for the superadsorb-
ing polymer used in personal hygiene means is equal to 10 g of water per 1 g of 
solid. The processing we offered here allows to receive the material comparable or 
surpassing in moisture capacity of the polymers that are traditionally used in the 
absorbing layers of personal hygiene. Producing the collagenic materials from skin 
of fresh-water fish by modification is expedient because it allows to increase a mate-
rial’s moisture capacity.
The results of histologic analysis of experimental animals in the wound healing 
research are the following:
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One day after the initiation of treatment: In all groups, the skin around the 
wounds was edematous and hyperemic; the palpation in the projection of a wound 
caused anxiety in an animal. The serous and hemorrhagic discharge was noted. In 
the groups where the collagenic sponges and collagenic substance from fish raw 
materials were used (the second control group and the main group), less expressed 
inflammatory reaction was noted visually (i.e., the reduction of hypostasis and 
hyperemia).
In the first control group, the histologic picture of a traumatic inflammation 
came to light: an injury of epidermis, hemorrhage, necrotic masses, or infiltration 
of a significant amount of neutrophilic leukocytes. Muscle fibers were displaced 
owing to intermuscular hypostasis. Connective tissue was inflamed. Hypostasis of 
tissue increased in paravual tissue and was followed by a compression of capillaries 
and venules, interfering with the blood outflow. The increased permeability of the 
vascular wall with an exit in tissue of forming elements and proteinaceous compo-
nents of blood was observed. The most intensive basophyly in the RNA identifica-
tion was observed within the basal and spike layers that indirectly indicate the most 
active metabolic processes at this level. The product of reaction (RNA) was sedi-
mented in the cells of epidermis in the form of a disperse basophyly in cytoplasm, 
and the cells with larger granules were found.
In the second control group, the defect of epidermis was infiltrated densely with 
polymorphonuclear leukocytes, lymphocytes, plasmocytes, and macrophages. The 
expressed plethora and swelling of collagenic fibers were observed. Muscle fibers 
were moved apart owing to hypostasis, and some of them had signs of expressed 
dystrophy and phenomena of myolysis. In intermuscular spaces, the inflammatory 
infiltration was observed, expressed mainly with polymorphonuclear leukocytes.
In the main group in the area of the wound inflammatory reaction, moderate 
necrosis and hypostasis of soft tissue with leucocyte infiltration were observed.
Three days after the initiation of treatment: The behavior of experimental animals 
practically did not differ from the behavior of healthy species.
In the first control group, moderate inflammatory and edematous reactions of 
surrounding tissue were observed, which were less expressed in comparison with 
the first days. Inflammatory infiltrate contained cellular components: leukocytes 
Figure 1. 
Kinetics of swelling capacity G of fish skin before processing in organic acids (curve 1) and after processing 
(curve 2).
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with decaying kernels and isolated tissue basophiles, macrophages, and lympho-
cytes; muscle fibers in the periphery of infiltrate had extended necrosis sites; single 
fibroblasts were visible; and in the wound, bottom isolated centers of granulated 
tissue were observed. Loss of fibrin was noted, which was connected with the walls 
of the wound defect. Insignificant amount of isolated collagenic fibers was observed 
in the mesh dermic layer. The intensity of epithelial cell coloring increased, espe-
cially in the deep layers of epidermis where uniform adjournment of basophile 
material or its localization in a perinuclear zone was observed.
In the second control group, moderate inflammatory and edematous reac-
tion in a paravualny zone was observed, and granulation tissue and vascular and 
capillary network was formed on the surface, containing the visible organized 
(regular) fibrin, fibroblasts, histiocytes, and endoteliocytes, small congestions of 
polymorphic-nuclear leukocytes.
In the main group, the defect of epidermis was reduced, and edges of the wound 
were edematous. Restoration of skin integrity was observed, which was seen in the 
thickening of regional epidermis as a result of activation of reparative regeneration. 
The divergence of muscle fibers was noted due to the inflammatory infiltration fill-
ing the intermuscular spaces, and young granulations were formed in the periphery 
of the wound, which was the proliferative reaction of epidermis and skin elements. 
Collagenic fibers contained numerous infiltrated macrophages, fibroblasts, and 
eosinophilic leukocytes.
Seven days after the initiation of treatment: In the first control group, inflam-
matory reaction became less expressed, and infiltration with inflammation cells 
remained. The surface of the wound was filled with granulation tissue, and micro-
abscesses of various localizations came to light. In the hem formation area, the 
increased quantity of fibroblasts, collagenic fibers wavy with the primary horizon-
tal direction, and small capillaries in the formation phase were observed.
In the second control group, minimum signs of inflammatory reaction were 
observed, and in some wounds, there were leukocytes still, together with the 
expressed collagenic and angiogenesis. The surface of the wound was covered with 
epidermis with underlying granulation tissue enriched with completely filled blood 
vessels and capillaries, with a large number of eosinophils, fibroblasts, histiocytes 
and tissue basophiles, and a significant amount of collagenic fibers. On the periph-
ery, there were the corpulent cells. In the depth of the wound, in intermuscular 
spaces, there was the formation of small capillaries.
In the main group, the restoration of tissue in a zone of wound defect was 
observed, and in the dermic layer, there were the well-formed collagenic fibers and 
granulation tissue.
Eleven days after the initiation of treatment: By the eleventh day, a hem had been 
formed completely in all groups, and the newly formed granulation tissue was clini-
cally observed, which completely covered the wound.
In the second control group, the new epithelized hem was formed.
In the main group, the wound closed completely, and in the dermic layer, new 
collagenic fibers had been formed.
The wound area of all animals decreased in the main group, and in the second 
control groups, it was quicker, compared to that in the first control group  
(see Table 2).
Proceeding from clinical signs (Table 3), it is possible to conclude that after the 
initiation of treatment by the second day in the second control group and in the main 
group, and by the third day in the first control group, complete cut off of inflamma-
tion signs was noted with healing of wounds under a scab strip. It should be noted 
that the signs of inflammation or the first phase of wound process was stopped in the 
main group on average for 34–65% earlier compared to the first control group.
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thickening of regional epidermis as a result of activation of reparative regeneration. 
The divergence of muscle fibers was noted due to the inflammatory infiltration fill-
ing the intermuscular spaces, and young granulations were formed in the periphery 
of the wound, which was the proliferative reaction of epidermis and skin elements. 
Collagenic fibers contained numerous infiltrated macrophages, fibroblasts, and 
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Seven days after the initiation of treatment: In the first control group, inflam-
matory reaction became less expressed, and infiltration with inflammation cells 
remained. The surface of the wound was filled with granulation tissue, and micro-
abscesses of various localizations came to light. In the hem formation area, the 
increased quantity of fibroblasts, collagenic fibers wavy with the primary horizon-
tal direction, and small capillaries in the formation phase were observed.
In the second control group, minimum signs of inflammatory reaction were 
observed, and in some wounds, there were leukocytes still, together with the 
expressed collagenic and angiogenesis. The surface of the wound was covered with 
epidermis with underlying granulation tissue enriched with completely filled blood 
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and tissue basophiles, and a significant amount of collagenic fibers. On the periph-
ery, there were the corpulent cells. In the depth of the wound, in intermuscular 
spaces, there was the formation of small capillaries.
In the main group, the restoration of tissue in a zone of wound defect was 
observed, and in the dermic layer, there were the well-formed collagenic fibers and 
granulation tissue.
Eleven days after the initiation of treatment: By the eleventh day, a hem had been 
formed completely in all groups, and the newly formed granulation tissue was clini-
cally observed, which completely covered the wound.
In the second control group, the new epithelized hem was formed.
In the main group, the wound closed completely, and in the dermic layer, new 
collagenic fibers had been formed.
The wound area of all animals decreased in the main group, and in the second 
control groups, it was quicker, compared to that in the first control group  
(see Table 2).
Proceeding from clinical signs (Table 3), it is possible to conclude that after the 
initiation of treatment by the second day in the second control group and in the main 
group, and by the third day in the first control group, complete cut off of inflamma-
tion signs was noted with healing of wounds under a scab strip. It should be noted 
that the signs of inflammation or the first phase of wound process was stopped in the 
main group on average for 34–65% earlier compared to the first control group.
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Histochemical indicators of wound process are shown in Table 4, which shows 
that in all stages of its healing in the main group, the RNA level and SH-group are 
higher than in the first and second control groups. It prompts the actively going 
metabolic processes and approximately high rates of maturing and differentiation 
of epidermis.
When comparing the morphology of wounds, more expressed positive dynam-
ics of healing of wounds in the second control and main groups is noted, revealed 
by the earlier decrease in tissue puffiness, organization of fibrin, and formation of 
collagen. It is established that the collagenic material imposed on a wound surface 
promoted local hemostatic action.
The analysis of toxicity of active ingredients showed that the acute state is not 
revealed in the experiment. Deviations of frequency of respiratory movements and 
warm reductions were within the norm regardless of the group of animals. Body tem-
perature varied within ±0.7–0.8°C regardless also of the group of animals. The neu-
rologic and behavioral status did not change. The total “Open field” test was 52.4 s, 
and the gravity ‘sagging’ test was 11.2 s. The qualitative analysis of immunoglobulin E 
showed the lack of sensibilization effect on the seventh day of the experiment.
*Reliability of distinctions in comparison with 1-control group r < 0.05.
Table 3. 
Clinical signs of a course of wound process, days.
1Reliability of the distinctions in comparison with basic data;
2Reliability of distinctions in comparison with data of the 1st control group.
Table 2. 
Wound area change dynamics, for animals, mm2.
Table 4. 
Histochemical indicators of wound process.
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Thus, during the course of the experimental study of the wound healing 
process, no distinctions were found between the application of a standard colla-
genic sponge and collagenic substance from fish raw material. In comparison with 
the control group of the animals who did not receive additional treatment the 
data confirming the acceleration of reparative processes in soft tissue under the 
influence of a standard collagenic sponge and collagenic substance from the fish 
raw materials which are especially expressed in the first phase of wound healing 
process that was shown in the stimulation of a collagenic genesis, activation of 
the metabolic processes which are followed by the increased level of reactions 
of RNA and SH-group identification. The conducted pilot studies did not reveal 
toxic and allergic effects of collagenic substance made of fish raw material both 
in the analysis of clinical data and when studying the results of histologic and 
histochemical analysis.
The results of the research of sanitary and hygienic safety of collagenic sub-
stance made of fish collagen are shown in Table 5, which goes to show that devia-
tions from safety standards were not revealed.
In the allergenicity tests during the entire period of the experiment, there were 
no changes in the clinical status of animals and no changes in the skin condition 
over the area of collagenic substance applications. Based on the received results, the 
response on allergenicity was estimated negatively.
The main mechanism of influence of collagen is the implementation of repara-
tive function of connecting tissue. Introduction of collagen-based composition 
of medicines promotes the extension of the medicines’ effect due to high osmotic 
activity providing the dehydrating action on a tissue in the inflammation. Such 
medicines can be used as an effective wound covering [7]. The napkins based on 
collagen impregnated with antibiotics have good compatibility with skin tissue, 
thanks to low allergenicity and biodestruction of collagen. For example, the best 
results of surgical treatment were received for the approbation in Maykop, the 
Republic of Adygea, at the Adygeian Republican Clinical Hospital. During the 
tests, 10 patients with different diagnoses were observed, i.e., acute paraproctitis, 
acute osteomyelitis, postoperative hems, burns, and trophic ulcers. When imposing 
Table 5. 
Results of tests of the modified collagen for sanitary and hygienic safety.
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a collagen-based napkin as a bandage to patients with a sharp paraproctitis, the 
satisfactory condition of the patient, without therapeutic side effects, the lack of 
necrosis, and the formation of granulation tissue, with positive wound healing 
results (Figure 2), were observed.
Collagen-based napkins were applied on the acute osteomyelitis wounds, which 
arose after foot amputation (on the lower extremity, see Figure 3). The results are 
positive, viz., the patient’s satisfactory dynamics without therapeutic side effects 
and stable formation of granulation tissue were observed.
Collagen film covering was applied for the treatment of postoperative hems. The 
results are positive, viz., the patient’s satisfactory dynamics without therapeutic 
side effects and stable formation of granulation tissue and wound healing were 
observed on the fifth day. Film application is shown in Figure 4.
The offered covering allows the wounds, burns, and ulcers to be treated well 
and quickly, and it can be used for treatment of the bleeding traumatic damages, 
flat granulating slow wounds to a stage of regeneration, trophic ulcers, decubi-
tuses, and when healing donor sources. The of wound healing films demonstrate 
the stabilizing properties that remain reliable for a rather long time. Results of 
healing on the sixth day with the use of the collagen-based materials of fish origin 
are shown in Table 6.
Figure 2. 
Dynamics of treatment with application of collagen-based napkins (3 days): (a) result before use of collagen; 
(b) result after use.
Figure 3. 
Dynamics of treatment with collagen-based wipes (3 days): (a) the result before the collagen application;  
(b) the result after the application of collagen.
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5. Discussion
Processing of biopolymers in organic acids is quite often applied for the purpose 
of modification of biomacromolecules and adding to a material the necessary physi-
cal and chemical properties [23–25]. There are also mentions of processing of fish 
collagen organic acids for simplification of its dispergating [26, 27]. It is possible 
due to the processes of destruction of fibers of collagen [28] beginning when the 
processing in acids starts, apparently, it is connected with a rupture of communica-
tions between polypeptide chains of collagen. As a result of change of structure, the 
extensive capillary network where moisture is caught increases the general moisture 
capacity of the studied material.
Identical wound healing action of a standard collagenic sponge based on modi-
fied fish collagen can be explained as follows:
The molecule of collagen of mammals consists of three polypeptide α-chains, 
mutually coiled in a structure of the threefold right twirled superspiral like a three-
vein rope [11] that gives this structure high durability and big molecular weight. 
These chains are connected among themselves by cross links. Distinctive features 
of fish collagen are the ‘single-coil’ structure and the parallel arrangement of poly-
peptide chains, in which molecular mass is much lower than of collagen of mammals 
and it is preserved at the level of a tropocollagen [19]. As a result, fish collagen is not 
strong enough, and the collagen of mammals is possibly not so strongly connected 
with other elements of tissue. Therefore, fish collagen does not require preliminary 
hydrolysis, and when processed in weak alkaline and acid solutions, it is allocated 
easily from fish skins. Then, when in contact with the wound surface, the polypeptide 
chains of fish collagen are built into a structure of a regenerate, similar to the frag-
ments of a molecule of animal collagen after its long hydrolysis in the rigid modes.
Figure 4. 
Application of a collagen film.
Table 6. 
Results of healing for the 6th day.
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From the submitted data on a sanitary and epidemiologic condition of exam-
inees of samples it follows that the studied collagenic substance, contains ions of 
heavy metals in concentration tens times less than the admissible level, it does not 
render the skin irritating and all-toxic action, and an effect on mucous membranes, 
and moreover it contains much smaller amounts of mesophilic aerobic and faculta-
tive and aerobic microorganisms below the admissible threshold. In the studied 
samples, there were no pathogenic microflora at all. Thus, the obtained collagenic 
materials of fish origin are biologically safe, they have an expressed effect on wound 
healing, and the technology of their preparation differs favorably from the process 
of production of standard materials.
Except the excellent moisture-absorbing and wound-healing properties, the 
modified fish collagen has the essential occluding ability. Thus, in [29, 30], the 
high sorption capacity of fish collagenic substances have been proven due to  
the presence of various functional groups, hydrophilic and hydrophobic sites, in 
a molecule structure. This fact allows to assess positively the prospects of col-
lagenic substances’ use as a part of personal hygiene means with a deodorizing 
effect.
6. Conclusion
The results of research of physical and chemical characteristics of collagenic 
materials received in the real work from fresh-water fish with the modified struc-
ture testify to prospects of their use as the absorbing layer of personal hygiene 
means, in view of the high moisture-absorbing ability which is 10 times higher than 
a moisture capacity of the raw collagen and is higher than the moisture capacity of 
the super-adsorbing polymers demanded for use in personal hygiene means. The 
material thus obtained conforms to the requirements of sanitary and epidemiologic 
safety, allergenic action of skin as it is possible to conclude by results of tests on 
animals, it does not render. This material accelerates the reparative processes as 
much as the collagen used in standard hemostatic sponges, having the simplicity 
of technology of its production, low cost, and availability of raw materials. These 
results altogether give the grounds for perspective considerable development of 
domestic production of fish collagenic materials including their use as a part of 
personal hygiene means and surgery.
New environmentally friendly sources for production of collagen—an urgent 
scientific and technical problem of the present as it is popular and proved 
conclusions in biomedical technologies, structure of specialized food for 
rehabilitation and during the post-operational and post-traumatic periods. It 
has an extraordinary demand in cosmetology for the production of cosmetics of 
various functionalities: as a part of shampoos, creams, etc.; for restoration and 
improvement of structure of hair; increase in their volume; and rejuvenation of 
skin. The research of properties and the characteristic of unique biopolymers 
of the collagenic nature shall give way to operate respective technologies in the 
production of food, cosmetics, and medical products and medicines; to extend 
this segment and to stabilize the situation of Russia in the international market; 
and to expand the range and scopes of products of cutting of fish. Thus, it is 
possible to claim that production of collagen from collateral fish raw materials 
answers the principles of rational environmental management and, at last, it is 
economic.
Its application is competitive and perspective both in its original form and for 
the production of foodstuff, medical supplies, and cosmetics in the internal and 
world markets.
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Abstract
Natural biomolecules are increasingly relevant for biomedical applications 
and tissue engineering for being able to produce an effect on chemical signals, 
organization of cells, and restitution of extracellular matrix in lesioned tissues. In 
this chapter, we will address the potential of plant macromolecules, in particular, 
carbohydrates and proteins such as hemicelluloses and lectins. While lectins are 
mostly carbohydrate-binding proteins, which can interact with cell surfaces to 
initiate anti-inflammatory pathways, as well as immunomodulatory functions, 
hemicelluloses are remarkably known by their ability to form viscous solutions even 
at low concentrations, which makes them an excellent candidate as vehicle to carry 
different sorts of biomolecules. Taking into account the complexity of the whole 
healing process, as an overlapping and coordinated cascade of events, most of the 
properties presented here by those materials may be of interest to the wound-care 
market.
Keywords: lectins, galactomannans, biomolecules, polysaccharides
1. Introduction
Skin is the largest organ, which presents a fairly robust arrangement, working as 
a natural shield against physical, chemical, and bacterial damage to the body. When 
it suffers any disruption in this arrangement by means of acute lesions, the skin goes 
through a fascinating repair process finalizing in wound closure and leaving some 
scars. This complex mechanism is dependent on many cell types and mediators 
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1. Introduction
Skin is the largest organ, which presents a fairly robust arrangement, working as 
a natural shield against physical, chemical, and bacterial damage to the body. When 
it suffers any disruption in this arrangement by means of acute lesions, the skin goes 
through a fascinating repair process finalizing in wound closure and leaving some 
scars. This complex mechanism is dependent on many cell types and mediators 
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interacting to maintain the physiological regulation of skin [1, 2]. Chronic wound 
results in situations such as diabetes or vascular lesions, when defective skin usually 
persists causing the loss of integrity, and in some cases, the overlapping of struc-
tural layers, as well as delayed skin tissue recovery [3].
Human body tissues present a wide range of physical characteristics, which 
include stiffness and porosity. A multidisciplinary interface between areas such 
as cell biology, biotechnology, mechanics, materials science, bioengineering, and 
clinical research has been used to contribute significantly to tissue engineering. 
Many wound dressings have been developed seeking to restore and improve tissue 
function by generating new biocompatible substitutes or by rebuilding these tissues 
[4, 5]. However, these sorts of materials are quite costly, which might affect the 
widespread adoption.
From this perspective, an ideal wound dressing would maintain a microen-
vironment in the injured bed and would direct the specific healing properties 
for each type of wound or disease that affects the patient under treatment. The 
dressing should also keep the moisture balance, which works as a barrier of protec-
tion against infections and would provide thermal insulation for the wound [6]. 
Therefore, recent technologies for biomedical applications invest in the develop-
ment of scaffolds able to mimic the natural environment for skin grown and 
regeneration after damage [4].
Polysaccharide-based biomaterials emerge in the field of tissue engineering, as 
they are mainly used as hydrogels for the effective treatment of wounds and skin 
burns. They can be categorized as neutral (e.g., glucans, dextran, and cellulose), 
acids (acid hyaluronic), basic (chitosan) or sulfated polysaccharides (heparin and 
chondroitin). The most popular and naturally produced biomaterials of polysaccha-
ride origin are chitosan, hyaluronic acid, and alginate. These polysaccharides may 
also be subdivided into homopolysaccharides such as glucans, cellulose, dextran and 
chitosan, and heteropolysaccharides such as alginates, agarose, carrageenan, pectin, 
galactomannans and xyloglucans. All exhibit peculiar physicochemical properties 
and a considerable biocompatibility and biodegradability, and thus have important 
applications in biomedical fields [4].
In this chapter, we focus our attention to plant macromolecules such as carbo-
hydrates and proteins (in particular hemicelluloses and lectins) as biomolecules for 
wound healing applications.
2. Wound healing
Wound healing is a critical, complex and highly coordinated process to maintain 
skin function. Immediately after injury, a multitude of molecular and cellular 
systems are activated to suspend blood loss, eliminate microorganisms and foreign 
materials, and recompose injured tissue [3]. These cellular and biochemical events 
in wound repair can be divided into the following steps: hemostasis, inflammatory 
response, cell proliferation and synthesis of the elements that make up the extracel-
lular matrix (ECM), and the later period, called remodeling. These stages are not 
mutually exclusive but overlapping over time [7].
In physiological conditions, platelets circulate in the vicinity of the vascular 
walls and are activated when the continuity of the endothelial layer is ruptured and 
the underlying subendothelial matrix is exposed, initiating the first stage of tissue 
repair, characterized by hemostasis and the formation of a matrix in the wound 
bed. This matrix is the result of the adhesion and aggregation of circulating platelets 
to the components of the underlying ECM. Damaged tissue and aggregated platelets 
trigger extrinsic and intrinsic coagulation pathways to stabilize the fibrin platelet 
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clot. This whole process forms a framework for the migration and proliferation 
of other cells involved in wound healing, as well as a reservoir for cytokines and 
growth factors [8].
The inflammatory phase then begins as an innate immune response to promote 
the elimination of cellular and extracellular debris as well as pathogenic microor-
ganisms. Both platelets and leukocytes release inflammatory cytokines providing 
a chemotactic gradient for additional leukocytes to be attracted and potentiate 
the inflammatory process. Among the inflammatory factors are interleukin IL-1α, 
IL-1β, IL-6, IL-8, tumor necrosis factor (TNF-α), platelet-derived growth factor 
(PDGF) and transforming growth factor-β. Clearly, PDGF plays an important role 
early in the chemotaxis of neutrophils, monocytes, smooth muscle cells and fibro-
blasts, while TGF-β stimulates cytokine secretion from macrophages and enhances 
chemotaxis of fibroblasts and smooth muscle cells [9].
The initial leukocyte response is dominated by neutrophils in the first 2–5 days, 
with macrophages taking over from the third day. Neutrophils have three main 
functions. First, they generate free radicals via the myeloperoxidase pathway to kill 
bacteria, an important action for healing because wounds that have bacterial infec-
tion will not heal normally. They also debride the wound through the secretion of 
specific proteolytic enzymes that break non-viable tissue, such as serine proteases 
and matrix metalloproteinase (MMP-2 and -9). Hence, the neutrophils phagocyte 
the dead bacteria and the remained matrix. They usually undergo apoptosis when 
their tasks are completed and are cleansed by macrophages [9, 10].
The monocytes begin to migrate to the wound and mature into macrophages. 
They become the most important regulatory cell in the inflammatory reaction. In 
the early stages of inflammation, M1 phenotype macrophages are associated with 
the phagocytic activity of remaining bacteria, sequestration and production of 
pro-inflammatory mediators. After this period, M1 becomes the subset M2, reveal-
ing a reparative phenotype of macrophages [1]. M2 macrophages are involved in the 
synthesis of anti-inflammatory mediators and tissue cleansing. These cells remove 
obsolete neutrophils, non-functional host cells, damaged matrix, and foreign debris. 
M2 cells also secrete various cytokines, growth factors and other mediators, such as 
TGF-α, TGF-β, basic fibroblast growth factor (β-FGF), PDGF and vascular endo-
thelial growth factor (VEGF) to amplify and resolve inflammation. At this stage 
of healing, macrophages regulate the proliferative stage by stimulating fibroblasts, 
keratinocytes and endothelial cells to differentiate, proliferate and migrate, leading 
to new ECM deposition, re-epithelialization and wound neovascularization [11].
The goal of the proliferative stage is to decrease the area of contracted tissue 
and fibroplasia, establishing a viable epithelial barrier to activate keratinocytes. 
TGF-β stimulated fibroblasts differentiate into myofibroblasts rich in alpha smooth 
muscle actin and can amplify pseudopodia, joining fibronectin and collagen in the 
ECM. This event provides wound contraction, which is important in the repair 
process, helping the edges of the wound approach. These cells are also producers 
of ECM substances (collagen, fibronectin, glycosaminoglycans, proteoglycans and 
hyaluronic acid), which interact with the cells to mediate migration, growth and 
differentiation. This stage is characterized by the lesion closure, which includes 
angiogenesis, fibroplasia and re-epithelialization [7, 12].
The final stage of wound healing is characterized by the development of new 
epithelium and formation of scar tissue, a process known as remodeling, which can 
last for a year or stay for a longer period. The main purpose of the remodeling step 
is to achieve maximum tensile strength through reorganization, degradation and 
resynthesis of ECM. Together with intracellular matrix maturation, collagen bun-
dles increase in diameter, whereas hyaluronic acid and fibronectin are degraded. 
The force of traction of the wound progressively increases with the deposition of 
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interacting to maintain the physiological regulation of skin [1, 2]. Chronic wound 
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clot. This whole process forms a framework for the migration and proliferation 
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collagen, and these fibers can recover approximately 80% of the force compared to 
normal tissue, but the force of the original tissue can never be recovered again [12].
As demonstrated, many factors can alter positively or negatively the cell inter-
actions and the signaling mechanisms during the wound healing process. Plant-
derived compounds are among these factors and are able to improve the healing 
process through different mechanisms.
3. Plant-derived compounds
Medicinal plants have been extensively used worldwide as traditional treatment 
for various diseases due to being a source of phytochemicals, which are nonnutri-
tive substances present in plants enhancing tissue regeneration and acting as 
pro-angiogenic agents for wound healing. In addition, bioactive products extracted 
from plants arouse scientific and commercial interests for the development of new 
drugs [13]. On the other hand, plants are also source of many macromolecules such 
as carbohydrate and proteins extensively used as biomaterials for wound healing 
applications.
3.1 Essential oils
Essential oils (EOs) are the largest group of secondary metabolites biosynthe-
sized by plant as a complex of monoterpenes (10 carbons) and sesquiterpenes (15 
carbons), mainly related to plant defense mechanisms. Also known as volatile oils 
or aromatic plant essences, they can be found in a multitude of plant tissues such 
as flowers, leaves, barks, etc. Obtained by aqueous extraction or steam distillation, 
or cold pressing in the case of citric fruits, they have been extensively employed in 
cosmeceuticals and dermaceutical products [14, 15].
In the healing process, the OEs stand out for their anti-inflammatory and 
antimicrobial properties. The efficacy in inhibiting bacterial development, includ-
ing antibiotic-resistant strains, yeasts and filamentous fungi, has boosted the study 
of the antimicrobial activity of essential oils. Some oils extracted from medicinal 
plants demonstrated therapeutic potential in combating biofilms, a mechanism of 
virulence produced by pathogenic microorganisms, resistant to antibiotics [16]. 
Carvacrol and Thymol, for example, are monoterpenes widely found in essential 
oils Origanum genus, presenting antibacterial and antifungal activities [17] in addi-
tion to analgesic effect [18]. In several studies, it has been reported that interactions 
between the components of EOs, even in small concentrations, may lead to antago-
nistic, additive or synergistic effects [15].
Although EOs are a mix of plant molecules with many applications such as anti-
microbial, anti-inflammatory, besides potential healing properties, as stated above, 
we draw our attention here to plant polysaccharides and lectins.
3.2 Carbohydrates
Essentially, seeds play an important role in the reproductive strategies of certain 
species and represent a critical phase in life cycle of plants. Also, they play a vital 
role in diet and human health, which fosters a wide range of potential applications 
explored by science and technology. Substantial contributions to human well-being 
and health have emerged from these applications in fields such as the development 
of biopharmaceuticals [19].
All cells in higher plants present in their cell wall a complex network formed by 
numerous polymers including cellulose, non-cellulosic polysaccharides (pectin), 
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structural glycoproteins and, on the secondary wall, lignin. A singular characteris-
tic of plant cell walls is the presence of cellulose, consisting of glucose chains linked 
to β-(1→4), organized in microfibrils [20, 21]. Intertwined with these microfibrils, 
a series of hemicelluloses, which are polysaccharides that have similar characteris-
tics to cellulose, are found crosslinked to it.
3.2.1 Plant cell wall polysaccharides
Cell wall polysaccharides can be divided into structural and storage polysac-
charides. Primary and secondary walls contain cellulose and hemicelluloses, pectin 
in addition to enzymes and structural proteins, while the secondary walls contain 
few proteins or pectin, but usually contain lignin. Secondary cell walls appear 
when the cell interrupts its growth and often exhibit elaborate specializations for 
which the incorporation of lignin is usually the most distinctive characteristic. 
Therefore, the secondary walls of cotyledonary and endospermic cells in seeds of 
many species do not have lignin and contain low cellulose [22, 23].
On the other hand, in some seeds, cell wall of storage tissues (endosperm or 
cotyledon) is quite thick and contains deposits of polysaccharides, which are mobi-
lized after germination. These polysaccharides are called cell wall storage polysac-
charides (CWSPs) and are split into: mannans; galactomannans and glucomannans; 
xyloglucans and galactans [22].
Storage polysaccharides are mostly water soluble and form viscous and stable 
dispersions, normally absorbing a large amount of this solvent. It assures water 
around the embryo during the imbibition and germination process, helping protect 
against dehydration [22].
3.2.1.1 Galactomannans
Galactomannans are neutral cell wall polysaccharides, commonly found in 
endosperm of dicotyledonous seeds. They perform the storage function, being 
usually catabolized to provide energy and carbon skeletons to the plant during 
germination. They are more abundant in seeds of Leguminosae family in which the 
four major sources of commercial importance are locust bean (Ceratonia siliqua), 
guar (Cyamopsis tetragonoloba), tara (Caesalpinia spinosa Kuntze) and fenugreek 
(Trigonella foenum-graecum L.) [24].
As can be seen in Figure 1, galactomannan are heterogeneous polysaccharides 
presenting a linear chain of D-mannopyranose residues linked by β-glycoside bonds 
(1→4) with D-galactopyranosyl attached to these via α-type glycosidic bonds 
(1→6). In spite of this structure, galactomannans are also called hemicelluloses, 
Figure 1. 
General structure of galactomannan, considered a hemicellulose by sharing the equatorial β-(1→4)-linked 
backbone with cellulose. Galactosyl residues are attached to the main backbone by α-glycosyl bonds.
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structural glycoproteins and, on the secondary wall, lignin. A singular characteris-
tic of plant cell walls is the presence of cellulose, consisting of glucose chains linked 
to β-(1→4), organized in microfibrils [20, 21]. Intertwined with these microfibrils, 
a series of hemicelluloses, which are polysaccharides that have similar characteris-
tics to cellulose, are found crosslinked to it.
3.2.1 Plant cell wall polysaccharides
Cell wall polysaccharides can be divided into structural and storage polysac-
charides. Primary and secondary walls contain cellulose and hemicelluloses, pectin 
in addition to enzymes and structural proteins, while the secondary walls contain 
few proteins or pectin, but usually contain lignin. Secondary cell walls appear 
when the cell interrupts its growth and often exhibit elaborate specializations for 
which the incorporation of lignin is usually the most distinctive characteristic. 
Therefore, the secondary walls of cotyledonary and endospermic cells in seeds of 
many species do not have lignin and contain low cellulose [22, 23].
On the other hand, in some seeds, cell wall of storage tissues (endosperm or 
cotyledon) is quite thick and contains deposits of polysaccharides, which are mobi-
lized after germination. These polysaccharides are called cell wall storage polysac-
charides (CWSPs) and are split into: mannans; galactomannans and glucomannans; 
xyloglucans and galactans [22].
Storage polysaccharides are mostly water soluble and form viscous and stable 
dispersions, normally absorbing a large amount of this solvent. It assures water 
around the embryo during the imbibition and germination process, helping protect 
against dehydration [22].
3.2.1.1 Galactomannans
Galactomannans are neutral cell wall polysaccharides, commonly found in 
endosperm of dicotyledonous seeds. They perform the storage function, being 
usually catabolized to provide energy and carbon skeletons to the plant during 
germination. They are more abundant in seeds of Leguminosae family in which the 
four major sources of commercial importance are locust bean (Ceratonia siliqua), 
guar (Cyamopsis tetragonoloba), tara (Caesalpinia spinosa Kuntze) and fenugreek 
(Trigonella foenum-graecum L.) [24].
As can be seen in Figure 1, galactomannan are heterogeneous polysaccharides 
presenting a linear chain of D-mannopyranose residues linked by β-glycoside bonds 
(1→4) with D-galactopyranosyl attached to these via α-type glycosidic bonds 
(1→6). In spite of this structure, galactomannans are also called hemicelluloses, 
Figure 1. 
General structure of galactomannan, considered a hemicellulose by sharing the equatorial β-(1→4)-linked 
backbone with cellulose. Galactosyl residues are attached to the main backbone by α-glycosyl bonds.
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and variations in this Gal/Man ratio cause significant changes in physicochemical 
parameters such as average molecular weight, intrinsic viscosity and polydispersity 
of this natural polymers. In addition, the solubility in water is significantly affected 
by this sugar ratio, which may vary depending of source and isolation procedure. 
As observed, the higher is the main backbone substituted by galactosyl residues, the 
more is soluble the galactomannan in water [25].
3.2.1.2 Xyloglucans
Xyloglucans are plant polysaccharides with both structural and storage function, 
found in the primary cell wall of cotyledon of various seeds. Their main chain consists 
of D-glucopyranose linked by β-(1→4) and branched in O-6 by α-D-xylopyranoside 
units, which can also be substituted in O-2 by units of β-D-galactopyranosyl [22]. 
This group of polysaccharides plays a fundamental role controlling cell expansion. 
Experimental results evidenced xyloglucans associated with microfibrils, suggesting 
that like other hemicelluloses, they are able to provide mechanical resistance and 
physical integrity to the complex arrangements in plant cell walls [26].
With reference to this association to cellulose, xyloglucans are bound via hydro-
gen bonds and due to their long polysaccharide chains, they assure the maintenance 
of network microfibrils in cell wall expansion [22]. Figure 2 displays the common 
structure of storage xyloglucans, which make them able to form hydrogels and 
films solutions to be molded in wound dressings able to carrier potential healing 
molecules [27].
3.2.2 Exudate gums (Arabic, tragacanth and cashew gum)
Exudate gums are hydrocolloids of high molecular weight and viscous appear-
ance, derived from the exudates of branches and bark of the trunks of some plant 
species. In order to obtain these compounds, a process called gummosis must occur, 
phenomenon generated as a physiological defense response by chemical, physical 
and biological stimulus [28]. Chemically, they are made of a complex structure 
found in arabinogalactans, galacturonans, glucoronomannan or glucoronoman-
nan of acid nature, branched and replaced by major elements (C, H, O and N), 
inorganic ions and secondary metabolites synthesized from the phenylpropanoid 
pathway (tannins, terpenoids and other phenolic compounds) [29].
Arabic gum (AG) is a polysaccharide with complex and branched structures 
(adhesive and cohesive properties) composed of side and main-chains with 
Figure 2. 
Xyloglucan structure. As a hemicellulose, they have a backbone composed of β-(1,4)-linked glucans, and 
conversely to galactomannan structure, xyloglucans present β-(1,2)-linked galactosyl residues. This latter can 
also be found branched with an α-l-fucosyl residue. However, storage xyloglucan is not fucosylated.
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β(1,3) and (1,6), respectively, and D-galactopyranosyl, α-L-arabinofuranosyl, 
α-L-rhamnopyranosyl and β-D-glucopyran units. In some cases, GA is covalently 
associated with protein fractions and a high content of hydroxyproline, leucine, 
serine and proline residues [30]. Among its recognized pharmacological properties, 
we can cite its performance as mucous and intestinal anti-inflammatory, antibacte-
rial and antioxidant, biochemical factors that are probably influential in the wound 
healing process [31–33].
Tragacanth gum (TG) is an anionic acid branched hetero-polymer with residual 
units of arabinose, glucose, xylose, galactose rhamnose, fucose and galacturonic 
acid [32], and TG has important biological characteristics, such as biodegrad-
able and biocompatible biomaterials, resulting in suitable materials in the design 
of hybrid scaffolds with pharmaceutical applications, development of polymeric 
systems for controlled release of drug and guided tissue regeneration [34].
Similar to the polymer gums described above, cashew tree gum is extracted from 
Anacardium genus species, which are abundant Brazilian Northeast. The chemical 
structure is composed of a main-chain of β-galactose (1–3) and branched-bonds 
(1–6), containing side-residues of glucuronic acid, 4-O-methyl glucuronic arabi-
nose, rhamnose, xylose, glucose and mannose [32]. The biochemical characteristics 
associated with biological activities demonstrate anti-inflammatory properties, 




Latex is produced and stored by laticifer ducts found in some plant species. This 
fluid is a rich source of natural compounds such as secondary metabolites, glyco-
sides and proteases [36]. Latex proteins have been studied by several researchers as 
innovative natural compounds for biomedical applications [37]. Among the most 
common macromolecules from protein origin are cysteine and serine peptidases, 
also known as latex proteases or latex peptidases. These macromolecules provide 
the front line of defense against natural enemies in plants acting by synergism with 
others latex sap proteins [36].
Proteases are also present in animals and humans, and these enzymes have 
gained notoriety in medical and pharmaceutical field due to their proteolysis func-
tions, specificity and bioactivity [38]. In human biological systems, proteases such 
as metalloproteinases are endogenously released by fibroblasts, macrophages, mast 
cells and endothelial cells after injury in extracellular matrix [39]. These enzymes 
initially participate in the inflammatory phase of healing by debriding the wound 
necrotic tissue and contributing to collagen remodeling and reduction of scar ten-
sile strength, the later phase of cicatricial process [40]. Proteases and their inhibi-
tors also contribute to degradation and deposition of ECM, creating a balance that 
is essential for the adequate and coordinated cutaneous wound healing [41].
The modulation of ECM proteases with laticifer proteins has been used as a 
strategy to improve the performance of healing processes in acute and chronic 
wounds [42]. Recent advances in plant latex biotechnology has contributed to 
study the pharmacological properties of proteases-rich fractions from Calotropis 
procera latex revealing its potential role in procoagulation and blood clot hydrolysis 
[43], modulation of inflammation [44, 45] and enhanced wound healing in animal 
models using biomembranes of polyvinyl alcohol as vehicle for releasing laticifer 
proteins [46, 47]. In addition, a phytomodulatory galactomannan-based hydrogel 
has been successfully used to carrier latex proteases from C. procera in experimental 
Wound Healing
38
and variations in this Gal/Man ratio cause significant changes in physicochemical 
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initially participate in the inflammatory phase of healing by debriding the wound 
necrotic tissue and contributing to collagen remodeling and reduction of scar ten-
sile strength, the later phase of cicatricial process [40]. Proteases and their inhibi-
tors also contribute to degradation and deposition of ECM, creating a balance that 
is essential for the adequate and coordinated cutaneous wound healing [41].
The modulation of ECM proteases with laticifer proteins has been used as a 
strategy to improve the performance of healing processes in acute and chronic 
wounds [42]. Recent advances in plant latex biotechnology has contributed to 
study the pharmacological properties of proteases-rich fractions from Calotropis 
procera latex revealing its potential role in procoagulation and blood clot hydrolysis 
[43], modulation of inflammation [44, 45] and enhanced wound healing in animal 
models using biomembranes of polyvinyl alcohol as vehicle for releasing laticifer 
proteins [46, 47]. In addition, a phytomodulatory galactomannan-based hydrogel 
has been successfully used to carrier latex proteases from C. procera in experimental 
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excisional wound models. It was observed a synergic effect between both galacto-
mannan and proteases macromolecules, enhancing the healing [48].
3.3.2 Lectins
Lectins (from Latin “legere,” to pick out or choose) are proteins or glyco-
proteins found in nonimmune nature which can specifically recognize and 
reversibly bind carbohydrate moieties without altering the covalent structure of 
their glycosyl ligands. Indeed, this attractive characteristic distinguishes lectins 
from other carbohydrate binding proteins and enzymes. They are also widely 
distributed in the plant kingdom, usually from leguminous seed origin and play 
crucial roles and functions in biological processes such as molecular recognition, 
storage proteins and plant defense mechanisms. Their interaction with glycosyl 
ligands occurs mainly through hydrogen bonds, van der Waals’ forces, hydro-
phobic interactions and, less frequently, electrostatic interactions [49]. Here, we 
emphasize lectins from jackfruit, breadfruit and chempedak (Figure 3) and their 
biological applications.
Lectins were first discovered in plants and, although ubiquitously distributed 
in nature (animals, insects, viruses, fungi and bacteria), and the majority have 
been characterized from plant protein extracts, reflecting ease of extraction and 
relatively high yields usually via a simple one-step affinity chromatographic method 
[50]. After the discovery of jacalin, novel lectins sharing high homology to it were 
placed into a family of jacalin-related lectins (JRL), now divided into two different 
subgroups. The first comprises galactose-specific lectins (gJRL) and a few other 
Moraceae lectins, which exhibit specificity toward galactose and are built up of sub-
units consisting of a short β chain and a long α chain. The second is the mannose-
binding subgroup (mJRL), which occurs in different plant families with the lectins 
exhibiting exclusive specificity toward glucose/mannose residues with the binding 
subunits contained within a single polypeptide chain [51, 52].
Figure 3. 
Artocarpus species. (A) Jackfruit. (B) Cut section of jackfruit. (C) Jackfruit seeds. (D) Breadfruit  
(var. seminifera). (E) Cut section of breadfruit (var. seminifera). (F) Breadfruit (var. seminifera) seeds.  
(G) Breadfruit (var. apyrena). (H) Cut section of breadfruit (var. apyrena). (I) Chempedak.
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3.3.2.1 Artocarpus lectins
Artocarpus is a genus comprising about 60 trees and shrubs of Southeast Asian 
and Pacific origin, belonging to the Moraceae family; all species are lactiferous with 
leaves, twigs, and stems producing milky sap. The name is derived from the Greek 
words artos (“bread”) and karpos (“fruit”). Although most species of Artocarpus 
are restricted to Southeast Asia, such as A. hypargyreus (kwai muk), A. lakoocha 
(lakoocha), A. kemando (pudau), A. hirsutus (anjily), A. chama (chaplaish) and 
A. odoratissimus (marang), several species are widely distributed and cultivated 
throughout the tropics due to their edible fruits and timber. These include A. hetero-
phyllus (jackfruit), A. altilis and A. integer (cempedak, also known as chempedak) 
[53–55], well-known species conspicuous as substantial sources of plant lectins 
which are readily recovered from their seed flour.
3.3.2.1.1 Jackfruit (jacalin, ArtinM and jackin)
The species has an extensive record of use in folk medicine including treatment 
of asthma, dermatitis, anemia, diarrhea and fever; antisyphilitic and anthelmintic 
properties; sedative effects in convulsions; and also wound healing properties [56]. 
Indeed, jackfruit are in high demand in areas such as cosmeceutical, pharmaceutical 
and natural food handling for supplement markets, due to numerous studies on 
phytochemical and pharmacological properties of all parts of the plant (pulp, leaf, 
root and bark) [57, 58].
Extracts and metabolites from jackfruit possess several useful bioactive com-
pounds and may confer multiple health-promoting effects for heart and skin 
disorders and to treat ulcers and cancer [59]. Moreover, new studies of jackfruit 
properties provide additional biological findings consistent with antibacterial, 
antitubercular, antiviral, antifungal, antiplatelet and antiarthritic actions, thereby 
indicating therapeutic applications [56].
The occurrence of jacalin, the D-galactose-binding lectin from A. integrifolia 
seeds was first reported in 1979 [60] and found to exceed 50% of the protein in 
jackfruit crude seed extracts. This is also the case for galactose-binding lectins in 
the Artocarpus genus such as frutalin and CGB (chempedak galactose-binding). 
Jacalin is a tetrameric two-chain lectin of 65 kDa combining a heavy α-chain of 
133 amino acids and light β-chain of 20–21 amino acid to form a 3D structure as a 
single globular unit. By SDS-PAGE, this lectin shows two bands between 20 and 
14 kDa, which correspond to glycosylated and slightly or non-glycosylated forms, 
respectively [61].
The carbohydrate-binding site (CBS) of jacalin mainly involves residues Gly1, 
Tyr78, Val80, Gly121, Tyr122, Trp123 and Asp125. In D-galactose-jacalin complexes, 
the O4 hydroxyl group of the galactose axial position forms hydrogen bonds with 
the side chain of Asp125 and the terminal amino group of Gly1. If O4 is at the 
equatorial position, as in glucose and mannose, Asp125 can still interact with O4, 
but not the amino group. This explains the high specificity of jacalin for galactose 
compared to glucose and mannose at the primary binding site. Additionally, the 
post-translational cleavage and removal of the “T-S-S-N” peptide linker assure a 
stronger hydrogen bond connecting the α- and β-chains, as non-cleavage leaves a 
neutral peptide NH group [62, 63].
Further studies post-discovery of jacalin revealed that jackfruit seed extracts 
also possess small amounts of a D-mannose-binding lectin [64]. Previously named 
artocarpin, the term was provisionally replaced by the name KM+; the lectin 
had become confused with distinct substances from Artocarpus spp. which were 
Wound Healing
40
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biological applications.
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been characterized from plant protein extracts, reflecting ease of extraction and 
relatively high yields usually via a simple one-step affinity chromatographic method 
[50]. After the discovery of jacalin, novel lectins sharing high homology to it were 
placed into a family of jacalin-related lectins (JRL), now divided into two different 
subgroups. The first comprises galactose-specific lectins (gJRL) and a few other 
Moraceae lectins, which exhibit specificity toward galactose and are built up of sub-
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binding subgroup (mJRL), which occurs in different plant families with the lectins 
exhibiting exclusive specificity toward glucose/mannose residues with the binding 
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words artos (“bread”) and karpos (“fruit”). Although most species of Artocarpus 
are restricted to Southeast Asia, such as A. hypargyreus (kwai muk), A. lakoocha 
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A. odoratissimus (marang), several species are widely distributed and cultivated 
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which are readily recovered from their seed flour.
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The species has an extensive record of use in folk medicine including treatment 
of asthma, dermatitis, anemia, diarrhea and fever; antisyphilitic and anthelmintic 
properties; sedative effects in convulsions; and also wound healing properties [56]. 
Indeed, jackfruit are in high demand in areas such as cosmeceutical, pharmaceutical 
and natural food handling for supplement markets, due to numerous studies on 
phytochemical and pharmacological properties of all parts of the plant (pulp, leaf, 
root and bark) [57, 58].
Extracts and metabolites from jackfruit possess several useful bioactive com-
pounds and may confer multiple health-promoting effects for heart and skin 
disorders and to treat ulcers and cancer [59]. Moreover, new studies of jackfruit 
properties provide additional biological findings consistent with antibacterial, 
antitubercular, antiviral, antifungal, antiplatelet and antiarthritic actions, thereby 
indicating therapeutic applications [56].
The occurrence of jacalin, the D-galactose-binding lectin from A. integrifolia 
seeds was first reported in 1979 [60] and found to exceed 50% of the protein in 
jackfruit crude seed extracts. This is also the case for galactose-binding lectins in 
the Artocarpus genus such as frutalin and CGB (chempedak galactose-binding). 
Jacalin is a tetrameric two-chain lectin of 65 kDa combining a heavy α-chain of 
133 amino acids and light β-chain of 20–21 amino acid to form a 3D structure as a 
single globular unit. By SDS-PAGE, this lectin shows two bands between 20 and 
14 kDa, which correspond to glycosylated and slightly or non-glycosylated forms, 
respectively [61].
The carbohydrate-binding site (CBS) of jacalin mainly involves residues Gly1, 
Tyr78, Val80, Gly121, Tyr122, Trp123 and Asp125. In D-galactose-jacalin complexes, 
the O4 hydroxyl group of the galactose axial position forms hydrogen bonds with 
the side chain of Asp125 and the terminal amino group of Gly1. If O4 is at the 
equatorial position, as in glucose and mannose, Asp125 can still interact with O4, 
but not the amino group. This explains the high specificity of jacalin for galactose 
compared to glucose and mannose at the primary binding site. Additionally, the 
post-translational cleavage and removal of the “T-S-S-N” peptide linker assure a 
stronger hydrogen bond connecting the α- and β-chains, as non-cleavage leaves a 
neutral peptide NH group [62, 63].
Further studies post-discovery of jacalin revealed that jackfruit seed extracts 
also possess small amounts of a D-mannose-binding lectin [64]. Previously named 
artocarpin, the term was provisionally replaced by the name KM+; the lectin 
had become confused with distinct substances from Artocarpus spp. which were 
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similarly designated. Additionally, artocarpin was used to name the galactose-
binding lectin in Artocarpus lakoocha seeds [65].
The origin of the name KM+ comes from the successive affinity chromatography 
steps in immobilized D-galactose matrices to remove jacalin (retained fraction J). 
The unretained fraction was called K, while M+ refers to the retained fraction on 
immobilized mannose matrices. Nevertheless, there remained confusion over this 
adopted nomenclature, which led to the proposal for a rational name change to 
ArtinM based on the universal code for plant proteins. This takes into account both 
a lectin’s origin and specificity of sugar recognition [66]. Hereafter, we will apply 
ArtinM to include early work and mentions of KM+ (artocarpin).
ArtinM is a single polypeptide of 150 amino acids devoid of covalently attached 
carbohydrates with four isolectins and a pI range of 5–6.5, sharing 52% sequence 
identity with jacalin [67]. Unlike jacalin, there are no aromatic residues on the CBS 
of ArtinM, comprising Gly15, Asp138, Leu139 and Asp141. Indeed, it is believed 
that the galactose specificity of jacalin was achieved by a two-step process with 
ArtinM as its putative precursor: mutation of key aliphatic residues close to the 
sugar binding pocket to aromatic ones; and then cleavage of a short loop, a key step 
as it creates a positively charged N-terminal which interacts specifically with O4 at 
the axial position [68, 69].
Besides jacalin and ArtinM, jackfruit seeds are the source of a third lectin named 
jackin due to its affinity for chitin. Nevertheless, its low yield from natural sources 
still hampers further characterization, though this might soon be overcome with 
high-yield heterologous production in microbial systems [70].
3.3.2.1.2 Breadfruit
The Pacific Islands are the center of origin and diversity of breadfruit (A. altilis), 
sometimes referred to as A. communis or A. incisa. The species was derived from a 
seeded, diploid ancestor, A. camansi, giving two varieties, one seeded (var. semi-
nifera) whose rind spines are as prominent as those on jackfruit, and one seedless 
(var. apyrena), which presents a spineless outer layer. The latter is well-appreciated 
by local Brazilians when cooked, because of its large starchy content of compound 
fruits with high levels of minerals and provitamin A carotenoids [53, 55, 71]. 
Breadfruit flour was approved in 2016 by the US Food and Drug Administration 
(FDA) as a food Generally Recognized as Safe (GRAS).
As of 1983, our group started to survey lectins in A. incisa seeds and found 
lectins with similar behavior to those in jackfruit seeds [72]. Breadfruit seeds are 
composed of a high-water content (up to 60%) and moderate protein content 
(12.25% of dry weight). Most of this protein is recovered as frutalin in chromato-
graphic methods using crude extracts of seed flour. Therefore, frutalin is the most 
abundant lectin of this species, presenting multiple-binding properties in which 
the same CBS recognizes a range of different ligands, although it has higher affini-
ties for α-D-galactose monosaccharides and complex carbohydrates that contain 
Galα1–3 glycans [73].
The CBS of frutalin in the binding of galactose is dominated by hydrogen 
bonding through O1, O3, O5 and O6 and backbone/side chain hydroxyl groups. 
Similar to the Moraceae lectins, the CBS of frutalin is located in a domain close to 
the N-terminus of the α chain, consisting of four key residues Gly25, Tyr146, Trp147 
and Asp149. About 10 interactions occur, involving the C1 hydroxyl to residue 
Tyr146, hydroxyl C3 to residue Gly25, hydroxyl C4 to residues Gly25 and Asp149, 
and hydroxyl C6 to residues Tyr146, Trp147 and Asp149 [74]. Moreover, there is 
evidence to suggest that frutalin possesses stereospecificity, capable of specifically 
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binding α-D-galactose, since it was previously isolated on a cross-linked galacto-
mannan column, but not on β-galactosyl-immobilized matrices [73, 75].
Frutapin (FTP) is the next most abundant lectin in breadfruit seed extracts. 
Preliminary, FTP investigations began in 1998, describing three different lectins 
with distinct carbohydrate recognition within the same species [76]. However, 
further studies proved difficult since native FTP was hampered by very low yields 
and contamination with Frutalin, a notable factor as frutalin binds diverse sugar 
moieties and has high abundance in plant extracts. Recombinant FTP production 
is now a feasible approach to circumvent this problem, allowing large-scale heter-
ologous expression to give continuous supplies for further characterization and to 
improve potency, particularly for biomedical applications [77].
FTP is a hololectin defined as a homotetramer with an identical CBS per 
protomer, able to bind either the same or structurally similar sugars. The CBS is 
formed of four residues, namely Gly16, Asp139, Leu140 and Asp142, distributed in 
a few loops connecting the strands β5 and β6, β7 and β8, and β11 and β12. Several 
hydrogen bonds (HB) occur in FTP-glucose and FTP-mannose complexes involving 
Gly16, Leu90, Gly138, Asp139, Leu140, Asp142 and O3, O4, O5, O6 of the carbohy-
drates. In MD simulations, Lys60 plays an important role forming salt bridges with 
Asp139 in FTP-glucose complexes, reducing the interaction between this former 
residue and mannose and minimizing the repulsion of the mannose hydroxyl groups 
with oxygen. In this case, mannose was more completely surrounded in the carbo-
hydrate-binding site and also stabilized by indirect interaction with Asp139 through 
water molecules. This local structuring is more stable in the case of mannose than 
glucose, indicating a higher affinity of FTP for mannose residues than glucose [78].
Further studies of breadfruit seeds also revealed a lectin similar to jackin, named 
frutackin. Both lectins have a 14 kDa polypeptide chain, built up of three chains 
linked by disulfide bonds, the partial amino acid sequences of the two lectins show-
ing their homology to each other in terms of molecular mass, secondary structure, 
and primary sequence, but not to other plant chitin-binding proteins. Both jackin 
and frutackin inhibit the growth of F. moniliforme and S. cerevisiae [70].
3.3.2.1.3 Chempedak
Although widely known in the tropics as chempedak or chempedak, Artocarpus 
integer (Thumb.) Merr. is native to India with similar fruits to jackfruit. The A. integer 
species is rich in phenolic compounds, presenting a strong cytotoxic activity against 
murine leukemia P-388 [79]. Moreover, a chempedak paste of the inner bark prevents 
infection and helps healing when applied on wounds, as well as heated leaf extract [80].
Chempedak galactose-binding lectin (CGB) is found in high levels A. integer 
seed flour extracts. The lectin’s bioactivity was first noted when extracts were tested 
for selective stimulation of peripheral blood mononuclear cells; at 20 μg/mL CGB 
stimulated proliferation of T-lymphocyte populations [81, 82]. Like frutalin and 
jacalin, CGB is transcribed as a propeptide and then post-translationally processed 
into a typical gJRL lectin, having a 13-kDa α-chain (133 amino acids) and a 2.1-kDa 
β-chain (21 amino acids). CGB has six different amino-acids compared to jacalin, 
giving 97% identity for their amino-acid sequences [83].
As with jacalin complexes, the interactions are well conserved, presenting the same 
CBS. In Gal-CGB complexes, the O atoms on the sugar ring are bound with the side-
chain and main-chain N and O atoms on the α chain (O3 and Gly1 N; O4 and Gly1 N 
and Asp125 OD1; O6 and Trp123 O, Trp123 N and Tyr122 N; and O5 and Tyr122 N). 
Similarly, GalNac-CGB complexes present bound disaccharide in the same region 
though hydrogen bonds (O3 and Gly1 N; O4 and Gly1 N and Asp125 OD1; and O6 
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and Asp125 OD1). Also, there are a number of hydrophobic interactions contributed 
by Tyr78, Gly121 and Tyr122. Although closely related to jacalin’s structure, CGB was 
unable to bind mannose as judged by isothermal calorimetry and co-crystallization 
studies. It is believed that this change in CGB specificity is caused by subtle differences 
in the environment near the sugar-binding site, including solvent molecules.
Extracts of Artocarpus integer seeds are a source of CMB, previously termed 
chempedak lectin-M [84]. The lectin is ~20-fold more abundant than ArtinM in 
crude extracts of A. heterophyllus seeds. Structural studies reveal CMB to be a 64-kDa 
tetramer with some of the polypeptides being disulfide-linked to give dimers. The 
functional activity of CMB was assessed by studying interactions with different iso-
types of human immunoglobulins: strong binding to IgE and IgM was noted, unlike 
CGB and jacalin which strongly interact with IgA1. The lectin also shows a similar 
pattern of carbohydrate binding specificity to ArtinM with Man-α-1–3Man the most 
potent inhibitor, followed by methyl-α-D-mannopyranose and D-mannose [84].
It appears that the Artocarpus genus employs a plurality of lectins, though 
to date few of these lectins have been purified and functionally characterized. 
Nevertheless, a consistent pattern is that Artocarpus seeds contain more than one 
lectin with distinct carbohydrate recognition features [70, 76]. Altogether, the JRL 
family is complex with a vast diversity in biochemical properties and activities, 
which have drawn much attention because of their pivotal biomedical applica-
tions. Owing to carbohydrate-binding interactions of plant lectins with cell wall 
glycoproteins, they are promising targets to selectively modulate immune responses 
in plants. Hence, it is important to delineate the molecular details of lectin bind-
ing to CBS domains and how downstream activation of cellular immune signaling 
proceeds [85]. In this context, it is of particular note that Artocarpus lectins have a 
distinct repertoire of biological activities, despite their high sequence and structural 
homology, as can be seen in Figure 4.
Figure 4. 
Sequence alignment using Clustal W and structural superposition of Artocarpus lectins. (A) Sequence 
alignment of galactose-binding lectins: Jacalin (PDB 1UGW), Frutalin (PDB 5BN6), and CGB (PDB 4AKB). 
(B) Sequence alignment of mannose-binding lectins: ArtinM (PDB 1J4S), frutapin (PDB 5KRP) and CMB 
(PDB 4AKD). (C) Structural superposition of galactose-binding lectins with their carbohydrate interacting 
residues in complex with D-galactose: jacalin (cyan), frutalin (red) and CGB (magenta). (D) Structural 
superposition of mannose-binding lectins with the carbohydrate interacting residues highlighted: ArtinM 
(green), frutapin (yellow) and CMB (blue).
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4. Recent advances using plant biomaterials for wound healing
The worldwide increasing number of chronic-wound patients has driven 
an intense effort in the wound-care market in search of low cost and effective 
wound healing technologies [86]. Therefore, much of this knowledge is eligible 
for patents that play an important role in identifying technology development 
trends [86].
In the following table, we highlight the main efforts in the last 5 years on the 
development of biomaterials using plant macromolecules as source of biomolecules 
with potential for wound healing applications (Table 1).
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5. Conclusion
As an orchestrated sequence of biochemical and cellular events for tissue repair, 
the healing process becomes a challenging in a way to develop a universal dressing, 
attending all the sorts of wound and lesions. It is here that biomaterials are notably 
relevant for biomedical applications once multiple properties of them can be com-
bined in formulations of new treatments strategies of wound healing and repair. 
Many plants have been used traditionally in therapeutic treatments of lesions, 
which make them a remarkable source of biomolecules to wound-care market.
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Modulation of Inflammatory 
Dynamics by Insulin to Promote 




About 5% of the world population is diabetic and are at a risk of slow non-
recoverable wound formation. Estimated 15–25% of diabetic patients develop foot 
ulcers, 6% among them needing clinical attention among which 15–20% will need 
an amputation. This counts for around 50% of all traumatic amputation. Wound 
leads to activation of dynamic inflammatory cascade responsible for the healing 
process. But in diabetes, a persistent rise of pro-inflammatory cytokines and low 
anti-inflammatory cytokines blocks the dynamic cascade. Wounding induces vari-
ous pro-inflammatory cytokines such as IL-1, IL-6, IL-12, IL-18, IFN-γ, and TNFs 
causing accumulation of free radicals leading to inflammation which become per-
sistent in diabetes. Inhibition of proinflammatory cytokines drives the equilibrium 
towards the expression of anti-inflammatory cytokines such as IL4, IL-10, IL-11, 
IL-13, IFN-α, and TGF-β, which is necessary for the wound recovery process. Here 
in this chapter, the inflammatory modulatory roles of different drugs/formulations 
have been discussed to unravel their significance to promote wound recovery.
Keywords: diabetic wound, tissue inflammation, pro-inflammatory cytokines,  
anti-inflammatory cytokines, nanoformulation for wound recovery
1. Introduction
Over the last 25 years, there has been found a four-fold increase in the number of 
diabetes mellitus cases commonly called diabetes [1]. 422 million people worldwide 
in 2016 have been reported to have diabetes mellitus. Diabetes in the year 2012 
was a cause of 1.5 million deaths worldwide; according to WHO (World Health 
Organization), diabetes becomes the 8th leading cause of death [2]. Diabetes melli-
tus is mainly identified by the presence free glucose at high or the chronic level in the 
body fluids like sweat, urine, blood, etc. [3]. The major reason for diabetes mellitus 
among others was the hormone-mediated metabolism regulation failure. Hormones 
like glucagon and insulin play an important role in regulating the level of blood sugar 
or maintaining its balance [4]. The sugar balance in blood is important for perfect 
functioning of human body [5]. High/chronic level of glucose in body fluids is 
responsible for different pathological conditions like infection susceptibility, leading 
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About 5% of the world population is diabetic and are at a risk of slow non-
recoverable wound formation. Estimated 15–25% of diabetic patients develop foot 
ulcers, 6% among them needing clinical attention among which 15–20% will need 
an amputation. This counts for around 50% of all traumatic amputation. Wound 
leads to activation of dynamic inflammatory cascade responsible for the healing 
process. But in diabetes, a persistent rise of pro-inflammatory cytokines and low 
anti-inflammatory cytokines blocks the dynamic cascade. Wounding induces vari-
ous pro-inflammatory cytokines such as IL-1, IL-6, IL-12, IL-18, IFN-γ, and TNFs 
causing accumulation of free radicals leading to inflammation which become per-
sistent in diabetes. Inhibition of proinflammatory cytokines drives the equilibrium 
towards the expression of anti-inflammatory cytokines such as IL4, IL-10, IL-11, 
IL-13, IFN-α, and TGF-β, which is necessary for the wound recovery process. Here 
in this chapter, the inflammatory modulatory roles of different drugs/formulations 
have been discussed to unravel their significance to promote wound recovery.
Keywords: diabetic wound, tissue inflammation, pro-inflammatory cytokines,  
anti-inflammatory cytokines, nanoformulation for wound recovery
1. Introduction
Over the last 25 years, there has been found a four-fold increase in the number of 
diabetes mellitus cases commonly called diabetes [1]. 422 million people worldwide 
in 2016 have been reported to have diabetes mellitus. Diabetes in the year 2012 
was a cause of 1.5 million deaths worldwide; according to WHO (World Health 
Organization), diabetes becomes the 8th leading cause of death [2]. Diabetes melli-
tus is mainly identified by the presence free glucose at high or the chronic level in the 
body fluids like sweat, urine, blood, etc. [3]. The major reason for diabetes mellitus 
among others was the hormone-mediated metabolism regulation failure. Hormones 
like glucagon and insulin play an important role in regulating the level of blood sugar 
or maintaining its balance [4]. The sugar balance in blood is important for perfect 
functioning of human body [5]. High/chronic level of glucose in body fluids is 
responsible for different pathological conditions like infection susceptibility, leading 
to various diseases such as arthritis, hypertension, cardiovascular problems, cataract, 
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retinopathy, neuropathy, damage of kidneys, damaging of blood vesicles, wound 
healing delay, etc. (Figure 1) [5, 6]. Due to the linkage of diabetes mellitus with other 
different diseases, the International Diabetes Foundation (IDF), in 2014, recorded 
that the 4.9 million lives loss and ~1.25% dead were diabetic patients, either directly 
by diabetes mellitus or indirectly through other diseases [7]. All these diseases are 
linked causing various effects on different body organs with various pathways; 
pathological/hyperglycemic conditions are linked with the inflammation of tissue 
[8]. Diabetes is responsible for lower gradation inflammation in a systemic way and 
leads to the promotion of different diseases like arthritis, retinopathy, etc. [9, 10].
One of the major problems associated with diabetes mellitus is inflammation in 
wounds and results in wound recovery delay [11]. The chronic wounds in diabetes 
mainly show the persistent increase in the level of pro-inflammatory cytokine 
and the absence of the signals, which are responsible for signals in the damaged 
tissues [12]. The treatments used in diabetes mellitus are also helpful in control-
ling the level of glucose blood and helps in delaying the further progression of 
other diseases linked with diabetes mellitus, like retinopathy, contract, arthritis, 
neuropathy, retinopathy, etc., but very less is known in the literature about diabetes 
mellitus treatment’s effects on diabetic wound recovery [13]. Wound results in 
release of the pro-inflammatory cytokines such as interleukin-6 (IL-6), IL-1, IL-12, 
IL-18, and tumor necrosis factors (TNFs) and interferon-gamma (IFN-γ), which 
results in inflammation of tissues [14]. Pro-inflammatory cytokines like IL-6 and 
IL-1β are released from the macrophages and monocytes in the wound and result 
in pain responses by signaling the neurons [15]. IFN-γ, IL-1β, and TNF-α induce 
apoptosis and pyroptosis mediated by the activation of innate immunity and 
oxidative stress [16]. IFN-γ is an activator; it activates macrophages by stimulating 
STAT1 expression in order to activate the defense mechanism against the pathogens 
in the infected area [17]. IL-12 stimulates TNF-α and IFN-γ production and reduces 
the expression of IL-4, an anti-inflammatory cytokine, and negatively controls the 
expression of IFN-γ; IL-4 also through the activation of STAT-3 signaling inhibits 
IFN- γ [18]. IL-18 for defense against pathogens activates T cells and natural killer 
Figure 1. 
M1 macrophages (also known as classically activated), such as IL-12, IL-1β, IL-10, STAT1, TNF-α, and 
NFkβP50/P65, are leads to wound inflammation. Alternatively, active, that is, M2 macrophages, such as 
STAT3, HIF-α, PKC, NFkβP50/P50, etc., help in healing of the wound by decreasing inflammation. People 
having diabetes show prolonged M1 macrophage expression in wounds in comparison to nondiabetic wounds 
that delay M1 to M2 macrophage transition.
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(NK) cells and promotes the expression of of IFN-γ cytokines at the wound site 
[19]. However, the prolonged expression of inflammatory cytokines leads the dam-
age of tissues, which results in a delay in the repairing process of wounds. IL-1 is a 
TNF activator and is responsible for the damaging of cells. IL-1β overproduction is 
responsible for neuronal tissue inflammation, leads to damage of neuro-muscular 
junctions and ultimately leads to delaying in wound healing [20]. In the presence of 
pathogens, the macrophages secrete IL-6 which in turn increases Toll like receptor 
expression (TLR)-9 response-mediated defense for killing foreign particles. In 
case of prokaryotes, unmethylated DNA activates the TLR-9 pathway and helps 
in killing the pathogen at the wound site; mitochondrial DNA spillage, essentially 
the unmethylated DNA, triggers similar kind of responses in the tissue of wound 
[21]. In tissues, the angiogenesis is inhibited by IL-12 by overexpression of IFN-γ-
mediated interferon-gamma-induced protein 10 (CXCL-10 or IP-10) [22]. Vascular 
endothelial growth factor (VEGF) expression is negatively controlled by IL-18, 
essential for the development of new blood vessels at the wound site and is essential 
for the growth and repair at wound tissue [23].
To start and control the wound healing mechanism, the inflammation is most 
important. In the nondiabetic wounds, anti-inflammatory cytokines like IL-4, IL-10, 
IL-13, IL-11, and transforming growth factor-beta (TGF-β) and interferon-alpha 
(IFN-α) play an important role in the wound healing process [24]. At the initial 
stage of wound recovery, TLR-9 induces the instant expression of pro-inflammatory 
signals like TNF-α through the increase in expression of mitogen-activated protein 
kinase (MAPK)/p38 and c-Jun N-terminal kinase (JNK) pathway [25]. In non-
diabetic wounds, MAPK activation is prolonged and leads to MAPK phosphatase 
enzyme activation, which works as a negative regulator of JNK and MAPK/p38 path-
ways, resulting in the negative regulation of TNF-α production. The de-phosphory-
lation of MAPK/p38 leads to more expression of anti-inflammatory cytokines such as 
IL-10 a homodimeric cytokine, which is produced by the macrophages, monocytes 
and induce signaling of TGF-β, and can enhance the division of cells [26]. Cytokines 
like IL-4, IL-13, and IL-10 can stimulate extracellular matrix and fibrinogen, mainly 
collagen synthesis. IL-4, cytokines secreted by macrophages, mast cells and inflamed 
T cells activate the Janus kinase/signal transducer and transcription-6 (Jak/STAT6) 
pathway activator which promotes the wound repairing [27]. IL-4 is responsible for 
the extracellular matrix synthesis, mainly collagen which gives the physical sup-
port for the healing of the wound [28]. Another kind of cytokine, L-1RA, secreted 
from immune cells, adipocytes cells and cells of epithelia, leads the inhibition of 
pro-inflammatory IL1β cytokine effect by binding with the (IL-1R) interleukin-1 
receptor. On the other hand, deregulation of TNF-α and IL-1β prolongs the phase of 
inflammation phase and leads to delay in wound healing [29]. IL-11 released from 
cells of bone marrow expresses anti-inflammatory effect. IL-11 inhibits the synthesis 
of IL-1 and TNF-α synthesis by the inhibition of NFkβP50/P65 with increasing the 
expression of inhibitory NFkβP50/P50 synthesis in monocytes/macrophage cells 
[30]. Transition between cytokines of pro and anti-inflammatory is balanced in 
nondiabetic wounds but in case of diabetic wounds, it gets impaired (Figure 1).
For the type-1 diabetes treatment or insulin-dependent diabetes, insulin is 
administrated systematically.
2.  Activation of anti-inflammatory cytokines and increased 
differentiation of cells by signaling through insulin
Insulin, released from pancreatic gland produced in its beta cells of the islets 
of Langerhans is a peptide hormone. Insulin precursor is proinsulin in humans, is 
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(NK) cells and promotes the expression of of IFN-γ cytokines at the wound site 
[19]. However, the prolonged expression of inflammatory cytokines leads the dam-
age of tissues, which results in a delay in the repairing process of wounds. IL-1 is a 
TNF activator and is responsible for the damaging of cells. IL-1β overproduction is 
responsible for neuronal tissue inflammation, leads to damage of neuro-muscular 
junctions and ultimately leads to delaying in wound healing [20]. In the presence of 
pathogens, the macrophages secrete IL-6 which in turn increases Toll like receptor 
expression (TLR)-9 response-mediated defense for killing foreign particles. In 
case of prokaryotes, unmethylated DNA activates the TLR-9 pathway and helps 
in killing the pathogen at the wound site; mitochondrial DNA spillage, essentially 
the unmethylated DNA, triggers similar kind of responses in the tissue of wound 
[21]. In tissues, the angiogenesis is inhibited by IL-12 by overexpression of IFN-γ-
mediated interferon-gamma-induced protein 10 (CXCL-10 or IP-10) [22]. Vascular 
endothelial growth factor (VEGF) expression is negatively controlled by IL-18, 
essential for the development of new blood vessels at the wound site and is essential 
for the growth and repair at wound tissue [23].
To start and control the wound healing mechanism, the inflammation is most 
important. In the nondiabetic wounds, anti-inflammatory cytokines like IL-4, IL-10, 
IL-13, IL-11, and transforming growth factor-beta (TGF-β) and interferon-alpha 
(IFN-α) play an important role in the wound healing process [24]. At the initial 
stage of wound recovery, TLR-9 induces the instant expression of pro-inflammatory 
signals like TNF-α through the increase in expression of mitogen-activated protein 
kinase (MAPK)/p38 and c-Jun N-terminal kinase (JNK) pathway [25]. In non-
diabetic wounds, MAPK activation is prolonged and leads to MAPK phosphatase 
enzyme activation, which works as a negative regulator of JNK and MAPK/p38 path-
ways, resulting in the negative regulation of TNF-α production. The de-phosphory-
lation of MAPK/p38 leads to more expression of anti-inflammatory cytokines such as 
IL-10 a homodimeric cytokine, which is produced by the macrophages, monocytes 
and induce signaling of TGF-β, and can enhance the division of cells [26]. Cytokines 
like IL-4, IL-13, and IL-10 can stimulate extracellular matrix and fibrinogen, mainly 
collagen synthesis. IL-4, cytokines secreted by macrophages, mast cells and inflamed 
T cells activate the Janus kinase/signal transducer and transcription-6 (Jak/STAT6) 
pathway activator which promotes the wound repairing [27]. IL-4 is responsible for 
the extracellular matrix synthesis, mainly collagen which gives the physical sup-
port for the healing of the wound [28]. Another kind of cytokine, L-1RA, secreted 
from immune cells, adipocytes cells and cells of epithelia, leads the inhibition of 
pro-inflammatory IL1β cytokine effect by binding with the (IL-1R) interleukin-1 
receptor. On the other hand, deregulation of TNF-α and IL-1β prolongs the phase of 
inflammation phase and leads to delay in wound healing [29]. IL-11 released from 
cells of bone marrow expresses anti-inflammatory effect. IL-11 inhibits the synthesis 
of IL-1 and TNF-α synthesis by the inhibition of NFkβP50/P65 with increasing the 
expression of inhibitory NFkβP50/P50 synthesis in monocytes/macrophage cells 
[30]. Transition between cytokines of pro and anti-inflammatory is balanced in 
nondiabetic wounds but in case of diabetic wounds, it gets impaired (Figure 1).
For the type-1 diabetes treatment or insulin-dependent diabetes, insulin is 
administrated systematically.
2.  Activation of anti-inflammatory cytokines and increased 
differentiation of cells by signaling through insulin
Insulin, released from pancreatic gland produced in its beta cells of the islets 
of Langerhans is a peptide hormone. Insulin precursor is proinsulin in humans, is 
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encoded by the INS gene and is a single polypeptide; after processing of proinsulin, 
two secretory proteins are produced, one chain having two chains namely A (21 
amino acids) and B (30 amino acids), which forms mature insulin, and the second is 
C-chain known as C-peptide having 31 amino acids [31, 32]. Chain “A” is more com-
pact having (2 small) α-helix region; on other hand, B chain has 1 such region. Two 
disulfide bonds between A20-B19 and A7-B7 hold chain A and chain B together; in 
addition to this, there is a disulfide bridge between A7-A11 cys amino acids of chain 
A. In the presence of Zn2+ and at ~6.0 favorable insulin pH, it folds to hexameric 
forms and is stored in pancreas. After diffusion of insulin in blood, with change in 
the pH, the hexameric insulin form changes to its monomeric form and shows bind-
ing with the insulin receptor [33]. The insulin binding with receptors depends on 
the regions present in the insulin monomeric form. The binding regions are present 
on the surface of insulin receptors; the changes or mutations in the binding regions 
reduce the insulin binding affinity [34]. The regions are located at TyrA19, AsnA21, 
CysA20, on the “A” chain C-terminus, IleA2, GlyA1, GluA4, ValA3, on the N terminus 
and at PheB24, GlyB23, TyrB26, and PheB25 at B” chain C-terminus (Figure 2) [35].
The insulin is found only in the humans, but peptides which are like insulin are 
also present in invertebrates like insects and molasses. Insulin-like peptides are hav-
ing growth-related functions, and it indicates that the insulin is not only involved 
in metabolism of glucose but has other functions as well [37]. Drugs which can 
balance between the pro-inflammatory and anti-inflammatory cytokines can also 
be helpful for the treatment of other insulin-independent or dependent diabetes 
mellitus and its linked disease conditions. Using insulin as a wound-healing agent, 
very few studies have been found.
The anti-inflammatory effect by insulin is shown by activating the cytokine 
expression that can decrease the inflammation and help in recovery of the wound. 
Through metabolism and synthesis activities, insulin shows its effect on the differ-
entiation and survival of cells. Insulin promotes NF-kβP50/P50 upregulation by the 
suppression of TNF-α and p65 expression. NF-kβP50/P65 expression suppression 
leads to decrease in expression of proinflammatory cytokines like IL-12, IL-1β, IL-6, 
and TNF-α cytokines at the site of wound [38]. Proinflammatory cytokine inhibi-
tion shifts the equilibrium towards the anti-inflammatory cytokine expression, like 
Figure 2. 
Insulin structure (a) showing the sequence of amino acids present in insulin protein (b) showing the 3-D model 
of insulin [36].
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IL-4, IL-10, and VEGF, etc., inhibits the apoptosis of cells, and increases prolifera-
tion of cell similarly like IGF [39]. Below sections show the regulation of cytokine 
dynamics by the insulin: (a) Inactivation of NFkβp50/p65 by insulin results in 
decrease in inflammation by inducing uptake of glucose uptake, (b) biosynthesis of 
fatty acid induction by insulin and inactivation through TNF-α, (c) role of insulin 
in cell differentiation and growth by synthesis of protein and inhibition of prote-
olysis by inactivation of FOXO to promote the survival of cell, (d) insulin functions 
like IGF and activates the same signaling pathway and reduces inflammation, and 
(e) anti-inflammatory action of insulin by reduction in proinflammatory cytokines 
and increased expression of the anti-inflammatory cytokines (Figure 3).
2.1 Role of insulin to promote wound recovery
2.1.1  Inactivation of NFkβp50/p65 by insulin results in decrease in inflammation 
by inducing uptake of glucose
The presence of high concentration of glucose at the wound site promotes 
microbial growth and leads to inflammatory signaling activation. The main func-
tion of insulin in the body is regulation of blood glucose level. It helps in the utiliza-
tion of the glucose present in the blood through activation of glucose transporters 
and stored in glycogen form in the cells. The glycogen stored in the tissue of muscles 
behaves as a source of energy and gets used aerobically [40]. Wounds mainly in 
peripheral nerves, renal cortex, and retina are results from microcirculatory dam-
age mainly due to increment in consumption of wound by the inflammatory cells, 
which leads to switch from aerobic glycolytic to anaerobic glycolytic [41]. The direct 
result of this is the lactic acid formation as the end glycolysis product. In addition to 
this, other resources of anaerobic glycolysis are the wound-proliferating cells, which 
are showing anaerobic respiration in the muscle cells [42]. In the blood, the lactic 
acid gets used in the liver to form glucose.
Lactate converts into pyruvate and nicotinamide adenine dinucleotide (NADH); 
NADH behaves as a substrate for nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and helps in the formation of reactive species of oxygen (ROS) 
induced by lactate [43]. Due to more NADPH synthesis, NADPH to NAD+ ratio 
Figure 3. 
Insulin plays an important role as an anti-inflammatory agent and helps in the survival of cells by synthesis 
and metabolic pathways. Glucose metabolism activates NFk-β, and biosynthesis of fatty acids leads to TNF-ɑ 
activation which can inactivate the inflammatory signaling. By this signaling, insulin helps in the survival of 
cells and synthesis of protein. Along with this, the insulin activates the Akt pathway and can increase mTOR, 
MMPs, and eNOS expression leading to the formation of new blood vessels. Insulin can also decrease the 
NFkβP50/P65 expressions by the ERK and MEK pathways like the pathway for glucose uptake.
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reduces, which leads to the VEGF activation and angiogenesis. NADPH and pyru-
vate, both lead to the formation of new blood vessels and collagen through the 
inactivation of prolyl hydroxylase hypoxia inducible factor (HIF PHD) [44].
HIF causes the damage of tissue and inflammation at the wound [45]. Hypoxia is 
also responsible for the damage of peripheral blood vessels and also causes activates 
NADP oxidase (NOX) to generate oxidative stress in the wound, regulating key 
factor in the process of wound recovery and leading to inter-cellularly ROS over-
expression [46]. High ROS level induces oxidation of protein and peroxidation of 
lipid, which causes apoptosis of cells [47]. The production of ROS leads to accumu-
lation of NFkβP50/ P65 and inhibits HIF1 α and mTOR expression. In addition to 
mTOR and HIF1 inhibition, NFkβp50/NFkβp65 induces resistin expression, and 
both are responsible for intercellular insulin resistance [48]. The resistin leads to the 
activation of vicious cycle through p65 overexpression [49]. P65 activation shifts 
the equilibrium from NFκβp50/p50 to NFκβp50/p65 and results in insulin resistance 
generation [50]. It also induces mTOR and HIF1, by activation of the AKT path-
way and inhibition of TNFα [51]. HIF1 activation shifts back to NFκβp50/p65 to 
NFκβp50/p50 equilibrium. The blood glucose normalization is possible with insulin 
proper functioning and also by the effective reduction of NFkβP50/P65 expression 
[52]. NFkβP50/P50 activation reduces expression of proinflammatory cytokines 
like IL-6 and IL-1β, induces high anti-inflammatory cytokine expression, leads to 
reduction in inflammation stage, and enhances repairing of tissue [50].
Pyruvate and NADPH inactivate the expression of HIF PHDs, by the oxidation 
of ascorbic acid and Fe (II). HIF PHDs are the dioxygenase and are 2-oxoglutarate 
and Fe (II)-dependent and require ascorbic acid. In lactate presence, ascorbic acid 
and Fe (II) get oxidized and inhibit damage of tissue and increase IL-8release, 
basal fibroblast growth factor (bFGF) and NF-kβP50/P50 activation [53]. Lactate 
also upregulates the expression of NF-kβP50/P50 by suppressing the formation 
of NF-kβP50/P65 and results in reduction of expression of IL-12, IL-1β, TNF-α, 
and IL-6 cytokines. This pathway ultimately results in more cell viability. Also, 
ROS-dependent IkBɑ expression inhibition and VEGF receptors are responsible 
for synthesis of collagen and angiogenesis [54]. IkBɑ helps in NFkβ translocation 
from nucleus, and p65 gene expression in turn is responsible for inflammation [55]. 
Along with this, NF-kβP50/P65 expression suppression happens through the phos-
phorylation of ERK through signaling of insulin [56]. In contrast to these findings, 
the lactate formed in skeletal muscles impairs the signaling of insulin and results in 
glucose metabolism inhibition [57]. Glucose metabolism signaling of insulin occurs 
through 6-phosphofructo-1-kinase (PFK-1), which in turn is formed by pyruvate 
dehydrogenase (PDH) and fructose-2, 6-biphosphate and used for the conversion 
pyruvate to oxaloacetate. This signaling of insulin is inhibited by lactate through 
the production of more citrate and reducing fructose-2, 6-biphosphate, and inhibits 
and promotes PFK-1 expression, respectively. Inhibition of PDH by rising ratio of 
NADH to NAD ultimately stops the pyruvate to oxaloacetate transformation [58]. 
This negative effect of lactate on glucose metabolism shows that it acts as an glycol-
ysis inhibitor and results in increase in concentration of glucose in the blood serum 
[59]. The glucose high concentration in the blood leads to long-time expression of 
the inflammation cytokines at the wound site (Figure 4).
2.1.2  Fatty acid biosynthesis induction by insulin and inactivation through TNF-α 
pathway
Insulin also plays different other functions like it can stimulate the synthesis 
of protein and lipogenesis, as well as differentiation and growth of cells [60]. 
The lipogenesis is the fatty acid synthesis process which converts acetyl-CoA 
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to triglycerides [61]. Lipogenesis is stimulated by insulin through two types of 
enzyme activation, PDH (pyruvate dehydrogenase), responsible for pyruvate con-
version to acetyl CoA and another acetyl CoA carboxylase helps in conversion of 
acetyl to malonyl CoA. In the cytoplasm, Malonyl CoA gives 2-C building blocks, 
used for larger fatty acid synthesis [62]. Transportation of acetyl CoA from mito-
chondria to cytoplasm occurs by tricarboxylate translocase enzyme, after forma-
tion of citrate by reaction with oxaloacetate. The glucose shows a role in increasing 
the release of both citrate and insulin [63].
Fatty acids, mainly polyunsaturated, play an important role in the formation 
of cell membrane. Cell membrane composition affects the absorption of enzymes 
which are responsible for cell phosphatidylinositol 4-kinase (PI4K) proper func-
tioning; membrane associated phosphatidylinositol kinase shows an important role 
in signaling of cell [64]. The fat metabolism products activate PI4K, which in turn 
regulates the Protein Kinase C (PKC) functioning and controls proinflammatory 
cytokine TNF-ɑ signaling [65]. PKC also induces inflammation through increasing 
the NFkβ and p38MAPK expression. In PI4K presence, the activity of PKC is inhib-
ited, which leads to the reduction of proinflammatory cytokine (TNF-ɑ) release 
[66]. The free fatty acid component plays an important role in the wound recovery 
process (Figure 4).
Figure 4. 
Transition pathway from M1 to M2 macrophages. TNF ɑ and IFN ϒ activate NFk β, STAT1, and IRF-3 at 
the wound site and help in the release of IL-10, IL-12, NFkβP50/P65, TNF-α, IL-1β, and STAT-1 leading to 
inflammation. M1 to M2 transition is important for wound recovery. IL-10, IL-4, IL-13, VEGF, insulin, and 
IGF can activate HIF-α, STAT3, and NFkβP50/P50 cytokines to activate the anti-inflammatory action.
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to triglycerides [61]. Lipogenesis is stimulated by insulin through two types of 
enzyme activation, PDH (pyruvate dehydrogenase), responsible for pyruvate con-
version to acetyl CoA and another acetyl CoA carboxylase helps in conversion of 
acetyl to malonyl CoA. In the cytoplasm, Malonyl CoA gives 2-C building blocks, 
used for larger fatty acid synthesis [62]. Transportation of acetyl CoA from mito-
chondria to cytoplasm occurs by tricarboxylate translocase enzyme, after forma-
tion of citrate by reaction with oxaloacetate. The glucose shows a role in increasing 
the release of both citrate and insulin [63].
Fatty acids, mainly polyunsaturated, play an important role in the formation 
of cell membrane. Cell membrane composition affects the absorption of enzymes 
which are responsible for cell phosphatidylinositol 4-kinase (PI4K) proper func-
tioning; membrane associated phosphatidylinositol kinase shows an important role 
in signaling of cell [64]. The fat metabolism products activate PI4K, which in turn 
regulates the Protein Kinase C (PKC) functioning and controls proinflammatory 
cytokine TNF-ɑ signaling [65]. PKC also induces inflammation through increasing 
the NFkβ and p38MAPK expression. In PI4K presence, the activity of PKC is inhib-
ited, which leads to the reduction of proinflammatory cytokine (TNF-ɑ) release 
[66]. The free fatty acid component plays an important role in the wound recovery 
process (Figure 4).
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Transition pathway from M1 to M2 macrophages. TNF ɑ and IFN ϒ activate NFk β, STAT1, and IRF-3 at 
the wound site and help in the release of IL-10, IL-12, NFkβP50/P65, TNF-α, IL-1β, and STAT-1 leading to 
inflammation. M1 to M2 transition is important for wound recovery. IL-10, IL-4, IL-13, VEGF, insulin, and 
IGF can activate HIF-α, STAT3, and NFkβP50/P50 cytokines to activate the anti-inflammatory action.
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2.1.3  Role of insulin in cell differentiation and growth by synthesis of protein and 
proteolysis inhibition by the inactivation of FOXO to enhance the survival of 
the cell and tissue
Insulin stimulates the synthesis of protein in different cells and tissues. In muscle 
tissues, insulin affects the flow of blood and amino acids uptake by the tissues of 
muscle and helps in anabolism in the muscles [67]. It has been studied that insulin 
systematic uptake loses the muscle volume, which mainly happens due to insulin 
systematic infusion and results in the reduction of the amount of free amino acids 
in blood and plays an important role in the anabolism in muscles [68]. The defi-
ciency of insulin can be overcome by systematically giving insulin exogenously [69]. 
Essential protein formation is stimulated by promoting the concentration of RNA 
contents in the cells and tissues by the insulin functioning pathway through the 
translocation of the mRNA by the phosphoinositide-3-kinase (PI3K) pathway [70]. 
By the PI3K pathway, an Akt inhibits the tuberous sclerosis protein ½ (TSC1/2) 
functioning and behaves like an inhibitor of the mechanistic target of rapamycin 
(mTOR) and in the end by phosphorylation of 4E Binding protein (4EBP-1leads 
it activates the eukaryotic initiation factor (eIF4B)). The eukaryotic 20 structured 
mRNA 5’end eIF4B binds. During the synthesis of protein, eIF4B binds with 
subunits of eIF4A and eIF4G, further binding with ribosome 40S, and it has RNA 
helicase absent or low results in impairment in the synthesis of protein. The mTOR 
activation leads to proteolysis inhibition by MAPox activation [71]. High concen-
tration of insulin in the muscle cells inhibits the protein degradation and leads to 
muscle cell and tissue expansion [72]. Due to inhibition of protein degradation, the 
insulin ultimately leads to reduce the blood amino acids concentration [73]. This 
amino acid concentration regulation of insulin clearly indicates that insulin plays a 
very important part in the diabetic wound healing condition when the patients are 
on systemic treatment of insulin (Figure 4).
2.1.4  Insulin behaves the same as insulin-like growth factor and can also activate 
similar pathway to decrease the inflammation
Insulin-like growth factor (IGF) is composed of two IGF ligands such as IGF-I 
and II. At the time of embryogenesis, IGF are the proteins that regulate develop-
ment and growth, tissue differentiation in adults and show anti-inflammatory 
actions through the activation of anti-inflammatory cytokines. Insulin shows anti-
inflammatory effect by increasing release of IL-10 and IL-13/4. By decreasing pro-
inflammatory cytokines release (IFN-ϒ) [74]. IGFs show binding with the insulin 
receptor (IR), insulin-related receptor, and IGF receptor (IGF-1 and IGF-2). Main 
functions of IGF-I and II are mediated by Insulin Growth Factor Insulin receptor 
(IGF-IR) [75]. IGF-I is an important growth factor produced by the macrophages, 
fibroblast keratinocyte, and platelets. It enhances endothelial cell migration into 
the wound site. It enhances the mitosis and fibroblast cell proliferation for the new 
blood vessel formation and extracellular matrix and activation of protein kinase B 
signaling. In addition to this, it also enhances the synthesis of protein and blocks the 
muscles atrophy in order to skeletal hypertrophy catalysis [76].
Upon binding with receptor, the IGF-I activates the insulin receptor substrate-1 
(IRS-1) which in turn by phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K) 
phosphorylates the protein kinase B (Akt). Phosphorylated Akt activates the 
mTOR; PI3K-related kinase controls the proliferation of the cells [77]. Also, IGF-I 
enhances cell growth by activating the mitogen-activated protein kinase/extra-
cellular signal regulated kinase/MAPK/ERK pathway through RAF/RAS kinase 
phosphorylation of [78]. Along with this, IGF-I binding of receptor enhances the 
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secretion of anti-inflammatory cytokine such as IL-10 activates Akt by AMPK 
signaling. Likewise, such as IL-4 and IL-10 can also bind with Akt and plays role in 
M2 macrophages infiltration at the site of wound (Figure 4).
2.1.5  The anti-inflammatory action of insulin through a reduction in  
pro-inflammatory cytokine expression enhances the formation of  
anti-inflammatory cytokines
The decrease in action of insulin may be due to resistance of insulin or due to 
the insufficient insulin release, and it ultimately results in diabetes mellitus. The 
functioning of insulin either reduces due to the β-cells functioning loss or due to 
the improper functioning of insulin receptors or due to the kidney disease [79]. The 
insulin treatment systemically is already taken by 6 million people of America, and 
it keeps on increasing to control high blood glucose condition. High blood glucose 
concentration leads to the tissue damage by the oxidative stress through increasing 
flux of other sugars and glucose by the polyol pathway and also enhances the expres-
sion end products of advanced glycation and it’s activating ligand receptors and 
through the overexpression of the pathway of hexosamine and activation of protein 
kinase. The mechanisms mainly take place by the overexpression of mitochondrial 
ROS [80]. In the polyol pathway, due to more NADPH consumption in the glucose 
transport pathway, more redox stress is generated and remains insufficient to form 
the scavengers of ROS that is GSH reduced form advanced glycinated product pre-
cursor formation modifies the proteins of plasma that can bind with the receptors 
of the advanced glycination product present on the surface of macrophages, smooth 
cells and vascular endothelial cells. This activation of NFkβ transcription factor, 
in turns activates HIF-ɑ and results in hypoxia stimulated chemokines production 
through the ROS production [81]. In the presence of high glucose, the protein kinase 
enzyme shows hyperactivity and stimulates the expression of eNOS in the smooth 
muscles cells and leads to the destruction of tissue. Increased ROS expression shows 
the activation of different proinflammation pathways and helps in generating the 
epigenetic changes, which can result in the prolonged expression of the proinflam-
matory genes during the wound recovery. Matrix metalloproteinase (MMP-2, 4) 
excessive production impairs the recovery process of wound and results in extracel-
lular matrix protein breakdown such as vitronectin and fibronectin [82].
In nondiabetic wounds, the wound healing process involves the activation of 
the series of different physiological events for wound recovery like inflammation at 
wound site, cell proliferation, epithelisation of cells, vascularisation, maturation, 
and re-modeling at the site of wound [83]. Macrophages play an important role in 
the whole healing process. At early wound phase, in the wound recovery process, 
macrophages function by the cytokine release and activation of leucocytes, which 
leads to the production of inflammatory response at the site of the wound [84].
The infiltration of the macrophage at the wound site takes place by the effect of 
chemotaxis which induces the factors like Toll-like receptor (TLR) ligand, PAMP 
(pathogen-associated molecular patterns), LPS (lipopolysaccharide), PDGF, and 
IFN-gamma (IFN-ϒ) [85]. M1 macrophages lead to high level secretion of STAT1 
and expression of TNF-α or IFN-β. By the activation of the Akt/PI3 pathway, insulin 
stimulates STAT3, which inhibits STAT1 formation and activates the transition from 
M1 macrophages to M2 macrophages for the repairing of wound and tissue repair-
ing. M2 macrophages can help in the production of polyamines and ornithine by the 
pathway of arginase enzyme and anti-inflammatory pathway IL-10, IL-13and IL-4 
cytokines [86]. Insulin along with M2 macrophages activates the anti-inflammatory 
cytokines by Akt, or IP3K pathway activates biosynthesis of protein to induce fatty 
acid and blood vessel formation and division and migration of cells, to increase 
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cytokines by Akt, or IP3K pathway activates biosynthesis of protein to induce fatty 
acid and blood vessel formation and division and migration of cells, to increase 
Wound Healing
62
wound recovery. With resistance of insulin in diabetic condition, there is constant 
increase in concentration of proinflammatory cytokines TNFα and IL-6 have been 
shown in the figure. In the non-diabetic/normal glycemic condition, cytokines 
are produced by adipocytes such as IL-13, which can promote the M2 activa-
tion or alternative macrophages. Alternatively, M2 or activated macrophages are 
important for the expression of anti-inflammatory cytokine secretion such as IL-10 
and PPAR-ϒ (Peroxisome Proliferator-Activated Receptor Gamma) and insulin-
sensitizing factors, forming a vicious circle for the functionality of insulin. PPAR-ϒ 
also activates anti-inflammatory IL-10 cytokine [87] (Figure 4).
In the glycemic condition, there is an excessive proinflammatory macrophage 
expression of cytokines like TNF-α and IL-1β leading to impaired wound recovery. 
Overactivation of cytokines like IL-17, TNF-α or IL-1β reduces expression of inflam-
matory cytokines and upregulates genes responsible for wound healing and increases 
the healing process [86]. In the blood and adipose tissue, the high TNF-α cytokine 
concentration and TNF-α neutralization improve the insulin sensitivity in the 
humans or animals. High glucose condition stimulates changes in the gene expres-
sion and adipocyte metabolism and lipolysis increment and synthesis of fatty acids 
(FFAs) and proinflammatory cytokines induces the expressions of macrophages, like 
tumor necrosis factor α (TNF-α) and monocyte chemotactic protein-1 (MCP-1). M1 
macrophage activation produces an excessive concentration of cytokines responsible 
for inflammation such as TNFα, resistin, and IL-1β, which can act on the cells of 
adipocyte to make them insulin-resistant. This signaling pathway forms the feedback 
loop which can increase the resistance to insulin and inflammation [88].
TNF-α, an inflammatory cytokine, performs role in the healing of nondiabetic 
wound process, but activation of TNF-α for a long time leads to enhancing enzy-
matic activity of protease enzyme. In human diabetic wounds, MMPs are found in 
very high amount. In chronic or diabetic wounds, there is imbalance in the expres-
sion of cytokines causes proinflammation and their proteases, inhibitors, and their 
ant protease expression [89].
The switching of macrophages in the high glucose condition gets delayed due to 
MMPs, IL-1β, IL-6, and ROS cytokine oxidative stress (Figures 5 and 6). This leads 
to delay in M1 to M2 transition and is responsible for the inflammation for long time 
and leads to delay in the wound recovery [90, 91]. The insulin role in the switching 
from inflammatory state to anti-inflammatory state is shown in Figure 5.
2.1.6 The insulin-like activity of C-peptide
C-peptide consists of only 31 amino acids, is a short peptide and has glycine 
amino acid-rich regions and behaves like a linker between the two peptides 
of proinsulin A and B [93]. By ERK1/2 activation and Akt phosphorylation, 
C-peptide shows angiogenesis. The angiogenesis signaling pathway shows similar-
ity with the VEGF pathway and leads to the formation of nitric oxide by eNOS 
activation. C-peptide plays a curious role in the cell mitogenesis like insulin, by 
the same signaling pathway as the insulin protein [94]. C-peptide shows binding 
to the insulin receptor (IR) and results in intracellular substrate phosphorylation 
in Ras/MAPK. The PI3K/Akt signaling results in cell division and mitogenesis. 
Along with the abovementioned two functions, C-peptide also shows its anti-
inflammatory effect. C-peptide shows MIP-1ɑ, IL-8, MIP-1β, and IL-6 expression 
inhibition and other pro-inflammatory cytokine expression [95]. Like insulin, 
C-peptide can also reduce the problems linked with diabetes, such as vascular 
inflammation, neuropathy, and nephropathy, in diabetes case especially type 1 
diabetes case [96].
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The C-peptide level rises in the blood during diabetic mellitus type 2, which is 
due to resistance of insulin [97]. At this time, endothelial dysfunction initiated led 
by the C-peptide deposition in the blood vessel intima walls. The C-peptide deposi-
tion causes more inflammation in the blood vessels of the aortic arch and promotes 
atherosclerotic lesions. The inflammation effect of C-peptide is shown due to 
C-peptide chemotactic behaviour towards macrophages responsible for inflamma-
tion. Monocytes/T-lymphocytes/macrophages migrate through the vessel walls and 
then release TNF-ɑ, IL-6, and MIF etc., pro-inflammatory cytokines and chemo-
kines and nitric oxide, and activates intracellular signaling pathway [98].
Figure 5. 
Effect of insulin on switching of M1 to M2 macrophages. In insulin presence, (AMPK, Akt, STAT3, PKC, 
HIF-α, PI3K, NFkβP50/P50, and ERK) M2 macrophage expression increases show an anti-inflammatory effect 
and help in wound healing.
Figure 6. 
TEM micrographs of AgNPs and IAgNPs shown with insulin protein coating; the size of AgNPs shifts from 
around 22 ± 2 to 1.96 ± 0.1 nm. Scale bar: 50 nm [40].
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tion or alternative macrophages. Alternatively, M2 or activated macrophages are 
important for the expression of anti-inflammatory cytokine secretion such as IL-10 
and PPAR-ϒ (Peroxisome Proliferator-Activated Receptor Gamma) and insulin-
sensitizing factors, forming a vicious circle for the functionality of insulin. PPAR-ϒ 
also activates anti-inflammatory IL-10 cytokine [87] (Figure 4).
In the glycemic condition, there is an excessive proinflammatory macrophage 
expression of cytokines like TNF-α and IL-1β leading to impaired wound recovery. 
Overactivation of cytokines like IL-17, TNF-α or IL-1β reduces expression of inflam-
matory cytokines and upregulates genes responsible for wound healing and increases 
the healing process [86]. In the blood and adipose tissue, the high TNF-α cytokine 
concentration and TNF-α neutralization improve the insulin sensitivity in the 
humans or animals. High glucose condition stimulates changes in the gene expres-
sion and adipocyte metabolism and lipolysis increment and synthesis of fatty acids 
(FFAs) and proinflammatory cytokines induces the expressions of macrophages, like 
tumor necrosis factor α (TNF-α) and monocyte chemotactic protein-1 (MCP-1). M1 
macrophage activation produces an excessive concentration of cytokines responsible 
for inflammation such as TNFα, resistin, and IL-1β, which can act on the cells of 
adipocyte to make them insulin-resistant. This signaling pathway forms the feedback 
loop which can increase the resistance to insulin and inflammation [88].
TNF-α, an inflammatory cytokine, performs role in the healing of nondiabetic 
wound process, but activation of TNF-α for a long time leads to enhancing enzy-
matic activity of protease enzyme. In human diabetic wounds, MMPs are found in 
very high amount. In chronic or diabetic wounds, there is imbalance in the expres-
sion of cytokines causes proinflammation and their proteases, inhibitors, and their 
ant protease expression [89].
The switching of macrophages in the high glucose condition gets delayed due to 
MMPs, IL-1β, IL-6, and ROS cytokine oxidative stress (Figures 5 and 6). This leads 
to delay in M1 to M2 transition and is responsible for the inflammation for long time 
and leads to delay in the wound recovery [90, 91]. The insulin role in the switching 
from inflammatory state to anti-inflammatory state is shown in Figure 5.
2.1.6 The insulin-like activity of C-peptide
C-peptide consists of only 31 amino acids, is a short peptide and has glycine 
amino acid-rich regions and behaves like a linker between the two peptides 
of proinsulin A and B [93]. By ERK1/2 activation and Akt phosphorylation, 
C-peptide shows angiogenesis. The angiogenesis signaling pathway shows similar-
ity with the VEGF pathway and leads to the formation of nitric oxide by eNOS 
activation. C-peptide plays a curious role in the cell mitogenesis like insulin, by 
the same signaling pathway as the insulin protein [94]. C-peptide shows binding 
to the insulin receptor (IR) and results in intracellular substrate phosphorylation 
in Ras/MAPK. The PI3K/Akt signaling results in cell division and mitogenesis. 
Along with the abovementioned two functions, C-peptide also shows its anti-
inflammatory effect. C-peptide shows MIP-1ɑ, IL-8, MIP-1β, and IL-6 expression 
inhibition and other pro-inflammatory cytokine expression [95]. Like insulin, 
C-peptide can also reduce the problems linked with diabetes, such as vascular 
inflammation, neuropathy, and nephropathy, in diabetes case especially type 1 
diabetes case [96].
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The C-peptide level rises in the blood during diabetic mellitus type 2, which is 
due to resistance of insulin [97]. At this time, endothelial dysfunction initiated led 
by the C-peptide deposition in the blood vessel intima walls. The C-peptide deposi-
tion causes more inflammation in the blood vessels of the aortic arch and promotes 
atherosclerotic lesions. The inflammation effect of C-peptide is shown due to 
C-peptide chemotactic behaviour towards macrophages responsible for inflamma-
tion. Monocytes/T-lymphocytes/macrophages migrate through the vessel walls and 
then release TNF-ɑ, IL-6, and MIF etc., pro-inflammatory cytokines and chemo-
kines and nitric oxide, and activates intracellular signaling pathway [98].
Figure 5. 
Effect of insulin on switching of M1 to M2 macrophages. In insulin presence, (AMPK, Akt, STAT3, PKC, 
HIF-α, PI3K, NFkβP50/P50, and ERK) M2 macrophage expression increases show an anti-inflammatory effect 
and help in wound healing.
Figure 6. 
TEM micrographs of AgNPs and IAgNPs shown with insulin protein coating; the size of AgNPs shifts from 
around 22 ± 2 to 1.96 ± 0.1 nm. Scale bar: 50 nm [40].
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3. Insulin encapsulated mettalic nanoformulations for wound recovery
Nanoparticles of metals such as silver nanoparticles can be used for the delivery 
of insulin at the site of a wound. Silver nanoparticles have clinical applications due 
to its antibacterial, anti-inflammatory, and wound healing role. Due to the presence 
of charge on the surface of metal nanoparticle surface, they are highly reactive and 
can be surfaces modified by adsorbing different molecules or drugs. The drugs 
having thiol or amine can easily adsorb on the surface of silver nanoparticles, and 
due to this, it can help as a drug delivery agent. The anti-inflammatory effect and 
wound healing (non-diabetic and diabetic) efficiency of silver nanoparticles can be 
improved by encapsulating the insulin with silver nanoparticles [99, 100].
3.1 Synthesis and characterization of metal insulin nanoparticles
It is very easy to synthesize silver nanoparticles by using reducing and stabiliz-
ing agents. Plant extracts like tulsi leaf extract may be used as both reducing and 
stabilizing agents. The tulsi (Ocimum tenuiflorum) aqueous extract of leaves (ATE) 
was extracted by boiling 3 g of tulsi leaves in water (100 ml for 2 h). After extrac-
tion, the extract was allowed to cool and filtered, and the pH of the extract was 
adjusted to 7.4, and the pH adjusted extract was stored at 4°C for further use. AgNP 
synthesis was performed by using ATE as a reducing and capping agent. AgNO3 
240 μM was added in ATE (5000 μl) and for 10 min was kept under sunlight. The 
solution color changed from faint light yellow to reddish brown in the presence of 
sunlight. After this, AgNPs were incubated with insulin at physiological conditions, 
the temperature being 37°C for an hour in an incubator in order to produce insulin-
protected AgNPs (IAgNPs).
Surface plasmon of nanoparticles with or without protein was monitored using 
a UV–visible spectrophotometer equipped with Peltier, which showed a resonance 
peak observed at 352 nm due to the silver nitrate reduction by ATE in sunlight. 
After incubation with insulin, a blue shift (3 nm) with almost peak intensity double 
was observed, and λmax was obtained at 349 nm due to the formation of mono-
dispersed IAgNPs. The hydrodynamic size of 22 ± 2 and 42 ± 2 nm (approximately 
diameter) are observed for AgNPs and IAgNPs, respectively. The Zeta potential 
showed an increment in the potential values from −12.4 to −15.1 mV due to the 
conversion of AgNPs to IAgNPs. TEM micrographs showed that both AgNPs and 
IAgNPs are similar in shape (spherical in shape). AgNP have a size ranging between 
20 ± 4 nm, and further, it received a cap of 2 ± 0.5 nm when coated with insulin 
(IAgNPs) as shown in Figure 6.
3.2  Metallic insulin nanoformulation wound healing and anti-inflammatory 
effect
Wound recovery is promoted by both insulin and IAgNPs in hyperglycemic/dia-
betic and normal/nondiabetic animal conditions. In both in vivo and in vitro cases, 
the insulin promotes the wound healing in hyperglycemic and normal conditions. 
With IAgNPs 12 and 20%, faster wound recovery on treatment’s 5th day of the 
wound was found for nondiabetic and diabetic rats in comparison to the untreated 
control. Whereas in relation to the IAgNPs, faster wound recovery was shown by 
free insulin with lesser efficiency with an enhanced rate of 7.27 and 4.67%, respec-
tively, for the normoglycemic and diabetic rate in comparison to untreated rats. The 
% was 60.0 and 73.33% and with IAgNPs and 33.33 and 40% with only insulin in 
nondiabetic and diabetic models, respectively, on the 11th day, in comparison to the 
untreated controls as shown in Figure 7.
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The quantification of serum showed an increase in anti-inflammatory cytokine 
percentage and reduction in the expression of inflammatory cytokines in diabetic 
and normal/normoglycemic animals after treatment with insulin and IAgNPs 
in comparison to their respective controls. On 5th day, in diabetic rats, the IL-6 
concentration was 25%, and TNF-α is in double higher concentration than the 
normoglycemic control. With treatment of IAgNPs, 50% inhibition of expression of 
cytokine is much higher than free insulin in both the groups. On the 11th day, IL-6 
expression and TNF-α was 30% and 50%, respectively, in control than in normal 
models, which reduces to 45% in both hyperglycemic and normal animals after 
treatment with free insulin, and with IAgNPs, the inhibition was around 30% in 
TNF-α and 40% in IL-6. In addition to reduction in inflammatory cytokine expres-
sion, the anti-inflammatory cytokine percentage (IL-10) increases after treating 
with free insulin and IAgNPs. On the 5th day, IAgNP-treated rats showed that IL-10 
increased 50% in diabetic rats and 70% in normal and similarly showed increment 
in IL-10 concentration of 30% and 45% in diabetic and normal models, respectively, 
in free insulin-treated groups in comparison to control. On 11th day with IAgNPs 
anti-inflammatory cytokine concentration was increased by 50 and 65% and with 
insulin slightly less in both hyperglycemic and normal animals models, respectively. 
On the 5th and 11th days, the histological evaluations significantly decreased leu-
kocyte infiltration level; faster collagen deposition and fast re-epithelization were 
observed with insulin and IAgNPs in relation with sub-group (Figure 8).
Figure 7. 
Wound healing rate of AgNP, ATE-insulin and IAgNP treatment in both hyperglycemic and normal animals 
on 5th day and 11th day. (A) Wound contraction physical observation in various treatment and control groups. 
(B) Percentage of closure of wound in different treated groups (AgNPs, ATE-insulin, and IAgNPs) and 
respective controls of hyperglycemic and normal animals until complete healing of wound takes place.  
(C) Percentage of contraction of wound in four subgroups of hyperglycemic and normal animals on 5th day. 
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Insulin, a hormone which shows the various multiple functions in the body like 
controlling the inflammation, enhancing the differentiation of cells, biosynthesis of 
protein and lipid, etc., in addition to controlling the level of glucose in blood through 
metabolism of glucose. By the metabolism of glucose, the NFkβP50/P50 and IL-8 get 
activated, causing an inactivation of the IL-1β, TNF-α, NFkβP50/P65, IL-6, resistin 
IFN- ϒ, and NOX pro-inflammatory cytokines. The metabolism of fat by insulin 
through inactivating TNF-ɑ mediated pathway also inactivates the pro-inflammatory 
cytokines. The synthesis of protein gets induced by insulin through Akt; PI3K path-
way helps in survival of the cell through the formation of 4EBPI, ribosomal protein S6 
(rpS6). This indicates that along with maintaining the blood glucose level, the insulin 
also shows its anti-inflammatory effect, though the mechanistic aspects of the insu-
lin’s anti-inflammatory role is still remained to be elucidated and understood. In addi-
tion to biosynthesis and metabolism, insulin pathways have the similarity in structure 
with IGF-I, can also bind with receptor of IGF and can shows anti-inflammatory 
activity through PI3K and Akt signaling pathway, which leads to the activation of the 
Figure 8. 
Histological evaluation (40×) wound site of different groups (a and B, respectively). On the 5th and 11th day 
of post-treatment, infiltration of leukocyte, formation of exudates and deposition of collagen are denoted by 
red, yellow and white arrows respectively. Each micrograph represents an overall pattern of a 6-rats group. 
(C–E). Pro-inflammatory cytokines such as IL-6 and TNF-ɑ and the anti-inflammatory cytokines like IL-10 
concentration in all sub-groups of hyperglycemic/and normal animals at 5th and 11th day. TNF-ɑ and IL-6 
results show a significant reduction and IL-10 increment by IAgNP treatment in comparison to control, AgNPs, 
and ATE-insulin-treated animals of both sets on the 5th and 11th day, respectively. Values are shown by the 
average ± SD of group of six rats [40].
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pro-inflammatory cytokines such as STAT-3 and can activate Akt again and promote 
the formation of blood vessels and increases the eNOS production. Likewise, due to 
similarity in structure, insulin can bind with the receptors of IGF and activate the 
same pathway as GF/IGF-I, necessitating further studies on insulin, IGFs and their 
role in anti- response of inflammation (Figure 5). About 5% of the world population 
is diabetic and are in the risk of nonrecoverable or slow wound recovery. The insulin 
can increase the recovery of wound by inflammatory dynamics modulating, therefore 
insulin-like inflammatory modulators (such as IGF) or insulin novel formulations 
based on and have a huge potential for the different clinical applications such as 
including the diabetic care and should be explored for the beneficiary purposes.
5. Future perspective
Inflammatory regulation is one of the most important factors for wound recovery 
which caught attention lately. Here in this chapter, the authors have discussed the 
role of inflammatory regulators in controlling wound recovery taking insulin as an 
example and model drug for diabetes treatment where wound recovery get delayed to 
prolonged inflammation. Macrophages in the wound tissue play a critical role in con-
trolling the wound recovery process. Macrophage plasticity is curtailed in the initia-
tion of tissue regeneration, tissue remodeling, and epithelization. Anti-inflammatory 
activators which can promote M1 to M2 Macrophage transition have a great influence 
in the promotion of wound recovery. Therefore, anti-inflammatory molecules can be 
of great virtue for designing advanced wound recovery agents in the future.
Acknowledgements
Diptiman Choudhury is thankful to the DST/SERB project (ECR/2016/000486) 
for funding. Pawandeep Kaur is thankful to DST inspire, Govt of India, for inspire 
fellowship under inspire scheme (Award No. IF160636).
Conflict of interest
The authors declare that there is no conflict of interest.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 




Insulin, a hormone which shows the various multiple functions in the body like 
controlling the inflammation, enhancing the differentiation of cells, biosynthesis of 
protein and lipid, etc., in addition to controlling the level of glucose in blood through 
metabolism of glucose. By the metabolism of glucose, the NFkβP50/P50 and IL-8 get 
activated, causing an inactivation of the IL-1β, TNF-α, NFkβP50/P65, IL-6, resistin 
IFN- ϒ, and NOX pro-inflammatory cytokines. The metabolism of fat by insulin 
through inactivating TNF-ɑ mediated pathway also inactivates the pro-inflammatory 
cytokines. The synthesis of protein gets induced by insulin through Akt; PI3K path-
way helps in survival of the cell through the formation of 4EBPI, ribosomal protein S6 
(rpS6). This indicates that along with maintaining the blood glucose level, the insulin 
also shows its anti-inflammatory effect, though the mechanistic aspects of the insu-
lin’s anti-inflammatory role is still remained to be elucidated and understood. In addi-
tion to biosynthesis and metabolism, insulin pathways have the similarity in structure 
with IGF-I, can also bind with receptor of IGF and can shows anti-inflammatory 
activity through PI3K and Akt signaling pathway, which leads to the activation of the 
Figure 8. 
Histological evaluation (40×) wound site of different groups (a and B, respectively). On the 5th and 11th day 
of post-treatment, infiltration of leukocyte, formation of exudates and deposition of collagen are denoted by 
red, yellow and white arrows respectively. Each micrograph represents an overall pattern of a 6-rats group. 
(C–E). Pro-inflammatory cytokines such as IL-6 and TNF-ɑ and the anti-inflammatory cytokines like IL-10 
concentration in all sub-groups of hyperglycemic/and normal animals at 5th and 11th day. TNF-ɑ and IL-6 
results show a significant reduction and IL-10 increment by IAgNP treatment in comparison to control, AgNPs, 
and ATE-insulin-treated animals of both sets on the 5th and 11th day, respectively. Values are shown by the 
average ± SD of group of six rats [40].
67




School of Chemistry and Biochemistry, Thapar Institute of Engineering and 
Technology, Patiala, Punjab, India
*Address all correspondence to: diptiman@thapar.edu
pro-inflammatory cytokines such as STAT-3 and can activate Akt again and promote 
the formation of blood vessels and increases the eNOS production. Likewise, due to 
similarity in structure, insulin can bind with the receptors of IGF and activate the 
same pathway as GF/IGF-I, necessitating further studies on insulin, IGFs and their 
role in anti- response of inflammation (Figure 5). About 5% of the world population 
is diabetic and are in the risk of nonrecoverable or slow wound recovery. The insulin 
can increase the recovery of wound by inflammatory dynamics modulating, therefore 
insulin-like inflammatory modulators (such as IGF) or insulin novel formulations 
based on and have a huge potential for the different clinical applications such as 
including the diabetic care and should be explored for the beneficiary purposes.
5. Future perspective
Inflammatory regulation is one of the most important factors for wound recovery 
which caught attention lately. Here in this chapter, the authors have discussed the 
role of inflammatory regulators in controlling wound recovery taking insulin as an 
example and model drug for diabetes treatment where wound recovery get delayed to 
prolonged inflammation. Macrophages in the wound tissue play a critical role in con-
trolling the wound recovery process. Macrophage plasticity is curtailed in the initia-
tion of tissue regeneration, tissue remodeling, and epithelization. Anti-inflammatory 
activators which can promote M1 to M2 Macrophage transition have a great influence 
in the promotion of wound recovery. Therefore, anti-inflammatory molecules can be 
of great virtue for designing advanced wound recovery agents in the future.
Acknowledgements
Diptiman Choudhury is thankful to the DST/SERB project (ECR/2016/000486) 
for funding. Pawandeep Kaur is thankful to DST inspire, Govt of India, for inspire 
fellowship under inspire scheme (Award No. IF160636).
Conflict of interest
The authors declare that there is no conflict of interest.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
68
Wound Healing
[1] King H et al. IDF diabetes atlas: 
Global estimates for prevalence 
of diabetes mellitus and impaired 
glucose tolerance in. Diabetes Care. 
1993;16:157-177
[2] Harding JL. Global trends in diabetes 
complications: A review of current 
evidence. Diabetologia. 2018;62:3-16
[3] Wang Y et al. Relationship of 
diabetes with renal dysfunction 
in hypertensive adults. Medicine. 
2017;96:e7169
[4] Baynest HW. Classification, 
pathophysiology, diagnosis and 
management of diabetes milletus. 
Journal of Diabetes & Metabolism. 
2015;6:2155-6156
[5] Lechner J et al. The pathology 
associated with diabetic retinopathy. 
Vision Research. 2017;139:7-14
[6] Giacco F, Brownlee M. Oxidative 
stress and diabetes complications. 
Circulation Research. 2010;107: 
1058-1070
[7] Duff M et al. Cutaneous 
manifestation of diabetes mellitus. 
Clinical Diabetes. 2015;33:40-48
[8] Qing C. The molecular biology in 
wound healing & non-healing wound. 
Journal of Trauma and Acute Care 
Surgery. 2017:323-355
[9] Simo R et al. Neuro degeneration in 
an early event in diabetic retinopathy: 
Therapeutic implications. The 
British Journal of Ophthalmology. 
2012;96:1285-1290
[10] Patel S et al. Mechanistic insight 
into diabetic wounds: Pathogenesis, 
molecular targets and treatment 
strategies to pace wound healing. 
Biomedicine & Pharmacotherapy. 
2019;112:108-615
[11] Tang Y et al. Proresolution 
therapy for the treatment of delayed 
healing of diabetic wounds. Diabetes. 
2013;62:618-627
[12] Gouin JP, Kiecolt Glaser JK. The 
impact of physiological stress on wound 
healing: Methods and mechanisms. 
Immunology and Allergy Clinics of 
North America. 2011;31:81-93
[13] Clark JD et al. Autoinflammatory 
and autoimmune contributions to 
complex regional pain syndrome. 
Molecular Pain. 2018;14:1-13
[14] Rachel M et al. Analysis of serum 
interleukin IL-1β and IL-18 in systemic 
lupus erythematosus (SCLE). Frontiers 
in Immunology. 2018;9:1250
[15] Laudisi F et al. Cutting edge: 
The NLRP3 inflammasome links 
complement mediated inflammation 
and IL-1β release. Journal of 
Immunology. 2013;191:1006-1010
[16] Lamkanfi M, Dixit VM. Mechanism 
and function of inflammasomes. Cell. 
2014;157:1013-1022
[17] Xiao Y et al. Synergestic activation 
of inflammatory cytokine genes by 
interferon-ϒ induced chromatin 
remodelling and toll like receptor 
signaling. Immunity. 2013;39:454-469
[18] Rigante D. The board 
ranging panorama of systematic 
autoinflammatory disorders with 
specific focus on acute painful 
symptoms and hematologic 
manifestations in children. 
Mediterranean Journal of 
Hematology and Infectious Diseases. 
2018;10:e2018067
[19] Bernardo ME, Fibbe WE. 
Mesenchymal stromal cells: Sensors and 




Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
[20] Zhang JZ et al. Mitochondrial DNA 
induces inflammation and increases 
TLR9/NF-κB expression in lung tissue. 
International Journal of Molecular 
Medicine. 2014;33:817-824
[21] Sorensen WE et al. IL-2 suppresses 
vascular endothelial factor receptor 3 
expression on tumor vessels by distinc 
IFN-ϒ dependent mechanisms. Journal 
of Immunology. 2010;184:1858-1866
[22] Lee EY et al. CXCL10 and 
autoimmune diseases. Autoimmunity 
Reviews. 2009;8:379-383
[23] Harsoliya MS et al. Toxicity of 
Lps and Opa exposure on blood with 
different methods. Webmed Central. 
2011;2:WMC001696
[24] Ma TY et al. TNF-α induced 
increase in intestinal epithelial tight 
junction permeability require NFkβ 
activation. American Journal of 
Physiology. Gastrointestinal and Liver 
Physiology. 2004;286:367-376
[25] Lappas M et al. Mitogen activated 
protein kinase proteins regulate LPS-
stimulated release of pro-inflammatory 
cytokines and prostaglandins from 
human gestational tissues. Placenta. 
2007;28:936-945
[26] Vieira IR et al. TLR 9 stimulation 
induces increase in fungicidal activity 
of human dendritic cells challenged 
with Paracoccidioides brasiliensis. 
Journal de Mycologie Médicale. 
2017;56:911-915
[27] Duan XZ et al. Decreased numbers 
and impaired function of circulating 
dendritic cell subsets in patients with 
chronic hepatitis B infection. Journal 
of Gastroenterology and Hepatology. 
2005;20:234-242
[28] Kucukcelebi A et al. In vivo 
characterization of interleukin-4 as a 
potential wound healing agent. Wound 
Repair and Regeneration. 1995;3:49-58
[29] Dinarello CA. Immunological and 
inflammatory functions of interleukin-1 
family. Annual Review of Immunology. 
2009;27:519-550
[30] Sultani M et al. Anti-inflammatory 
cytokines: Important immuno regulatory 
factors contributing to chemotherapy 
induced gastrointestinal mucositis. 
Chemotherapy Research and Practice. 
2012;2012:11
[31] Kimmel JR, Pollock HG. Studies 
of human insulin from non diabetic 
and diabetic pancreas. Diabetes. 
1967;16:687-694
[32] Huang L. Zinc and its transporters, 
pancreatic β-cells and insulin 
metabolism. Vitamins and Hormones. 
2014;95:365-390
[33] Haeusler RA et al. Biochemical and 
cellular properties of insulin receptor 
signalling. Nature Reviews. Molecular 
Cell Biology. 2018;19:31-44
[34] Ward CW et al. The insulin receptor 
changes conformation in unforeseen 
ways on ligand binding: Sharpening the 
picture of insulin receptor activation. 
BioEssays. 2013;35:945-954
[35] Alberto M et al. The chemokines 
system in diverse forms of macrophages 
activation and polarization. Trends in 
Immunology. 2004;25:677-686
[36] (a) Human insulin. Stylized 
chemical structure. (b) PDB 4iyf 
biological assemblies and structure 
analysis Protein
[37] Rezvani O et al. A randomized, 
double blind, placebo controlled trial to 
determine the effects of topical insulin 
on wound healing. Ostomy/Wound 
Management. 2009;55:22-28
[38] Hrynyk M, Neufeld RJ. Insulin 




[1] King H et al. IDF diabetes atlas: 
Global estimates for prevalence 
of diabetes mellitus and impaired 
glucose tolerance in. Diabetes Care. 
1993;16:157-177
[2] Harding JL. Global trends in diabetes 
complications: A review of current 
evidence. Diabetologia. 2018;62:3-16
[3] Wang Y et al. Relationship of 
diabetes with renal dysfunction 
in hypertensive adults. Medicine. 
2017;96:e7169
[4] Baynest HW. Classification, 
pathophysiology, diagnosis and 
management of diabetes milletus. 
Journal of Diabetes & Metabolism. 
2015;6:2155-6156
[5] Lechner J et al. The pathology 
associated with diabetic retinopathy. 
Vision Research. 2017;139:7-14
[6] Giacco F, Brownlee M. Oxidative 
stress and diabetes complications. 
Circulation Research. 2010;107: 
1058-1070
[7] Duff M et al. Cutaneous 
manifestation of diabetes mellitus. 
Clinical Diabetes. 2015;33:40-48
[8] Qing C. The molecular biology in 
wound healing & non-healing wound. 
Journal of Trauma and Acute Care 
Surgery. 2017:323-355
[9] Simo R et al. Neuro degeneration in 
an early event in diabetic retinopathy: 
Therapeutic implications. The 
British Journal of Ophthalmology. 
2012;96:1285-1290
[10] Patel S et al. Mechanistic insight 
into diabetic wounds: Pathogenesis, 
molecular targets and treatment 
strategies to pace wound healing. 
Biomedicine & Pharmacotherapy. 
2019;112:108-615
[11] Tang Y et al. Proresolution 
therapy for the treatment of delayed 
healing of diabetic wounds. Diabetes. 
2013;62:618-627
[12] Gouin JP, Kiecolt Glaser JK. The 
impact of physiological stress on wound 
healing: Methods and mechanisms. 
Immunology and Allergy Clinics of 
North America. 2011;31:81-93
[13] Clark JD et al. Autoinflammatory 
and autoimmune contributions to 
complex regional pain syndrome. 
Molecular Pain. 2018;14:1-13
[14] Rachel M et al. Analysis of serum 
interleukin IL-1β and IL-18 in systemic 
lupus erythematosus (SCLE). Frontiers 
in Immunology. 2018;9:1250
[15] Laudisi F et al. Cutting edge: 
The NLRP3 inflammasome links 
complement mediated inflammation 
and IL-1β release. Journal of 
Immunology. 2013;191:1006-1010
[16] Lamkanfi M, Dixit VM. Mechanism 
and function of inflammasomes. Cell. 
2014;157:1013-1022
[17] Xiao Y et al. Synergestic activation 
of inflammatory cytokine genes by 
interferon-ϒ induced chromatin 
remodelling and toll like receptor 
signaling. Immunity. 2013;39:454-469
[18] Rigante D. The board 
ranging panorama of systematic 
autoinflammatory disorders with 
specific focus on acute painful 
symptoms and hematologic 
manifestations in children. 
Mediterranean Journal of 
Hematology and Infectious Diseases. 
2018;10:e2018067
[19] Bernardo ME, Fibbe WE. 
Mesenchymal stromal cells: Sensors and 




Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
[20] Zhang JZ et al. Mitochondrial DNA 
induces inflammation and increases 
TLR9/NF-κB expression in lung tissue. 
International Journal of Molecular 
Medicine. 2014;33:817-824
[21] Sorensen WE et al. IL-2 suppresses 
vascular endothelial factor receptor 3 
expression on tumor vessels by distinc 
IFN-ϒ dependent mechanisms. Journal 
of Immunology. 2010;184:1858-1866
[22] Lee EY et al. CXCL10 and 
autoimmune diseases. Autoimmunity 
Reviews. 2009;8:379-383
[23] Harsoliya MS et al. Toxicity of 
Lps and Opa exposure on blood with 
different methods. Webmed Central. 
2011;2:WMC001696
[24] Ma TY et al. TNF-α induced 
increase in intestinal epithelial tight 
junction permeability require NFkβ 
activation. American Journal of 
Physiology. Gastrointestinal and Liver 
Physiology. 2004;286:367-376
[25] Lappas M et al. Mitogen activated 
protein kinase proteins regulate LPS-
stimulated release of pro-inflammatory 
cytokines and prostaglandins from 
human gestational tissues. Placenta. 
2007;28:936-945
[26] Vieira IR et al. TLR 9 stimulation 
induces increase in fungicidal activity 
of human dendritic cells challenged 
with Paracoccidioides brasiliensis. 
Journal de Mycologie Médicale. 
2017;56:911-915
[27] Duan XZ et al. Decreased numbers 
and impaired function of circulating 
dendritic cell subsets in patients with 
chronic hepatitis B infection. Journal 
of Gastroenterology and Hepatology. 
2005;20:234-242
[28] Kucukcelebi A et al. In vivo 
characterization of interleukin-4 as a 
potential wound healing agent. Wound 
Repair and Regeneration. 1995;3:49-58
[29] Dinarello CA. Immunological and 
inflammatory functions of interleukin-1 
family. Annual Review of Immunology. 
2009;27:519-550
[30] Sultani M et al. Anti-inflammatory 
cytokines: Important immuno regulatory 
factors contributing to chemotherapy 
induced gastrointestinal mucositis. 
Chemotherapy Research and Practice. 
2012;2012:11
[31] Kimmel JR, Pollock HG. Studies 
of human insulin from non diabetic 
and diabetic pancreas. Diabetes. 
1967;16:687-694
[32] Huang L. Zinc and its transporters, 
pancreatic β-cells and insulin 
metabolism. Vitamins and Hormones. 
2014;95:365-390
[33] Haeusler RA et al. Biochemical and 
cellular properties of insulin receptor 
signalling. Nature Reviews. Molecular 
Cell Biology. 2018;19:31-44
[34] Ward CW et al. The insulin receptor 
changes conformation in unforeseen 
ways on ligand binding: Sharpening the 
picture of insulin receptor activation. 
BioEssays. 2013;35:945-954
[35] Alberto M et al. The chemokines 
system in diverse forms of macrophages 
activation and polarization. Trends in 
Immunology. 2004;25:677-686
[36] (a) Human insulin. Stylized 
chemical structure. (b) PDB 4iyf 
biological assemblies and structure 
analysis Protein
[37] Rezvani O et al. A randomized, 
double blind, placebo controlled trial to 
determine the effects of topical insulin 
on wound healing. Ostomy/Wound 
Management. 2009;55:22-28
[38] Hrynyk M, Neufeld RJ. Insulin 




[39] Azevedo FF et al. Insulin topical 
modulates inflammatory phase and 
the angiogenesis of the burns wound 
healing in diabetic induced rats. 
Diabetology and Metabolic Syndrome. 
2015;7:A259
[40] Kaur P et al. Novel nano-insulin 
formulation modulates cytokine 
secretion and remodelling to accelerate 
diabetic wound healing. Nano. 
2018;15:47-57
[41] Choi J et al. Soluble CD44 is 
cytotoxic to trabecular meshwork and 
cells in vitro retinal ganlion. Glaucoma. 
2005;46:214-222
[42] Price WA et al. Pro-and anti-
inflammatory cytokines regulate 
insulin-like growth factor binding 
protein production by fetal rat lung 
fibroblasts. American Journal of 
Respiratory Cell and Molecular Biology. 
2002;26:283-289
[43] Gould GW et al. The glucose 
transporter family: Structure, function 
and tissue specific expression. The 
Biochemist. 1993;295:329-341
[44] McMillan DE. The microcirculation 
in diabetes. Microcirculation, 
Endothelium, and Lymphatics. 
1984;1(1):3-24
[45] Li Q et al. Insulin regulates glucose 
consumption and lactate production 
through reactive oxygen species 
and pyruvate kinase M2. Oxidative 
Medicine and Cellular Longevity. 
2014;2014:504-953
[46] Hajjar DP, Gotto AM Jr. Biological 
relevance of inflammation and oxidative 
stress in the pathogenesis of arterial 
diseases. The American Journal of 
Pathology. 2013;182:1474-1481
[47] Kennedy KM et al. Tumor 
metabolism of lactate: The influence 
and therapeutic potential for MCT and 
CD147 regulation. Future Oncology. 
2010;6:127-148
[48] Grenz A et al. Hypoxia signaling 
during intestinal ischemia and 
inflammation. Current Opinion in 
Critical Care. 2012;18:178-185
[49] Zgheib C et al. Long non-coding 
RNA lethe regulates hyperglycemia 
induced reactive oxygen species 
production in macrophages. PLoS One. 
2017;12(5):e0177453
[50] Zeng T et al. Blocking nuclear 
factor-kappa B protects against 
diet-induced hepatic Steatosis and 
insulin resistance in mice. PLoS One. 
2016;11(3):e0149677
[51] Li L et al. Identification of dynamic 
molecular network in peripheral blood 
mononuclear cells in type-1 diabetes 
mellitus. Diabetes, Metabolic Syndrome 
and Obesity: Targets and Therapy. 
2019;12:969-982
[52] Steppan CM, Lazar MA. Resistin 
and obesity associated insulin 
resistance. Trends in Endocrinology and 
Metabolism. 2002;13:18-23
[53] Liu T et al. NFκB signalling in 
inflammation. Signal Transduction and 
Targeted Therapy. 2017;2:17023
[54] Paolo EP et al. Lactate stimulates 
angiogenesis and accelerates the 
healing of superficial and ischemic 
wounds in mice. Angiogenesis. 
2012;15(4):581-592
[55] Backert S et al. Lactate stimulates 
endothelial cell migration. Wound Repair 
and Regeneration. 2006;14:321-324
[56] Zgheib C et al. Long noncoding 
RNA lethe regulates hyperglycemia 
induced reactive oxygen species 
production in macrophages. PLoS One. 
2017;12(5):e0177453
[57] Wang Y et al. Artemisinin inhibits 
monocyte adhesion to HUVECs through 
the NF-κB and MAPK pathways in 
vitro. International Journal of Molecular 
Medicine. 2016;37:1567-1575
71
Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
[58] Lovejoy J et al. Insulin resistance 
in obesity is associated with elevated 
basal lactate appearance following 
intravenous glucose and insulin. 
Metabolism. 1992;41:22-27
[59] Guo X et al. Glycolysis in the 
control of blood glucose homeostasis. 
Acta Pharmaceutica Sinica B. 
2012;2:358-367
[60] Saltiel AR et al. Insulin signalling 
pathways regulating translocation of 
GLUT4. Nature. 2005;5:159-165
[61] Wu M et al. Antidiabetic and 
antisteatotic effects of the selective 
fatty acid synthase (FAS) inhibitor 
platensimycin in mouse model of 
diabetes. Proceedings of the National 
Academy of Sciences of the United 
States of America. 2011;108:5378-5383
[62] Murphy MP. Modulating 
mitochondrial intracellular location 
as a redox signal. Science Signaling. 
2012;5:39
[63] Ellen L et al. Selective superoxide 
generation within mitochondria by the 
targeted redox cycler mitoparaquat. 
Free Radical Biology and Medicine. 
2015;89:883-889
[64] James S et al. Fluid shear stress 
inhibits TNF-α activation of JNK but not 
ERK1/2 or p38 in human umbilical vein 
endothelial cells: Inhibitory crosstalk 
among MAPK family members. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2011;98:6476-6481
[65] Adolfo RAP et al. c-Fos activates 
and physically interacts with specific 
enzymes of the pathway of synthesis 
of polyphosphoinositides. Molecular 
Biology of the Cell. 2011;22:4716-4725
[66] Laurence H et al. Signaling 
pathways involved in LPS induced 
TNFalpha production in human 
adipocytes. Journal of Inflammation 
Research. 2010;7:1
[67] Greenhaff PL et al. Disassociation 
between the effects of amino acids 
and insulin on signaling, ubiquitin 
ligases, and protein turnover in human 
muscle. American Journal of Physiology. 
Endocrinology and Metabolism. 
2008;295(3):595-604
[68] Bagry HS et al. Metabolic syndrome 
and insulin resistance perioperative 
considerations. Anesthesiology: ASA. 
2008;108:506-523
[69] Bell JA et al. Short term insulin and 
nutritional energy provision do not 
stimulate muscle protein synthesis if 
blood amino acid availability decreases. 
American Journal of Physiology. 
Endocrinology and Metabolism. 
2005;289:999-1006
[70] Prodhomme M et al. Insulin and 
amino acids both strongly participate to 
the regulation of protein metabolism. 
Current Opinion in Clinical Nutrition & 
Metabolic Care. 2004;7:71-77
[71] Proud CG. Regulation of protein 
synthesis by insulin. Biochemical 
Society Transactions. 2006;34:213-216
[72] Vijayakumar A et al. Biological 
effects of growth hormone on 
carbohydrate and lipid metabolism. 
Growth Hormone & IGF Research. 
2010;20:1-7
[73] Guo JY et al. Activated Ras requires 
autophagy to maintain oxidative 
metabolism and tumorigenesis. Genes 
& Development. 2011;25:460-470
[74] Higashi Y et al. IGF-1, oxidative 
stress and atheroprotection. Trends 
in Endocrinology and Metabolism. 
2010;21:245-254
[75] Werner H et al. Similarities and 
differences between insulin and IGF-I: 
Structures, receptors, and signalling 




[39] Azevedo FF et al. Insulin topical 
modulates inflammatory phase and 
the angiogenesis of the burns wound 
healing in diabetic induced rats. 
Diabetology and Metabolic Syndrome. 
2015;7:A259
[40] Kaur P et al. Novel nano-insulin 
formulation modulates cytokine 
secretion and remodelling to accelerate 
diabetic wound healing. Nano. 
2018;15:47-57
[41] Choi J et al. Soluble CD44 is 
cytotoxic to trabecular meshwork and 
cells in vitro retinal ganlion. Glaucoma. 
2005;46:214-222
[42] Price WA et al. Pro-and anti-
inflammatory cytokines regulate 
insulin-like growth factor binding 
protein production by fetal rat lung 
fibroblasts. American Journal of 
Respiratory Cell and Molecular Biology. 
2002;26:283-289
[43] Gould GW et al. The glucose 
transporter family: Structure, function 
and tissue specific expression. The 
Biochemist. 1993;295:329-341
[44] McMillan DE. The microcirculation 
in diabetes. Microcirculation, 
Endothelium, and Lymphatics. 
1984;1(1):3-24
[45] Li Q et al. Insulin regulates glucose 
consumption and lactate production 
through reactive oxygen species 
and pyruvate kinase M2. Oxidative 
Medicine and Cellular Longevity. 
2014;2014:504-953
[46] Hajjar DP, Gotto AM Jr. Biological 
relevance of inflammation and oxidative 
stress in the pathogenesis of arterial 
diseases. The American Journal of 
Pathology. 2013;182:1474-1481
[47] Kennedy KM et al. Tumor 
metabolism of lactate: The influence 
and therapeutic potential for MCT and 
CD147 regulation. Future Oncology. 
2010;6:127-148
[48] Grenz A et al. Hypoxia signaling 
during intestinal ischemia and 
inflammation. Current Opinion in 
Critical Care. 2012;18:178-185
[49] Zgheib C et al. Long non-coding 
RNA lethe regulates hyperglycemia 
induced reactive oxygen species 
production in macrophages. PLoS One. 
2017;12(5):e0177453
[50] Zeng T et al. Blocking nuclear 
factor-kappa B protects against 
diet-induced hepatic Steatosis and 
insulin resistance in mice. PLoS One. 
2016;11(3):e0149677
[51] Li L et al. Identification of dynamic 
molecular network in peripheral blood 
mononuclear cells in type-1 diabetes 
mellitus. Diabetes, Metabolic Syndrome 
and Obesity: Targets and Therapy. 
2019;12:969-982
[52] Steppan CM, Lazar MA. Resistin 
and obesity associated insulin 
resistance. Trends in Endocrinology and 
Metabolism. 2002;13:18-23
[53] Liu T et al. NFκB signalling in 
inflammation. Signal Transduction and 
Targeted Therapy. 2017;2:17023
[54] Paolo EP et al. Lactate stimulates 
angiogenesis and accelerates the 
healing of superficial and ischemic 
wounds in mice. Angiogenesis. 
2012;15(4):581-592
[55] Backert S et al. Lactate stimulates 
endothelial cell migration. Wound Repair 
and Regeneration. 2006;14:321-324
[56] Zgheib C et al. Long noncoding 
RNA lethe regulates hyperglycemia 
induced reactive oxygen species 
production in macrophages. PLoS One. 
2017;12(5):e0177453
[57] Wang Y et al. Artemisinin inhibits 
monocyte adhesion to HUVECs through 
the NF-κB and MAPK pathways in 
vitro. International Journal of Molecular 
Medicine. 2016;37:1567-1575
71
Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
[58] Lovejoy J et al. Insulin resistance 
in obesity is associated with elevated 
basal lactate appearance following 
intravenous glucose and insulin. 
Metabolism. 1992;41:22-27
[59] Guo X et al. Glycolysis in the 
control of blood glucose homeostasis. 
Acta Pharmaceutica Sinica B. 
2012;2:358-367
[60] Saltiel AR et al. Insulin signalling 
pathways regulating translocation of 
GLUT4. Nature. 2005;5:159-165
[61] Wu M et al. Antidiabetic and 
antisteatotic effects of the selective 
fatty acid synthase (FAS) inhibitor 
platensimycin in mouse model of 
diabetes. Proceedings of the National 
Academy of Sciences of the United 
States of America. 2011;108:5378-5383
[62] Murphy MP. Modulating 
mitochondrial intracellular location 
as a redox signal. Science Signaling. 
2012;5:39
[63] Ellen L et al. Selective superoxide 
generation within mitochondria by the 
targeted redox cycler mitoparaquat. 
Free Radical Biology and Medicine. 
2015;89:883-889
[64] James S et al. Fluid shear stress 
inhibits TNF-α activation of JNK but not 
ERK1/2 or p38 in human umbilical vein 
endothelial cells: Inhibitory crosstalk 
among MAPK family members. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2011;98:6476-6481
[65] Adolfo RAP et al. c-Fos activates 
and physically interacts with specific 
enzymes of the pathway of synthesis 
of polyphosphoinositides. Molecular 
Biology of the Cell. 2011;22:4716-4725
[66] Laurence H et al. Signaling 
pathways involved in LPS induced 
TNFalpha production in human 
adipocytes. Journal of Inflammation 
Research. 2010;7:1
[67] Greenhaff PL et al. Disassociation 
between the effects of amino acids 
and insulin on signaling, ubiquitin 
ligases, and protein turnover in human 
muscle. American Journal of Physiology. 
Endocrinology and Metabolism. 
2008;295(3):595-604
[68] Bagry HS et al. Metabolic syndrome 
and insulin resistance perioperative 
considerations. Anesthesiology: ASA. 
2008;108:506-523
[69] Bell JA et al. Short term insulin and 
nutritional energy provision do not 
stimulate muscle protein synthesis if 
blood amino acid availability decreases. 
American Journal of Physiology. 
Endocrinology and Metabolism. 
2005;289:999-1006
[70] Prodhomme M et al. Insulin and 
amino acids both strongly participate to 
the regulation of protein metabolism. 
Current Opinion in Clinical Nutrition & 
Metabolic Care. 2004;7:71-77
[71] Proud CG. Regulation of protein 
synthesis by insulin. Biochemical 
Society Transactions. 2006;34:213-216
[72] Vijayakumar A et al. Biological 
effects of growth hormone on 
carbohydrate and lipid metabolism. 
Growth Hormone & IGF Research. 
2010;20:1-7
[73] Guo JY et al. Activated Ras requires 
autophagy to maintain oxidative 
metabolism and tumorigenesis. Genes 
& Development. 2011;25:460-470
[74] Higashi Y et al. IGF-1, oxidative 
stress and atheroprotection. Trends 
in Endocrinology and Metabolism. 
2010;21:245-254
[75] Werner H et al. Similarities and 
differences between insulin and IGF-I: 
Structures, receptors, and signalling 




[76] Ando Y et al. Epidermal growth 
factor and insulin like growth factor 
I enhance keratinocyte migration. 
Journal of Investigative Dermatology. 
1993;100:633-639
[77] Burks DJ, White MF. Beta cell and 
function in type 2 diabetes. Diabetes. 
2001;50:140
[78] Yamada Y et al. Activation of the Akt-
mTOR pathway and receptor tyrosine 
kinase in patients with solitary fibrous 
tumors. Cancer. 2014;120:864-876
[79] Cefalu WT. Insulin resistance: 
Cellular and clinical concepts. 
Experimental Biology and Medicine. 
2001;226:13-26
[80] Vatankhah N et al. Effect of 
systematic insulin treatment on diabetic 
wound healing. Wound Repair and 
Regeneration. 2017;25:288-291
[81] Novak ML, Koh TJ. Macrophage 
phenotypes during tissue repair. 
Journal of Leukocyte Biology. 
2013;93:875-881
[82] Falanga V. Advanced treatments for 
non healing chronic wounds. EWMAJ. 
2004;4:11-13
[83] McCormick SM et al. Regulation 
of macrophage, dendritic cell, and 
microglial phenotype and function 
by the SOCS proteins. Frontiers in 
Immunology. 2015;6(6):549
[84] Guo SA et al. Factors affecting 
wound healing. Journal of Dental 
Research. 2010;89:219-229
[85] Thomsen LH et al. Polarization of  
macrophages in metabolic diseases. 
Cellular Immunology. 2015;6(6):2
[86] Wang N et al. Molecular 
mechanisms that influence the 
macrophage M1–M2 polarization 
balance. Frontiers in Immunology. 
2014;5:614
[87] Ferreira AE et al. PPAR-g/IL-10 
axis inhibits MyD88 expression and 
ameliorates murine polymicrobial 
sepsis. Journal of Immunology. 
2014;192:2357-2365
[88] Chandirasegaran G et al. Diabetes 
millerus induced oxidative stress, 
inflammation and apoptosis: A concise 
review. ECDMR. 2009;1:10-17
[89] Zhu X et al. Micro environment and 
intra cellular metabolism modulation of 
adipose tissue macrophage polarization 
in relation to chronic inflammatory 
diseases. Diabetes/ Metabolism 
Research and Reviews. 2018;34:e2993
[90] Wetzler C et al. Large and 
sustained induction of chemokines 
during impaired wound healing 
in the genetically diabetic mouse: 
Prolonged persistence of neutrophils 
and macrophages during the late phase 
of repair. Journal of Investigative 
Dermatology. 2000;115:245-253
[91] Kasuya A et al. Attempts to 
accelerate wound healing. Journal 
of Dermatological Science. 
2014;76:169-172
[92] Porta C et al. Molecular and 
epigenetic basis of macrophage 
polarized activation. Seminars in 
Immunology. 2015;27:237-248. DOI: 
10.1016/j.smim.2015.10.003
[93] Jornvall H et al. Oligomerization 
and insulin interactions of pro-insulin 
C-peptide: Three folds relationships to 
properties of insulin. Biochemical and 
Biophysical Research Communications. 
2010;391:1561-1566
[94] Bhatt MP et al. C-peptide 
replacement as an emerging 
strategy for preventing diabetic 
vasculopathy. Cardiovascular Research. 
2014;104:234-244
[95] Haidet J et al. C-peptide reduces 
pro-inflammatory cytokine secretion 
73
Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
in LPS-stimulated U937 monocytes 
in condition of hyperglycemia. 
Inflammation Research. 2012;61:27-35
[96] Bloomgarden ZT. Diabetes 
complications. Diabetes Care. 
2004;27:1506-1514
[97] Hills CE et al. Cellular and 
physiological effects of C-peptide. 
Clinical Science. 2009;116:565-574
[98] Walcher D, Marx N. C-peptide in 
the veaael wall. The Review of Diabetic 
Studies. 2009;6:180
[99] Gunasekaran T et al. Silver 
nanoparticles as real topical bullets 
for wound healing. The Journal of the 
American College of Certified Wound 
Specialists. 2012;3:82-96
[100] Patra CR et al. Targeted 
delivery of gemcitabine to pancreatic 
adenocarcinoma using cetuximab as 




[76] Ando Y et al. Epidermal growth 
factor and insulin like growth factor 
I enhance keratinocyte migration. 
Journal of Investigative Dermatology. 
1993;100:633-639
[77] Burks DJ, White MF. Beta cell and 
function in type 2 diabetes. Diabetes. 
2001;50:140
[78] Yamada Y et al. Activation of the Akt-
mTOR pathway and receptor tyrosine 
kinase in patients with solitary fibrous 
tumors. Cancer. 2014;120:864-876
[79] Cefalu WT. Insulin resistance: 
Cellular and clinical concepts. 
Experimental Biology and Medicine. 
2001;226:13-26
[80] Vatankhah N et al. Effect of 
systematic insulin treatment on diabetic 
wound healing. Wound Repair and 
Regeneration. 2017;25:288-291
[81] Novak ML, Koh TJ. Macrophage 
phenotypes during tissue repair. 
Journal of Leukocyte Biology. 
2013;93:875-881
[82] Falanga V. Advanced treatments for 
non healing chronic wounds. EWMAJ. 
2004;4:11-13
[83] McCormick SM et al. Regulation 
of macrophage, dendritic cell, and 
microglial phenotype and function 
by the SOCS proteins. Frontiers in 
Immunology. 2015;6(6):549
[84] Guo SA et al. Factors affecting 
wound healing. Journal of Dental 
Research. 2010;89:219-229
[85] Thomsen LH et al. Polarization of  
macrophages in metabolic diseases. 
Cellular Immunology. 2015;6(6):2
[86] Wang N et al. Molecular 
mechanisms that influence the 
macrophage M1–M2 polarization 
balance. Frontiers in Immunology. 
2014;5:614
[87] Ferreira AE et al. PPAR-g/IL-10 
axis inhibits MyD88 expression and 
ameliorates murine polymicrobial 
sepsis. Journal of Immunology. 
2014;192:2357-2365
[88] Chandirasegaran G et al. Diabetes 
millerus induced oxidative stress, 
inflammation and apoptosis: A concise 
review. ECDMR. 2009;1:10-17
[89] Zhu X et al. Micro environment and 
intra cellular metabolism modulation of 
adipose tissue macrophage polarization 
in relation to chronic inflammatory 
diseases. Diabetes/ Metabolism 
Research and Reviews. 2018;34:e2993
[90] Wetzler C et al. Large and 
sustained induction of chemokines 
during impaired wound healing 
in the genetically diabetic mouse: 
Prolonged persistence of neutrophils 
and macrophages during the late phase 
of repair. Journal of Investigative 
Dermatology. 2000;115:245-253
[91] Kasuya A et al. Attempts to 
accelerate wound healing. Journal 
of Dermatological Science. 
2014;76:169-172
[92] Porta C et al. Molecular and 
epigenetic basis of macrophage 
polarized activation. Seminars in 
Immunology. 2015;27:237-248. DOI: 
10.1016/j.smim.2015.10.003
[93] Jornvall H et al. Oligomerization 
and insulin interactions of pro-insulin 
C-peptide: Three folds relationships to 
properties of insulin. Biochemical and 
Biophysical Research Communications. 
2010;391:1561-1566
[94] Bhatt MP et al. C-peptide 
replacement as an emerging 
strategy for preventing diabetic 
vasculopathy. Cardiovascular Research. 
2014;104:234-244
[95] Haidet J et al. C-peptide reduces 
pro-inflammatory cytokine secretion 
73
Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers
DOI: http://dx.doi.org/10.5772/intechopen.92096
in LPS-stimulated U937 monocytes 
in condition of hyperglycemia. 
Inflammation Research. 2012;61:27-35
[96] Bloomgarden ZT. Diabetes 
complications. Diabetes Care. 
2004;27:1506-1514
[97] Hills CE et al. Cellular and 
physiological effects of C-peptide. 
Clinical Science. 2009;116:565-574
[98] Walcher D, Marx N. C-peptide in 
the veaael wall. The Review of Diabetic 
Studies. 2009;6:180
[99] Gunasekaran T et al. Silver 
nanoparticles as real topical bullets 
for wound healing. The Journal of the 
American College of Certified Wound 
Specialists. 2012;3:82-96
[100] Patra CR et al. Targeted 
delivery of gemcitabine to pancreatic 
adenocarcinoma using cetuximab as 




Managing Patients with Pressure 
Ulcers
Eglantina Afonso, Dina Borges, Kátia Furtado,  
Maria do Céu Marques, Margarida Pedro, Inês Reis  
and Rita Morais
Abstract
This study describes care for the person and the informal caregiver with pressure 
ulcers. The qualitative methodological approach was used, and case study research 
and the data collection techniques used were the semi-structured interview and the 
questionnaire. The following scales were applied to the patient: Braden Pressure 
Ulcer Risk Assessment, Resvesch 2.0, Malnutrition Universal Screening Nutritional 
Assessment. Modified Barthel and direct observation of wounds, use of the acro-
nym Tissues, Inflammation/infection, Moisture, Edges/Epithelium. The nursing 
intervention at the patient’s home was positive in the evolution of the pressure ulcer 
healing and in the management of the caregiver’s emotions. Providing nursing 
home care to the injured person is a balm for patients and caregivers. It is an excel-
lent response to aging and consequent complications, for example, wounds. They 
promote gains in health and in the management of human and economic resources.
Keywords: pressure ulcers, home care nursing, caregiver and informal, caregiver 
burden
1. Introduction
The technological and scientific development of medicine has increased the 
average life expectancy. Today, living more years is not synonymous with quality 
of life. Society’s increased concern with the perception of the quality of life is not 
consensual, but its association with health is unanimous.
Health is a state of balance between the physical and the mental, without 
discomfort and suffering, which enables the individual to function as effectively 
as possible in the environment, and a change in this balance causes malaise 
[1]. Nowadays, health policies favor homecare for dependent people [2]. The 
Development Plan of the National Network for Integrated Continuous Care 
[RNCCI] reinforces this concept by stating that the community is the most privi-
leged place for patient care and that each person is responsible for their life and their 
family as a socio-family reference; therefore, home is a key aspect in health care [3].
With the increase in the population age as well as the need for care, new health 
requirements emerge. The RNCCI has formed Integrated Continuing Care [ECCI] 
to provide homecare, focusing on dependent people whose situation does not 
require hospitalization but who cannot move independently and where the focus of 
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care is centered on the patient and the informal caregiver, who are equally involved. 
This informal care is the care given to dependent people by their family, friends and 
neighbors [4]. The informal caregiver is undoubtedly a valuable aspect not only 
for patient care but also for the health teams provided by the state. This alliance 
requires the informal caregiver to be available as well as to develop caregiving 
skills. Given this scenario, the challenge of health policies will be to strike a balance 
between self-care, informal support and care provided by professionals [5].
Despite the growing interest in the positive aspects of care given by the care-
giver, there is still some predominance of negative impacts. Home nursing care 
is a difficult task influenced by different factors [6]. Thus, it is intended that the 
benefits become the core of the issue. Stimulating the role of the informal caregiver 
is essential to keep the patient at home, to optimize his quality of life and avoid his 
institutionalization [7].
Nursing as a science that takes care of the human being is committed to edu-
cating and guiding [8], as one of the competences of the general care nurse. As 
mentioned in article 5, it is the nurse’s responsibility to guide and supervise, trans-
mitting information to the patient aiming at changing behaviors for the acquisition 
of healthy lifestyles or health recovery, following this process and introducing 
the necessary adjustments [9]. The community nurse has the role of educating by 
promoting adequate education as well as information and training.
One of the reasons for admitting patients to ECCI is the treatment of pressure 
ulcers [PUs] and/or wounds, the admission criterion being the existence of an informal 
caregiver as a help from the home care team, so that continuity of care is guaranteed 
and to achieve the goals in the prevention and treatment of complex wounds.
Physical dependence leads to long periods of immobility, endangering skin 
integrity, leading to the appearance of PUs [1]. PUs represent a public health prob-
lem, both nationally and internationally. These entail marked economic burdens 
for a country, hence the growing political and economic concern [10], and are 
considered the third or fourth most expensive pathology in the world [11]. PUs are 
an indicator of the quality of health care provided. The personal suffering caused by 
this pathology affects the quality of life of patients and caregivers, which can lead to 
death in extreme situations [12].
The European Pressure Ulcer Advisory Panel [EPUAP] in 2014 defined PU as 
a localized lesion on the skin and/or underlying tissue, usually over a bony promi-
nence, as a result of pressure or a combination of torsion forces [13]. This entity 
classifies PUs according to their stage of evolution into six categories/grades, as 
follows: Category/Grade I: non-blanching erythema; Category/Grade II: partial loss 
of skin thickness; Category/Grade III: total loss of skin thickness; Category/Grade 
IV: total loss of tissue thickness; non-gradable/unclassifiable: indeterminate depth; 
and suspected deep tissue injury: indeterminate depth [13].
The appearance of a PU is largely due to an association of the following risk 
factors, such as immobilization, nutritional status, skin integrity, age and blood 
oxygenation level. PUs do not only occur in the geriatric population, but they can 
also occur in any individual who has one or more of the risk factors mentioned [14]. 
Demographic changes, such as the growth of the elderly population with multiple 
co-morbidities, lead to an increase in the number of people with injuries [15]; 
hence, the prevention and treatment are a challenge for health professionals, espe-
cially, nurses. According to the DGS Guideline, 95% of PUs are preventable by early 
identification of the degree of risk [12]. Therefore, the assessment and management 
of the risk of developing PUs require a general and multidisciplinary approach to 
the person [16].
This study aims to describe care for the person and informal caregiver with 
pressure ulcers.
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2. Methodology
This study consists of qualitative research, more specifically a case study, with 
a central focus on the user and the caregiver, who are provided nursing care by the 
Integrated Continuous Care Team of a city in southern Portugal.
After selecting the patient for the study, informed consent was requested from 
the legal representative, his wife, since the patient presented changes regarding his 
orientation of time and space, as evidenced by the application of the Mini-Mental 
State scale. The study was submitted to the Ethics Committee of the Baixo Alentejo 
Local Health Unit.
This type of study seeks to relate the evolution of a phenomenon associated with 
an intervention. For this, the following resources were used: data collection through 
semi-structured interviews with the informal caregiver and application of the Informal 
Caregiver Burden Assessment Questionnaire [QASCI]. Regarding the patient, the fol-
lowing were used: application of the Pressure Ulcer Risk Assessment Scale: Braden Scale 
[12]; application of the Resvech 2.0 Scale; application of the Malnutrition Universal 
Screening Nutritional Assessment Scale [MUST] [17]; application of the Barthel 
Modified Scale [18] and direct observation of the PU, through photographic recording 
and based on the acronym Tissues, Inflammation/infection, Moisture, Edges/Epithelium 
[TIME]; the data collection through the clinical process of the patient and the diagnostic 
evaluation according to the life activities following the Roper-Logan-Tierney theoretical 
model [19], related to the changed daily living activities [DLA] in the patient. For the 
elaboration of the diagnostic judgments, the language of the International Classification 
for Nursing Practice [ICNP] [20] was used, based on the Nursing Interventions 
Classification [NIC 2010] and the Nursing Outcomes Classification [NOC 2010].
3. Results
3.1 Appreciation
The case study was carried out to the AF patient, male, 70 years old, Caucasian, 
Portuguese nationality, who lives in Beja, with an Elementary School Education, 
retired, married, and living with his wife and a daughter.
Personal history: hypertension; depressive syndrome; ethanolic habits, cerebral 
vascular accident (CVA) in 2013 with left hemiparesis, senile dementia, vascular 
epilepsy, venous insufficiency of the lower limbs, inguinal hernioplasty, pneu-
monia, acute cholecystitis and urinary tract infection. Once part of the ECCI, the 
patient presented with four PUs, with three of them already cicatrized (sacred, left 
shoulder and right trochanter).
Daily medication: ®baclofen 50 mg at breakfast and bedtime; ®warfarin 1.25 mg 
at 7 pm; ®pantoprazole 40 mg before meal; ®sertraline 50 mg at breakfast; 
®enalapril 20 mg at breakfast and ®sodium valproate 500 mg every 8 h.
After the CVA in 2013, the patient started at RNCCI, having integrated three 
units. On August 11 of 2016, he was admitted in ECCI, referenced by the family 
health team for wound care at home. During a home visit, on August 12, 2016, four 
PUs were found instead of one (information given on the first day). For the healing 
of the sacred PU, there was a need for constant articulation with the family health 
team and surgery team. During the 27 months with the ECCI, the left trochanter PU 
did not have the expected evolution, despite its smaller size.
The patient presents with total dependence on ADL, as demonstrated by the 
Barthel Modified Scale Assessment with a zero score, with ankylosis of the joints, 
which makes hygiene care and mobilization difficult, maintains home support 
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three times a day (hygiene and transfers). The equipment that exists in the patient’s 
home is an alternating pressure mattress and a shower chair. The patient gets up 
daily to an armchair and sleeps in a double bed with inadequate equipment. The 
patient presents with incoherent speech, hydrated and flushed skin and mucous 
membranes, normal nutritional status, with a body mass index [BMI] of 23.1. The 
patient has as an informal caregiver his wife, who is less than two years old than 
the patient, manifesting difficulties in taking care of her husband, presenting with 
physical and mental stress overload.
To describe the ADL, the theoretical model previously mentioned was 
used. Regarding his breathing and controlling body temperature, it remained 
unchanged. Mobilization is compromised in bedridden and ankylosing patients, 
and they are dependent on transfers and positions. The patient was not sup-
ported by the team’s physiotherapist since he was already in a rehabilitation unit. 
His work and leisure time are compromised, due to his illness and dependence. 
Regarding the alimentation, it is his wife who prepares and feeds him soft diet 
meals and protein supplements, using a syringe. His wife is concerned about 
his well-being and quite motivated by the food aspects, which manifest with 
increased concern.
Personal hygiene and dressing are compromised, being performed by the 
home support team, with the supervision of the caregiver. Elimination is compro-
mised but without alteration of the bladder and intestinal pattern. Regarding the 
following: his sleep, sleep habits are maintained; sensations, the patient presented 
on the observer scale, without pain; integument, compromised with the presence 
of PU in the left trochanter; memory, patient is disoriented in space, time and 
himself.
3.2 Analysis and discussion of results
PUs are lesions that require prolonged and difficult treatment. It depends not 
only on the therapeutic care provided, such as the frequency of treatment and the 
suitability of the dressing material, but also on the general condition of the patient 
and the care provided to him or her by the informal caregiver, such as the frequency 
of positioning/repositioning; adaptive equipment; pressure reduction and relief. 
Based on the recommendations of NPUAP/EPUAP & PPPIA [13], the supporting 
surfaces are essential and should be chosen according to the pressure redistribution 
needs and other therapeutic functions of the individual.
Based on the diagnosis of needs, it is essential to define intervention strategies, 
to plan the nursing interventions appropriate to the individual, using appropriate 
assessment instruments.
Concerning the degree of risk of developing PU according to the Braden Scale, 
the patient’s FA has a total score of 13, which represents a high risk, since DGS 
[12] reports that a score less than or equal to 16 is high risk. According to the DGS 
[12], the assessment of the risk of developing PU is fundamental for planning and 
implementing PU prevention and treatment measures. From the application of 
the instrument to the patient, it is verified that the mobilization and the friction 
and sliding forces are the most relevant factors that condition the healing of the 
wounds and the reappearance of new injuries, despite the intervention with the 
caregiver through the transmitted information and the results and lessons learned: 
wheelchair acquisition, viscoelastic cushion, articulated bed and correct position-
ing techniques, and the informal caregiver due to individual and cultural factors 
did not adhere to the intervention proposals planned by health professionals. The 
patient has an alternating pressure mattress in the bed and the caregiver positions it 
without collaboration, however, and uses incorrect positioning techniques, causing 
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damage to tissue already regenerated, as occurred in the sacred region, not consid-
ering the guidelines of health professionals.
Regarding the patient alimentation, the caregiver is concerned about the food 
and water intake of the patient and makes daily protein supplements. In the applica-
tion of the MUST instrument, the assessment is low risk.
The informal caregiver demonstrates physical and psychological overload, 
proven by the application of the QASCI instrument (in October and December 
2018). Given the scores, it is noteworthy that the caregiver presents instability in 
the performance of her role as a caregiver. The caregiver’s condition worsened in 
November 2018, when she initiated restrictions on her health, through non-adher-
ence to the therapeutic regimen for arterial hypertension, dental abscesses and 
osteoarticular pain. The caregiver’s imbalance in biological, psychological and social 
factors has repercussions on the care she gives. ECCI’s multidisciplinary team from 
Beja articulated with the caregiver and family team referring her to a psychiatry 
consultation, having attended only one consultation.
When the patient had a stroke in 2013, PU appeared, and there was a need for 
nursing intervention and entry into the ECCI. In the beginning, the left trochanter 
PU was grade I, and it was aggravated due to the number of hours that the patient 
remained in the left lateral decubitus, to relieve the existing PU. In the begin-
ning, the treatment applied was once a day with ®hyperoxygenated fatty acid 
and protection with polyurethane foam with ®sodium carboxymethylcellulose. 
On September 19, 2016, the UP presented: devitalized tissue, bleeding tissue, 
without smell, bounded edges, with a dimension of 5 cm [cm] long by 3 cm 
wide. The treatment applied daily was enzymatic debridement due to the risk of 
hemorrhage, with irrigation with a solution of ®polyhexamethylene guanidine 
[PHMB], ®calcium alginate with silver and foam ®polyurethane with ®sodium 
carboxymethylcellulose. Articulation with the family team was carried out for 
close control of the international normalized ratio [INR] and respective thera-
peutic adjustment of the anticoagulant.
On November 14, 2016, the wound presented: hemorrhage in the wound bed, 
devitalized tissue, granulation tissue and odor. Despite being referred to the 
emergency department and a surgery doctor, his wife refused to go. Gelatin sponge 
dressing, pads and patching, dressing and treatment were initiated twice a day, 
as well as antibiotic therapy after medical observation. On November 20, 2016 
(Figure 1), there was PU with devitalized granulation tissue, without bleeding, 
with inflammatory signs (redness and erythema) and without odor. The treat-
ment applied was saline [S], ®carboxymethylcellulose single fibers, polyurethane 
Figure 1. 
Left trochanter November 2016, own source.
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ning, the treatment applied was once a day with ®hyperoxygenated fatty acid 
and protection with polyurethane foam with ®sodium carboxymethylcellulose. 
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wide. The treatment applied daily was enzymatic debridement due to the risk of 
hemorrhage, with irrigation with a solution of ®polyhexamethylene guanidine 
[PHMB], ®calcium alginate with silver and foam ®polyurethane with ®sodium 
carboxymethylcellulose. Articulation with the family team was carried out for 
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On November 14, 2016, the wound presented: hemorrhage in the wound bed, 
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with inflammatory signs (redness and erythema) and without odor. The treat-
ment applied was saline [S], ®carboxymethylcellulose single fibers, polyurethane 
Figure 1. 
Left trochanter November 2016, own source.
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foam and ®hydrocolloid plate. For a long period, the PU did not evolve, despite 
vacuum therapy being applied for 1 month, without favorable results due to care-
giver resistance. On September 18, 2018, the patient began treatment with honey, 
®carboxymethylcellulose single fibers and ®hydrocolloid plaque. In October 2018, 
the wound did not heal and presented with: devitalized tissue, increased exudate 
and purulent characteristics, inflammatory signs, and bad smell, the non-healing 
mnemonics was applied, increased exudate, red and bleeding surface tissue, Dobris 
[NERDS]. The use of honey was suspended due to the rejection of the informal 
caregiver; therefore, irrigation with PHMB and carboxymethylcellulose fibers with 
silver, calcium alginate, polyurethane foam and ®hydrocolloid plate were restarted.
On November 20, 2018, the wound presented: fibrin that was removed, 
granulation tissue and devitalized, odorless. The treatment was warm saline, 
®carboxymethylcellulose single fibers, polyurethane foam and ®hydrocol-
loid plate (Figure 2). Due to acute illness on December 15, 2018 (Figure 3), 
hospitalized patient referred to the unit. He was discharged on January 10, 2019, 
continuing with ECCI support. On January 23, 2019, PU with granulation and 
devitalized tissue, macerated and thickened edges, applied with warm saline and 
Figure 3. 
Left trochanter December 2018, own source.
Figure 2. 
Evolution with acronym TIME November 2018, own source.
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®carboxymethylcellulose single fibers, polyurethane foam and ®hydrocolloid 
plate. For a better understanding, Table 1 represents the comparison regarding PU 
bed preparation.
4. Final considerations
We can conclude that a correct diagnosis in favor of the needs felt by the infor-
mal caregiver and the patient is crucial in the planning of nursing interventions 
and the result of health gains for both the patient and those who take care. The 
positive aspects of the present study were the commitment of the caregiver together 
with the professionals in self-care in hygiene/comfort and nutrition, leading to the 
healing of three initial PUs. However, something remained to be done, the barriers 
created by the caregiver to the management of the physical space, the non-healing 
of the left trochanter PU and constant maceration of the sacred region, the care 
inherent in positioning/repositioning avoiding friction and sliding forces, despite 
the intervention through the teachings done over time. Taking care of a patient is 
not easy, and the nurse has to know the entire biopsychosociocultural context of 
the patient and the caregiver, to give the appropriate response to the detected needs. 
Homecare nurses can promote interventions aimed at favoring and promoting 
conditions so that the patient and the informal caregiver can transform the nega-
tive aspects into positive ones, as a way to achieve a quality of life. What makes the 
difference is people, for that it is necessary to rethink strategies and put them into 
practice.
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Abstract
Hypertrophic scars represent important problems because of the presence of 
pain, pruritus, contractures, as well as unsatisfactory aesthetic results. Currently, 
the evidence shows that a multidisciplinary management through prevention, 
adequate choice of suture, atraumatic surgical technique, and early noninvasive 
measures can favor the handling of these problems and continue with invasive 
measures that employ intralesional drugs. Clearly, the combination of surgical, 
technical, and pharmacological interventions will maximize therapeutic results.
Keywords: hypertrophic scar, scar, pathological scar, surgical scar
1. Introduction
Hypertrophic scars (HS) are defined as a pathological scars that have abnormal 
thickness and are raised from the previous wound [1]. Such scars are the most 
common complication of burn injury and abnormal wound healing response after 
traumatic injury, surgery, or inflammation [2, 3]. These lesions are characterized 
by their red to purple color, raised appearance, decreased pliability, and tenderness 
with concomitant symptoms including pruritus and pain [4–9]. Patients with HS 
may suffer from stiffness, cosmetic disfigurement, joint contractures, as well as 
impediment in physical function and daily activities, and even psychological issues 
such as depression or anxiety [1, 10–12].
2. Epidemiology
The best clinical predictor for the development of hypertrophic burn scars is a 
prolonged inflammatory wound healing phase. This result usually corresponds with 
a wound that has not epithelialized and continues to exudate for more than 3 weeks 
[13]. Hypertrophic scars generally develop at about 2 months after a burn and will 
continue to proliferate for a year or longer. HS maturation may not occur until 18 or 
even 24 months after a burn. The exact time point of regression or maturation of HS 
remains unknown [8–10, 14, 15].
According to the literature, about 32–72% of surgical skin wounds result in HS 
after 1 year [16, 17]. In Asian, the prevalence rate of HS after burn injury is as high 
as 70%, much higher than in Caucasian populations. Contractures after burns have 
a prevalence of 38–54% of patients, with up to 46% patients undergoing at least one 
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with concomitant symptoms including pruritus and pain [4–9]. Patients with HS 
may suffer from stiffness, cosmetic disfigurement, joint contractures, as well as 
impediment in physical function and daily activities, and even psychological issues 
such as depression or anxiety [1, 10–12].
2. Epidemiology
The best clinical predictor for the development of hypertrophic burn scars is a 
prolonged inflammatory wound healing phase. This result usually corresponds with 
a wound that has not epithelialized and continues to exudate for more than 3 weeks 
[13]. Hypertrophic scars generally develop at about 2 months after a burn and will 
continue to proliferate for a year or longer. HS maturation may not occur until 18 or 
even 24 months after a burn. The exact time point of regression or maturation of HS 
remains unknown [8–10, 14, 15].
According to the literature, about 32–72% of surgical skin wounds result in HS 
after 1 year [16, 17]. In Asian, the prevalence rate of HS after burn injury is as high 
as 70%, much higher than in Caucasian populations. Contractures after burns have 
a prevalence of 38–54% of patients, with up to 46% patients undergoing at least one 
reconstructive procedure after their acute hospital stays [18, 19] (Figure 1).
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In order to prevent and treat pathologic wounds, one must first understand the 
basics of normal wound healing.
3. Wound healing
The desirable result of normal wound healing is replacement of the initial hemo-
static clot with skin that approximates the aesthetic, mechanical, and functional 
properties of the preinjury tissue.
Historically, wound healing has been arbitrarily divided into three phases, with 
some authors adding hemostasis as the inciting phase. Although wound healing 
occurs on a time continuum, division of the process into phases allows for ease of 
description and evaluation. Changes in the steps of normal wound healing may 
result in either a “hypoplastic” or chronic nonhealing wound or a hypertrophic 
“over-healed” wound [20].
The clotting cascade is activated immediately after trauma, a consequence of 
the disruption of the vascular endothelium and exposure of the basal lamina that 
results in extravasation of blood constituents and concurrent platelet activation. 
Subsequently, the release of growth factors causes the deposition of extracellular 
matrix (transforming growth factor β), chemotaxis (platelet-derived growth fac-
tor), epithelialization (fibroblast growth factor and epidermal growth factor), and 
angiogenesis (vascular endothelial growth factor) [21, 22].
4. Inflammatory
An inflammatory phase develops and persists for 4–6 days. This phase is character-
ized by hemostasis and leukocytic infiltration led by polymorphonuclear leukocytes. 
Neutrophils, as well as monocytes, fibroblasts, and endothelial cells deposit on a fibrin 
scaffold formed by platelet activation. The presence of neutrophils is followed closely 
by monocytes that are quickly activated into tissue macrophages. These cells cause 
further tissue debridement and secrete additional cytokines as well as growth factors 
that promote fibroblast proliferation, angiogenesis, and keratinocyte migration [23].
5. Proliferative
The proliferative phase of wound healing begins at 4 days and persists up to 
14 days; this phase is heralded by the transformation of monocytes to macrophages. 
Figure 1. 




Keratinocytes initiate epithelialization and are present on the wound edge as well 
as from dermal appendages such as hair follicles, sweat, and sebaceous glands. 
Epidermal growth factor, fibroblast growth factor, transforming growth factor 
β, and multiple cytokines originate cell detachment and mitotic division; then, 
fibroblasts appear in the wound after 24 hours of this stimulation and produce 
collagen. This process requires adequate oxygen supply. In fact, without oxygen to 
assist in the hydroxylation of proline and lysine residues, chemical bonds will not 
form appropriately to create a mature form of collagen. These bonds are very criti-
cal because their absence can prolong the stage and result in a chronic wound. They 
serve as the basis for the final stage of maturation and remodeling [24].
6. Maturation
Appropriate wound maturation and remodeling result in a quickly healed and 
minimally visible scar; whereas, prolongation or deviations from this phase can 
cause hypertrophic, keloid scars or chronic nonhealing wounds. This initial collagen 
is thinner than uninjured. Type III collagen initially comprises 30% of the granula-
tion tissue matrix, compared with 10–20% in uninjured skin. Over time, the ratio 
of type III collagen decreases, and type I collagen increases. An overall increase in 
collagen formation is seen for 4–5 weeks; after this time wound strength increases 
and parallels the increase in type I collagen [25, 26].
7. Cellular basis, signals and pathways of hypertrophic scars
Fibroblasts and myofibroblasts are pivotal effectors cells in HS [27]. The activa-
tion of fibroblasts and differentiation into myofibroblasts (that are a phenotypi-
cally intermediate cell type between fibroblasts and smooth muscle cells) are the 
central processes in the pathophysiology of hypertrophic scars. The larger the area 
of the wound, the greater migration of myofibroblasts. This situation results in 
more prominent scarring [28, 29]. Many origins of fibroblasts or myofibroblasts 
have been characterized: local dermis and subcutaneous tissues around the wound 
Figure 2. 
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site, pericytes and vascular smooth muscle cells, tubular epithelial cells through 
epithelial-mesenchymal transition (EMT), tissue specific stem cells, and bone 
marrow-derived peripheral blood fibrocytes (Figure 2) [30].
The proliferative fibroblasts produce massive collagen and make extracellular 
matrix (ECM) that accumulates below the dermis. One sign thought to be of par-
ticular importance is that transforming growth factor-beta (TGF-b), acting through 
a signaling pathway in fibroblasts, appears to cause an increase in production of 
ECM and leads to cellular proliferation [31, 32]. Over time, some cells can develop 
autocrine TGF-b positive feedback loops that can lead to a self-propagating cycle of 
excessive extracellular matrix production and cell proliferation. Moreover, fibro-
blasts infiltrate and degrade the fibrin clot by producing matrix metalloproteinases 
(MMPs) and tissue inhibitor of metalloproteinases (TIMPs). This action results in 
an imbalance between the formation and degradation of matrix [33].
8. Risk factors
Risk factors for the development of pathologic scarring in the setting of burns 
have been reported to include darker skin color [1, 34], female sex [35], young age 
[17, 35, 36], allergy [16, 37], bacterial colonization [38], stretch and burns to the 
neck or upper limb [35], multiple surgical procedures [35], meshed skin graft [35], 
increased time to healing [1, 35, 38, 39], and burn depth [35].
Factors that reduce the risk of presenting HS are: chemotherapy [40], smoking [17], 
statins [41], and genetic background that does not have association [42] (Table 1).
9. Genetic
No convincing evidence exists for a familial pattern in patients who suffer from 
HS. In a systematic review, the authors did not find any pedigree studies on HS [42, 43].
10. Dark skin
In the literature, dark skin has a higher incidence of HS compared with lighter 
skin of Caucasians. Dark skin contains more and larger fibroblasts that deposit 
more collagen, related to what was previously written [1, 34, 36].
Increase HS
Darker skin color Stretch
Female sex Neck and upper limb
Young age Multiple surgical procedures
Allergy Meshed skin graft












Gangemi and colleagues observed in a multivariate regression model that 
female sex, young age, burn sites on the neck and/or upper limbs, multiple surgi-
cal procedures, and meshed skin grafts were risk factors for postburn pathologic 
scarring [35].
12. Age
Evidence supports the negative association of age with HS. Excessive scars 
develop mostly in younger patients between 11 and 30 years old. The inflammatory 
response decreases with age: epidermal turnover is slower in elderly individuals, 
and the epidermis contains fewer cells [17, 35, 36, 44].
13. Allergy
Hypothesize that increased degranulation of mast cells observed in allergic 
individuals supports HS formation. This relationship of allergy with HS formation 
is supported by level III evidence [16, 37].
14. Bacterial colonization
Bacterial toxins stimulate and prolong the inflammatory phase of wound healing 
and, thereby stimulate HS [38, 45].
15. Evaluation of hypertrophic scar
Currently no standardized system method exists to assess postsurgical scars. 
In the literature, scar assessment has mainly been focused on burn scars, but an 
increasing interest in postsurgical scars is seen, both to evaluate postoperatively as 
well as to have a closer and objective monitoring when therapeutic measures are 
applied so as to conclude whether the management is effective or, on the contrary 
worsening the situation of the scar [4, 9].
Comprehensive scar assessment must include three different dimensions: (a) 
physical characteristics; (b) cosmetic appearance; and (c) patient’s symptoms 
(Table 2).
To date, only four scales have been psychometrically studied: the Vancouver 
Scar Scale (VSS), the Patient and Observer Scar Assessment Scale (POSAS), the 
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16. Vancouver scar scale (VSS)
The VSS was created in 1990 and is the most widely used rating scale for scars. 
Four physical characteristics are scored: height, pliability, vascularity, and pigmen-
tation. Each variable is ranked to obtain a total score ranging from 0 to 13, with 0 
representing normal skin [46, 47] (Table 4).
17. Manchester scar scale
The MSS includes six items: contour, texture, color, distortion, shiny surface, 
and overall patient’s opinion [47].
18. Patient and observer scar assessment scale
The POSAS is a recent and promising scar assessment tool that incorporates both 
observer and patient scar ratings [47, 48].
Scar scales
Vancouver scar scale
Patient and observer scar assessment scale
Manchester scar scale
Stony Brook scar evaluation scale
Table 3. 






19. Stony Brook scar evaluation scale
Scars are assigned 0–1 point for the presence or absence of the following: width 
greater than 2 mm at any point of the scar, raised (or depressed) scar, and darker 
coloration than surrounding skin. The total score is then derived from the scale and 
ranges from 0 (worst) to 5 (best) [47, 49].
20. Treatment of hypertrophic scar
Different methods have been described for the treatment of hypertrophic scars. 
Among those have been found prevention, re-excision with primary closure, mas-
sages, compression clothes, silicone sheets, intralesional injections, laser therapy 
and topical treatments (Table 5).
21. Prevention
The prevention is the conjunction of measures that reduce inflammation and 
provide rapid wound closure such as early debridement of dead space, reducing the 
risk of infection through rinsing and disinfection, as well as optimal dressings that 
provide moist wound healing and/or early surgical wound coverage. During the 
operation, the surgeon should also use adequate sutures and avoid excessive ten-
sion. Surgical closure must be meticulous with an atraumatic technique to generate 
a successful and minimal linear scar. In the training of plastic surgery, the use of 
fine and atraumatic instruments is taught for the handling of the tissues for example 
hooks for retraction. Without a doubt, the tension found in the closure of a wound 
plays a very important role in widened and hypertrophic scars; these tension forces 
separate the edges of the wound and generate a wider scar with time. This result can 
be decreased with the liberation and advancement of the edges, in addition to the 
placement of correct subdermal sutures [50].
Once the wound has been prepared and is ready for closure, the proper suture 
and suture technique must be selected. Wounds may be closed with simple inter-
rupted, horizontal mattress, vertical mattress, figure-of-eight, or running sutures. 
The choice of the suture is of great importance, and most of the time despised, 
attention should be paid to the estimated time to resorption since the suture may 
or may not provide adequate support during the healing process. With a Level II 
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of Therapeutic Evidence, polydioxanone (PDS) has been found to result in less 
scar widening and less scar hypertrophy at 6 months compared with polyglycolic 
acid (PGA). In the first 3 weeks of wound healing, the strength of a wound is only 
a small fraction of its eventual strength. Sutures removed or degraded before this 
time have little effect in preventing wound spreading. Polyglactic acid suture loses 
strength after 3 weeks, at which time the wound is still relatively weak. These 
results are similar to removing a nylon suture from the wound in 1 week [51, 52].
Leaving a permanent intradermal suture in place for several months has been 
shown to decrease spreading, and a synthetic suture possibly retains strength for 
6–8 weeks and may have the same effect. This result is caused by the difference in 
the absorption time and what comes from the loss of tensile strength. On an average 
PGA scars were wider than PDS scars by 33% (means 9.6, 7.2), the difference that 
was statistically highly significant (Wilcoxon test p < 0.001) [51, 52].
In another study that used the Vancouver Scar Scale (VSS), the scar’s width and 
quality of polydioxanone (PDS) was compared with that of polyglactin 910. The 
scars were evaluated at 1, 3 and 4 months postoperatively. On follow-up, the mean 
scar width in Polyglactin 910 was significantly more than that of PDS. The VSS 
score was significantly lower in the PDS group at the third and fourth month follow 
up and signified better scar quality [53].
22. Noninvasive measures
22.1 Pressure garment therapy (PGT)
The theory behind the use of PGT may be quite simple and relies on two main 
concepts; first, the restriction of blood flow to the scar area inhibits the growth 
of hypertrophic scar tissue and second constant compression does too [54]. Some 
evidence indicates that PGT may have an effect on the remodeling of hypertrophic 
burn scar elements such as fibrillin and elastin [55]. In an experimental model with 
swine that received pressure treatment with a device mounting and delivery at 
30 mm Hg of constant pressure for 2 weeks, the total collagen quantification using 
hydroxyproline assay showed a 51.9% decrease after pressure initiation. Pressure 
treated scars also had lower levels of collagen I and III after pressure treatment 
(P < 0.05) compared with sham and untreated scars [56]. Using a newly developed 
pressure therapy system, the Smart Pressure Monitored Suits. Pre and post treat-
ment comparison demonstrated significant improvement in scar pigmentation, 
thickness, VSS scores, as well as scores of pain and itch (p < 0.01) for the early 
intervention group prescribed within 60 days after injuries compared with the late 
intervention group prescribed after 61 days. The early group demonstrated superior 
effect in improving scar lightness, yellowness (p < 0.01), thickness (p < 0.01), 
pigmentation score (p < 0.05) and pain score (p < 0.01) than the late group in 
comparison between the two groups at similar postburn timing [57].
However, a meta-analysis of clinical results suggests that PGT does not appear to 
alter global scar scores, but does appear to improve scar height, although this differ-
ence is small and of questionable clinical importance. The beneficial effects of PGT 
remain unproven while the potential morbidity and cost are not insignificant [58].
22.2 Scar massage
Scar massage is used in burn units globally to improve functional and cosmetic 
outcomes of hypertrophic scarring following a burn; however, the evidence to sup-





The three main groups of lasers that can be used to improve scars include pulsed 
dye lasers (PDLs), Nd:YAG lasers, as well as ablative and nonablative fractional 
lasers.
A systematic review of the effectiveness of the ablative 10,600 nm CO2 laser, 
shows objective improvement in scar color, thickness, and sensation, but not in 
scar elasticity. All studies reported improvements in the mean total VSS score and/
or VSS component scores (pliability, height, vascularity, pigmentation), without 
statistically significant differences between raters. Statistically significant improve-
ments in both the patient and the observer sections of the POSAS were reported 
after CO2 laser treatment. Despite these positive findings, all studies were of low 
or unclear quality. As a result, insufficient scientific evidence exists to determine 
the effectiveness of laser therapy for hypertrophic burn scars from this systematic 
review [60].
22.4 Silicone gel sheeting (SGS)
In 2006, a Cochrane review found weak evidence to support the use of SGS [61]. 
SGC was effective to reduce thickness, pain, itchiness, and pliability of hypertro-
phic scars in Chinese the population after 6 month’s intervention [62]. Silicone 
products, either in gel or sheet, are superior to onion extracts including heparin and 
allantoin in the treatment of the hypertrophic scar [63].
23. Invasive treatment
23.1 Intralesional corticosteroids
In patients with ongoing hypertrophy, more invasive measures are indicated. 
Intralesional corticosteroids is the only invasive option that has enough supporting 
evidence [64, 65]. The most commonly used is triamcinolone acetonide (TAC), the 
dose and treatment interval is variable ranging from 10 to 40 mg/ml given between 
2 and 4 weeks interval. The success rate is 50–100% in different studies with 9–50% 
experiencing recurrence [66, 67]. The TAC injection should be limited to the scar 
and avoid the periscar tissues. The adverse outcomes of skin atrophy, pigmentation, 
and telangiectasias are unacceptable by some patients [68–71].
The injection of TAC is not contraindicated in children, but that dose adaption 
to the child’s weight is advised to avoid systemic exposure [72, 73].
Additional injectable treatment options that may help to treat hypertrophic scars 
(and keloids) include 5-fluorouracil and verapamil.
23.2 5-Fluorouracil (5FU)
The use of antineoplastic agents as treatment options is logical because these 
abnormal tissues are in hypermetabolic states. 5-FU has been known to affect the 
fibroblast proliferation in tissue cultures because of its antimetabolite activity and 
has been shown to be an effective treatment for inflamed hypertrophic scars [28].
23.3 Triamcinolone acetonide and 5FU
This combination is associated with significantly greater reductions in scar 
size and erythema compared with triamcinolone acetonide alone in a 12-week 
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double-blind study of 40 patients [74]. In a randomized control trial that include 
120, patients the mean reduction in scar height was significant in 5FU + TAC group 
versus TAC alone. Recurrence was seen in 39.2% of patients of the TAC group while 
in 17.5% of 5FU + TAC group (P = 0.012) [75].
Verapamil is a calcium channel antagonist that both decreases collagen syn-
thesis and increases collagen breakdown. In a randomized, single-blind study of 
54 patients with hypertrophic scars or keloids, scar vascularity, pliability, height, 
and width were reduced with intralesional verapamil, although the rate of reduc-
tion in these parameters was slower than with intralesional triamcinolone [76]. 
A randomized controlled of 50 patients the VSS scores were achieved with no 
therapeutic event or significant improvement was seen in verapamil group versus 
TAC group [77].
Pruritus is a chronic problem associated with many hypertrophic scars. Besides 
the emollient creams mentioned above, the use of local or systemic antihistamines 
may be useful and depends on the total body surface area involved in the areas of 
Figure 3. 
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itchiness. Some early evidence suggests that naltrexone may be a useful treatment 
for burn-related itching [78].
23.4 Surgical treatment
Surgical interventions for burn scars are usually postponed until the scar is 
considered “mature” or what may be 6–12 months after maturity, primarily because 
of the concern of recurrence of the scar. This may also have been influenced by burn 
scar reconstructive release surgeries performed by grafting and flaps. Most believe 
that the best option is the treatment with flaps [79] (Figures 3 and 4).
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Figure 4. 
Multiple syndactyly release in a single time with seagull wings flap.
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Abstract
Negative pressure wound therapy (NPWT) is widely used for chronic and acute 
open wounds, with clinically proven benefits of faster wound healing by promoting 
granulation tissue growth and increased perfusion and facilitating epithelialization 
and contraction. Improved outcomes on open wounds prompted the application 
of NPWT on closed surgical incisions. The application of NPWT, in the immediate 
postoperative period, reduces surgical site infections (SSIs) and wound dehiscence 
by 50% in high-risk patients. The negative pressure reduces wound edema and 
improves local perfusion and lymphatic f low, thereby minimizing hematoma and 
seroma rates. The improved perfusion and oxygenation facilitate quicker wound 
healing as well as minimize ischemic complications like f lap necrosis. Recent 
literature supports enhanced wound healing and superior scar appearance as well 
as improved wound maturity, evidenced by 50% more force required to pull apart 
a sutured incision. Improved outcomes of incisional NPWT are reported from 
various surgical procedures on abdominal, breast, orthopedic, vascular, cardiac, 
and plastic surgeries. Further clinical studies and cost-benefit analysis are needed to 
recommend routine postoperative use of incisional NPWT in high-risk and low-risk 
patient population.
Keywords: negative pressure wound therapy, incisional NPWT, closed incision 
NPWT, wound healing, wound dehiscence, surgical site infections
1. Introduction
The concept of negative pressure wound therapy (NPWT) was pioneered in 
1997 by Morykwas, applying vacuum-assisted closure (VAC) on a pig wound 
model. Morykwas’ initial methodology involved packing the wound with foam, 
covering and sealing with an adhesive drape, and applying 125 mm Hg of negative 
pressure either continuously or intermittently [1]. The rudimentary NPWT led to 
increased blood f low, granulation tissue, and f lap survival, with decreased bacterial 
growth [1].
NPWT refers to wound healing technology consisting of three major parts: 
a wound dressing, covers, and a pump [2]. Wound dressing aids in transferring 
pressure from the pump to the wound itself, and modern NPWT typically utilizes 
reticulated open-pore polyurethane foam, intended to equalize the negative 
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pressure across the entire wound surface [2]. The cover creates an airtight seal over 
an open wound, and the pump applies the negative pressure [2, 3].
There are four major types of NPWT [4]. The first is a large, battery-powered 
NPWT in the acute inpatient setting, while the second is a portable, battery-pow-
ered NPWT designed for outpatient use, but cannot be purchased over the counter 
and tends to be noisy [4]. The third type is a longer-lasting battery-powered NPWT 
that can be purchased over the counter and is designed to last 7 days and subse-
quently discarded, while altered models designed for inpatient use that include 
additional functions, such as negative pressure wound therapy with instillation-
dwelling (NPWTi-d) and incisional negative pressure wound therapy (iNPWT), 
are the last [4].
1.1 Mechanism of action
By drawing f luid out of the wound, negative pressure increases blood f low, 
decreases the bacterial burden, cleans the wound, reduces local edema, and 
removes soluble inf lammatory mediators that may delay wound healing [2–4]. It 
has been postulated that NPWT draws antibiotics into the wound, but evidence 
is lacking [2]. The application of pressure applies forces to the wound, exerting 
effects macroscopically, through macrodeformation, as well as microscopically, 
through microdeformation [2, 5]. Naturally, negative pressure on a sealed wound 
draws the wound edges together [2]. However, it is important to note that the 
effect is reliant upon tissue parameters such as elasticity and tension, and the 
strength of the negative pressure does not seem to affect the amount of macrode-
formation that occurs [2].
With NPWT, 5–20% of the wound surface experiences tissue stress, and by 
using a reticulated wound dressing, the action of drawing the wound bed into each 
pore via negative pressure constitutes the microdeformation that promotes tissue 
healing processes: increases in cell proliferation, angiogenesis, granulation tissue 
formation, and epithelialization and decreases in inf lammation [2, 5]. NPWT has 
the potential to grow granulation tissue over exposed bone, tendon, or devices 
[4]. Specifically, NPWT increases the concentration of VEGF, TGF-beta, FGF-2, 
PDGF, and IL-8 in the wound, with IL-10 increasing in the body, and decreased 
concentrations of TNF-alpha, IL-1 beta, and matrix metalloproteases (MMPs) 
[2]. In patients with type-2 diabetes, the pro-angiogenic and pro-epithelization 
proteins GDNF family receptor alpha-2 (GFRA2), which complement C1q binding 
protein (C1QBP), RAB35, and synaptic inositol 1,4,5-triphosphate 5-phosphatase 1 
(SYNJ1), were increased [2].
2. NPWT
2.1 Early indications and need for NPWT
Traditional NPWT has been utilized for chronic and acute open wounds and has 
become a mainstay of wound management [4, 6, 7].
Indications for NPWT are as follows [5, 8]:
• Acute, chronic, and dehisced surgical wounds
• Diabetic, pressure, and venous leg ulcers
• Open abdominal wounds
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• Fasciotomies
• Split-thickness skin graft (STSG) recipient sites
• Flaps
• Partial-thickness burns
Contraindications of NPWT include fistulas, malignancy, osteomyelitis, or 
infection, and NPWT should never be applied over exposed critical anatomic struc-
tures or in wounds with necrotic tissue [4, 5]. Despite the benefits of NPWT, there 
are several key reminders to remember in order for treatment to be effective. The 
cover and drainage tube must be assessed carefully as loss of seal or f luid buildup in 
the tube can lead to skin loss or maceration [5]. It is also important to monitor the 
pump to minimize the risk of exsanguination.
There is significant variability regarding the application of NPWT that depends 
on wound characteristics [2, 5]. The wound packing can be foam or gauze [2]. The 
pump may be mechanically or electrically driven [2]. The strength of negative pres-
sure can vary from −50 mm Hg to −150 mm Hg [2]. The pattern of negative pressure 
application can be intermittent, continuous, or variable, with a continuous pattern 
the most common [2]. Selection of parameters is typically at the physician’s discre-
tion, but a recommended pressure is 125 mm Hg applied in a pattern alternating 
between a 5-minute negative pressure and a 2-minute suction [4, 5]. Although stud-
ies suggest intermittent NPWT is the most effective pattern in inducing granulation 
tissue formation and increasing blood f low, it also increases pain for the patient 
[4, 5]. As a result, continuous pressure is often used for painful wounds, as well as 
wounds with overlying skin grafts, and particularly edematous wounds [5]. Beyond 
wound outcomes, NPWT reduces the number of dressing changes, healthcare labor, 
time spent in the hospital, and costs, and this is most demonstrated in portable 
NPWT, which allows treatment to be done at home [5, 9].
2.2 Current applications
Beyond its indications listed previously, the use of NPWT has been expanding 
into newer wound types, including tunneling wounds and avascular tissue, and 
new published case series have demonstrated the use of NPWT in wounds such 
as necrotizing fasciitis [4, 5, 10]. Alterations to traditional NPWT led to negative 
wound pressure therapy with installation (NPWT-i) and incisional negative pres-
sure wound therapy (iNPWT), the latter of which is utilized on closed wounds.
3. Incisional NPWT
Incisional NPWT (iNPWT) has been used since 2006, as an adjunct treatment 
to augment wound healing and prevent surgical site infections (SSI) and wound 
complications.
3.1 Evolution and development
Surgical incisions are a break in the skin and its defenses in avoiding transloca-
tion of infectious pathogens into the deeper tissues. It’s imperative to cover and iso-
late these incisions by a sterile protective dressing in the sterile environment of the 
operating room. Advances in these sterile protective dressings have taken place over 
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decades and, in the present form, are made up of a nonadherent, antimicrobial-
containing dressing covered with sterile gauze or abdominal pads, which are held in 
place by tapes or transparent film.
In the 1990s, NPWT demonstrated promising results in the management of 
acute and chronic open wounds, and Argenta and Morykwas proposed improved 
perfusion and wound contraction, which had a profoundly positive effect on the 
success of wound healing [1].
Gomoll et al., in 2006, pioneered the idea of incisional NPWT and described the 
application of NPWT on 35 orthopedic trauma patients, considered high-risk for 
infections [11]. A permeable nonadherent dressing was applied over the incision 
and covered with standard VAC sponge cut into 1-inch wide strips and then sealed 
with conventional VAC adhesive material. The negative pressure was maintained 
for 3 days, and patients were followed up for SSI for a minimum of 3 weeks. None of 
these 35 patients reported infections, which led to heightened interest in application 
of NPWT for surgical incisions.
3.2 Mechanism of action
Efficacy of NPWT depends on a number of factors, namely, foam width, foam 
thickness, magnitude of negative pressure, and its duration and frequency.
To achieve reproducible and standardized results, the NPWT dressing includes 
a skin interface layer, which is directly placed over the incision site, over which 
reticulated foam dressing is secured with occlusive drape. The VAC pump along 
with the canister is then connected via tubes attached through the foam dressing 
and secured underneath the occlusive drape to maintain an airtight seal. It’s impera-
tive to secure and maintain an airtight seal, in order to achieve efficacy and prevent 
complications like maceration of peri-wound skin.
Several studies and trials have proposed these mechanisms of iNPWT 
(Figure 1):
• Physical barrier to external contamination
• Microdeformation of the wound edges and release of local growth factors
• Approximation of wound edges and minimizing lateral tension and dead space
• Fluid egress and exudate removal
The negative pressure is commonly used continuously within a range of −75 mm 
of Hg to −125 mm of Hg. Although a faster rate of granulation is seen with inter-
rupted pressure, the associated drastic changes in the foam contraction and expan-
sion often render it more painful and impractical for use.
Another alternative, to bridge the gap between continuous and interrupted 
pressure, is variable pressure. It combines the benefit of interrupted pressure and 
faster granulation tissue growth with gradual and smaller deviations in pressure, in 
an attempt to minimize pain.
The role of foam width and thickness is important, as it’s proportional to the 
lateral tension attenuation, as described later in the chapter. Hence, a standard foam 
width of 60 mm is recommended. Cutting thin strips of the foam and using as a 
construction dressing are also discouraged, as it limits the efficacy and benefits of 
the iNPWT.
The optimum negative pressure has been a debatable aspect of NPWT. A lot of 
research focused on negative pressure of −80 mm Hg with positive results, followed 
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by a paper published by Morykwas et al., using −125 mm Hg. The results of this trial 
were promising as it demonstrated improved healing and granulation as compared 
to the earlier results published by the same team and others. Recent literature and 
guidelines recommend a pressure of −125 mm Hg; however, pressures ranging from 
−80, −100, and −125 mm Hg have been employed, and encouraging results have 
been published.
Application of iNPWT on perineal wounds, following abdominoperineal resec-
tion (APR) for colonic and anal lesions, demonstrated improved wound healing and 
reduced complications and infection rates, while using pressure of −80 mm Hg. The 
increase in negative pressure beyond −125 mm Hg does not demonstrate improved 
wound outcomes, either in open or closed wounds.
As the uses and application of the NPWT system develop for closed incision 
surgical wounds, results of various large-scale clinical trials would emerge, and 
further modifications would evolve to maximize the clinical benefits of this promis-
ing therapeutic modality for postoperative surgical wounds.
3.3 Advantages of iNPWT
Several studies have described the benefits of incisional NPWT (iNPWT) in 
general, colorectal, cardiac, vascular, plastic, and orthopedic surgeries. These 
benefits have been classified as immediate, intermediate, and long-term effects 
and result from the sterile isolation of the incision; mechanical stabilization and 
reduction in the tensile forces; obliteration of dead space; reduction of local edema, 
hematoma, and seroma; and increased perfusion and lymphatic f low.
Nam et al. proposed benefits of iNPWT [12], as
• Immediate effects
 ○ Protection of incision from external contamination
 ○ Decreased lateral tension on the incision
 ○ Increased appositional strength
 ○ Normalized stress distribution
Figure 1. 
Cross-sectional depiction of an incision closed with sutures without incisional NPWT (a). Application of 
incisional NPWT decreases lateral tissue tension and increases incisional apposition (b), reducing dead space. 
The applied pressure causes microdeformation and release of local growth factors, promoting healing of the 
surgical incision (reprinted with permission from Ref. [36]).
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by a paper published by Morykwas et al., using −125 mm Hg. The results of this trial 
were promising as it demonstrated improved healing and granulation as compared 
to the earlier results published by the same team and others. Recent literature and 
guidelines recommend a pressure of −125 mm Hg; however, pressures ranging from 
−80, −100, and −125 mm Hg have been employed, and encouraging results have 
been published.
Application of iNPWT on perineal wounds, following abdominoperineal resec-
tion (APR) for colonic and anal lesions, demonstrated improved wound healing and 
reduced complications and infection rates, while using pressure of −80 mm Hg. The 
increase in negative pressure beyond −125 mm Hg does not demonstrate improved 
wound outcomes, either in open or closed wounds.
As the uses and application of the NPWT system develop for closed incision 
surgical wounds, results of various large-scale clinical trials would emerge, and 
further modifications would evolve to maximize the clinical benefits of this promis-
ing therapeutic modality for postoperative surgical wounds.
3.3 Advantages of iNPWT
Several studies have described the benefits of incisional NPWT (iNPWT) in 
general, colorectal, cardiac, vascular, plastic, and orthopedic surgeries. These 
benefits have been classified as immediate, intermediate, and long-term effects 
and result from the sterile isolation of the incision; mechanical stabilization and 
reduction in the tensile forces; obliteration of dead space; reduction of local edema, 
hematoma, and seroma; and increased perfusion and lymphatic f low.
Nam et al. proposed benefits of iNPWT [12], as
• Immediate effects
 ○ Protection of incision from external contamination
 ○ Decreased lateral tension on the incision
 ○ Increased appositional strength
 ○ Normalized stress distribution
Figure 1. 
Cross-sectional depiction of an incision closed with sutures without incisional NPWT (a). Application of 
incisional NPWT decreases lateral tissue tension and increases incisional apposition (b), reducing dead space. 
The applied pressure causes microdeformation and release of local growth factors, promoting healing of the 
surgical incision (reprinted with permission from Ref. [36]).
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 ○ Increased skin perfusion
• Intermediate effects
 ○ Decreased edema
 ○ Decreased hematoma/seroma formation
 ○ Increased lymphatic f low
• Long-term effects
 ○ Improved Incision quality
 ○ Mechanical strength
 ○ Histology
 ○ Gene expression
3.3.1 Prevention of external contamination and surgical site infections
Surgical site infections (SSIs) result in significant morbidity and increased 
healthcare costs, accounting for 21.8% of the 721,800 healthcare-associated infec-
tions recorded annually in the United States [13].
SSIs are estimated to increase average hospital stay by 9.6 days, resulting in an 
added cost of $38,656 and around $10 billion in direct and indirect costs annually [14].
With emphasis on lowering healthcare costs and advancing quality of care, SSIs 
pose a major physical, psychological, and economic burden.
Incisional NPWT immediately provides protection and isolation of the incision 
from external contamination. Multiple studies in trauma surgery, general surgery, 
and plastic surgery have attributed decreased local edema, f luid egress, lower 
hematoma/seroma rates, lower time to healing, and improved genomic profile, 
in terms of reduction of pro-inf lammatory cytokines and chemokines in surgical 
incisions covered with NPWT. An international expert panel in 2017 recommended 
ciNPWT for patients at high risk for surgical site complications [15]. Notable high-
risk features include diabetes, ASA score ≥ 3, obesity (BMI ≥ 30 kg/m2), tobacco 
use, hypoalbuminemia, corticosteroid use, high-tension wounds and revision 
surgery.
Multiple studies across different specialties reported a threefold to fivefold 
reduction in the surgical site infection risk, following the use of ciNPWT [16–18].
Notably, Grauhan and team reported findings of a prospective study of 150 
obese patients who underwent cardiac surgery via a median sternotomy. A sig-
nificant reduction of fourfold in the incidence of wound infection was seen in 
the iNPWT group compared to conventional dressings, at 1 week of surgery [19]. 
Similar findings were reported by Matatov in groin infections covered with iNPWT, 
after vascular procedures (6 vs. 30%, p = 0.0011) [20]. Bonds described a reduc-
tion in the rate of SSIs in the iNPWT group, after open colectomy (12.5 vs. 29.3%, 
p < 0.05) [21].
Contrastingly, a study analyzing 398 patients concluded incisional NPWT 
improved short-term wound complications but had no effect on long-term infection 
rate following knee and hip arthroplasty. A higher proportion of iNPWT patients 
reported wound drainage at day 7, though similar increase was not seen at different 
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time intervals. This study is the largest RCT comparing outcomes of NPWT dress-
ing in elective lower extremity arthroplasty and supporting improved soft tissue 
healing response and lower wound-related complications, but no effect on the risk 
of late superficial or deep infections [22].
Evidence supporting the use of iNPWT in hand and spine surgery is new and 
fewer. SSIs occur is 0.4–20% of patients undergoing spine surgery and contribute to 
increased morbidity, hospitalization, and costs [23–26]. Various treatment modali-
ties such as drains, copious irrigation, and prophylactic antibiotics are employed. 
Adogwa et al. reported a 30% reduction in wound infection rate and 50% reduction 
in wound dehiscence rates in patients after long-segment thoracolumbar spine 
fusion and suggested ciNPWT as a safe and effective means of wound management 
for high-risk spine incisions.
Recent literature suggests incisional NPWT as a safe and effective method in 
preventing SSIs and wound complications in high-risk patients.
3.3.2 Cost analysis of iNPWT
As modern healthcare strives to deliver quality and efficient yet cost-effective 
care, continued efforts are warranted to evaluate economic viability of NPWT use 
and its application in various specialties.
An estimated cost of $100 per day was associated with the use of the 
PREVENA (V.A.C therapy, KCI, San Antonio, TX) system, which showed signifi-
cant reduction in SSI risk [27]. With a typical use of 5–7 days, cost of ciNPWT is 
estimated around $500–700. When used in high-risk populations and higher-cost 
wound management modality, such additional costs of the NPWT system are 
validated, as they lead to overall reduction in total healthcare expenditure. SSIs 
prolong hospital stay, on an average of 9 days, and are associated with an increase 
in costs up to $20,000 [28].
When compared with indirect costs associated with treatment of wound 
dehiscence and complications, and direct costs such as daily dressing changes, the 
economic viability of the iNPWT system in high-risk population seems justified. 
Chopra et al. found an estimated cost saving of $1456 with ciNPWT use in abdomi-
nal wall surgeries. Raymund Horch and his team proposed a cost saving of $163 in 
obese patients and $203 in morbidly obese patients employing iNPWT in post-
bariatric patients undergoing abdominal and thigh dermolipectomy. The authors 
determined that a 28 and 25% reduction in SSIs’ rate in the obese and morbidly 
obese patients, respectively, was needed to achieve cost savings with iNPWT. Lewis 
et al. proposed cost savings with iNPWT if wound complications are reduced by 
one-third in patients undergoing laparotomy for gynecological malignancies [29]. 
Further evaluation of the applicability of the NPWT system and its costs is war-
ranted in diverse patient population (high vs. low risk), healthcare setups (inpatient 
vs. at-home), and specialties.
3.3.3 Wound healing
NPWT has been applied successfully as a therapeutic modality to treat open 
wounds for decades, which led to heightened interest in the scientific community to 
use it over closed wounds, incisions, and skin grafts. Many trials and studies have 
proposed the following mechanisms of incisional NPWT:
• Foam dressing protects wound from external mechanical stress.
• Decrease wound tension and tensile forces in deeper dermal layers.
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 ○ Increased skin perfusion
• Intermediate effects
 ○ Decreased edema
 ○ Decreased hematoma/seroma formation
 ○ Increased lymphatic f low
• Long-term effects
 ○ Improved Incision quality
 ○ Mechanical strength
 ○ Histology
 ○ Gene expression
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Surgical site infections (SSIs) result in significant morbidity and increased 
healthcare costs, accounting for 21.8% of the 721,800 healthcare-associated infec-
tions recorded annually in the United States [13].
SSIs are estimated to increase average hospital stay by 9.6 days, resulting in an 
added cost of $38,656 and around $10 billion in direct and indirect costs annually [14].
With emphasis on lowering healthcare costs and advancing quality of care, SSIs 
pose a major physical, psychological, and economic burden.
Incisional NPWT immediately provides protection and isolation of the incision 
from external contamination. Multiple studies in trauma surgery, general surgery, 
and plastic surgery have attributed decreased local edema, f luid egress, lower 
hematoma/seroma rates, lower time to healing, and improved genomic profile, 
in terms of reduction of pro-inf lammatory cytokines and chemokines in surgical 
incisions covered with NPWT. An international expert panel in 2017 recommended 
ciNPWT for patients at high risk for surgical site complications [15]. Notable high-
risk features include diabetes, ASA score ≥ 3, obesity (BMI ≥ 30 kg/m2), tobacco 
use, hypoalbuminemia, corticosteroid use, high-tension wounds and revision 
surgery.
Multiple studies across different specialties reported a threefold to fivefold 
reduction in the surgical site infection risk, following the use of ciNPWT [16–18].
Notably, Grauhan and team reported findings of a prospective study of 150 
obese patients who underwent cardiac surgery via a median sternotomy. A sig-
nificant reduction of fourfold in the incidence of wound infection was seen in 
the iNPWT group compared to conventional dressings, at 1 week of surgery [19]. 
Similar findings were reported by Matatov in groin infections covered with iNPWT, 
after vascular procedures (6 vs. 30%, p = 0.0011) [20]. Bonds described a reduc-
tion in the rate of SSIs in the iNPWT group, after open colectomy (12.5 vs. 29.3%, 
p < 0.05) [21].
Contrastingly, a study analyzing 398 patients concluded incisional NPWT 
improved short-term wound complications but had no effect on long-term infection 
rate following knee and hip arthroplasty. A higher proportion of iNPWT patients 
reported wound drainage at day 7, though similar increase was not seen at different 
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time intervals. This study is the largest RCT comparing outcomes of NPWT dress-
ing in elective lower extremity arthroplasty and supporting improved soft tissue 
healing response and lower wound-related complications, but no effect on the risk 
of late superficial or deep infections [22].
Evidence supporting the use of iNPWT in hand and spine surgery is new and 
fewer. SSIs occur is 0.4–20% of patients undergoing spine surgery and contribute to 
increased morbidity, hospitalization, and costs [23–26]. Various treatment modali-
ties such as drains, copious irrigation, and prophylactic antibiotics are employed. 
Adogwa et al. reported a 30% reduction in wound infection rate and 50% reduction 
in wound dehiscence rates in patients after long-segment thoracolumbar spine 
fusion and suggested ciNPWT as a safe and effective means of wound management 
for high-risk spine incisions.
Recent literature suggests incisional NPWT as a safe and effective method in 
preventing SSIs and wound complications in high-risk patients.
3.3.2 Cost analysis of iNPWT
As modern healthcare strives to deliver quality and efficient yet cost-effective 
care, continued efforts are warranted to evaluate economic viability of NPWT use 
and its application in various specialties.
An estimated cost of $100 per day was associated with the use of the 
PREVENA (V.A.C therapy, KCI, San Antonio, TX) system, which showed signifi-
cant reduction in SSI risk [27]. With a typical use of 5–7 days, cost of ciNPWT is 
estimated around $500–700. When used in high-risk populations and higher-cost 
wound management modality, such additional costs of the NPWT system are 
validated, as they lead to overall reduction in total healthcare expenditure. SSIs 
prolong hospital stay, on an average of 9 days, and are associated with an increase 
in costs up to $20,000 [28].
When compared with indirect costs associated with treatment of wound 
dehiscence and complications, and direct costs such as daily dressing changes, the 
economic viability of the iNPWT system in high-risk population seems justified. 
Chopra et al. found an estimated cost saving of $1456 with ciNPWT use in abdomi-
nal wall surgeries. Raymund Horch and his team proposed a cost saving of $163 in 
obese patients and $203 in morbidly obese patients employing iNPWT in post-
bariatric patients undergoing abdominal and thigh dermolipectomy. The authors 
determined that a 28 and 25% reduction in SSIs’ rate in the obese and morbidly 
obese patients, respectively, was needed to achieve cost savings with iNPWT. Lewis 
et al. proposed cost savings with iNPWT if wound complications are reduced by 
one-third in patients undergoing laparotomy for gynecological malignancies [29]. 
Further evaluation of the applicability of the NPWT system and its costs is war-
ranted in diverse patient population (high vs. low risk), healthcare setups (inpatient 
vs. at-home), and specialties.
3.3.3 Wound healing
NPWT has been applied successfully as a therapeutic modality to treat open 
wounds for decades, which led to heightened interest in the scientific community to 
use it over closed wounds, incisions, and skin grafts. Many trials and studies have 
proposed the following mechanisms of incisional NPWT:
• Foam dressing protects wound from external mechanical stress.
• Decrease wound tension and tensile forces in deeper dermal layers.
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• Continuous removal of exudate and f luids.
• Decrease local edema improving physiologic adaptation of the wound.
• Increase in local perfusion, oxygenation, and lymphatic f low.
• Decrease hematoma/seroma rates.
• Decrease in time-to-heal duration.
On a molecular level, iNPWT has been hypothesized to remove toxic inf lam-
matory mediators and increase the concentration of local tissue growth factors, via 
microdeformation [30].
An immediate benefit of the iNPWT is the foam dressing that protects the 
incision/wound from external contamination as well as its ability to minimize the 
lateral tension around the suture line by 50%. It also normalizes tensile forces in 
the deep dermal tissue to decrease dead space, which aids in wound healing and 
reduced seroma/hematoma rates. In wound mechanics, study conducted on an inci-
sion made on silicon surface found when iNPWT was applied, 51% more force was 
required to pull apart a sutured incision, and 43% more force was required to pull 
apart a stapled incision than non-iNPWT-treated incisions. An interesting correla-
tion was the proportional association between the width of the foam dressing and 
the force required to pull the incision apart. The study concluded that a foam width 
of 60 mm is required to increase the tensile strength of the incision.
Studies on earlier techniques of NPWT discouraged the construction method 
(dressing of the incision by cutting foam into thin strips) as it likely decreased the 
positive effect of reduced lateral tension on the incision [1].
Early application of iNPWT on pig wound model demonstrated improved 
healing in terms of mechanical, histomorphometric, and gene expression proper-
ties. These incisions showed significantly improved mechanical properties (strain 
energy density, peak strain) and a narrower scar, extending in the deep dermis [31].
Long-term genomic analysis on surgical wounds reveals pro-inf lammatory che-
mokine and cytokine signals in conventional dressing (sterile absorbent abdominal 
dressing)-treated incisions compared to iNPWT-treated incisions. Thus, the latter 
seemed superior in wound strength and wound maturity compared to conventional 
dressing-covered incisions [31].
Early application of iNPWT promotes f luid egress and continuous removal of 
exudates. This leads to reduction in local edema, reduced hematoma/seroma rates, 
improved time to hematoma resolution, decreased time to wound healing, and 
with split-thickness skin grafts (STSG), improved survival with NPWT [12]. When 
used with grafts and skin substitutes, the f luid egress with iNPWT minimizes 
sheer stress and provides tight apposition to the underlying recipient wound bed, 
which promotes incorporation of the graft or skin substitutes and reepithelializa-
tion of graft interstices [32–34]. Maruccia et al. described faster healing, fewer 
dressing changes, and quicker maturity of mesh skin grafts when combined with 
NPWT. This combined treatment provides higher integration, better immobiliza-
tion of the graft, expulsion of f luids, and a moist clean wound bed [35].
The reduction in local edema and removal of f luids in sites such as the abdomen 
and breast help in reducing the need for postoperative drainage. There is renewed 
interest in analyzing results to conclude reduced need and duration for postopera-
tive drains. Several studies in general surgery, plastic surgery, and orthopedic 
surgery have demonstrated reduced drainage with iNPWT-covered incisions. 
Raymund Horch and his team, in 2014, demonstrated the benefits of iNPWT in 
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a post-bariatric patient population undergoing dermolipectomy of the abdomen 
and who presented with reduced exudate formation, earlier drain removal, and 
decreased length of hospitalization [36].
3.3.4 Pain relief
Pain relief with iNPWT has been reported rarely, as very few studies have 
focused on reporting pain scores with this modality. Maruccia et al., in 2016, 
reported a statistically significant reduction in pain scores and wound area in skin 
graft patients. This could be explained by faster healing and improved uptake of the 
graft, along with less frequent need for dressing changes [35].
3.3.5 Scar appearance
Recent literature shows scar appearance improvement with the iNPWT sys-
tem, across various incision sites. Keeney et al., in 2018, reported a trend toward 
better outcomes and improved scar appearance in total knee arthroplasty (TKA) 
patients [22]. Similar improvements have been reported with breast, abdominal, 
and lower and upper extremity incisions too. This is explained by faster wound 
healing, decreased time-to-heal time, reduced wound area and lateral tension, 
and reduced scarring in the deep dermal layers. Optimization in wound heal-
ing and avoidance of complications, such as wound dehiscence and hematoma/
seroma formation, reduce secondary scarring and augurs well for improved scar 
appearance.
3.3.6 Perfusion and oxygen saturation
An important aspect of iNPWT is its ability to alter microcirculation and 
improve tissue perfusion and oxygen saturation, in the immediate, intermediate, and 
long-term analysis of surgical wounds. The purported mechanisms of action are 
microdeformation of wound and increased neo-angiogenesis via release of local 
growth factors [37]. Improved perfusion is demonstrated in the cutaneous arterioles 
(along the skin edges) as well as the deeper tissues, as evidenced by Atkins et al., 
in peri-sternal perfusion after cardiac surgery via median sternotomy. The iNPWT 
was also able to compensate for the reduced perfusion rendered by mammary artery 
harvesting in these patients. In a study published in 2014, Raymund Horch and 
his team demonstrated improved SaO2 and blood f low at all time intervals, over 
abdomen and thigh wounds in post-bariatric surgery patients undergoing dermoli-
pectomy. This was recorded by placing sensors and O2C probe over the abdominal 
skin and thighs [36].
Timmers et al. found a fivefold increase in perfusion, assessed with Doppler 
probes, after application of NPWT over the forearms of healthy volunteers [38].
In a study on iNPWT published in 2016 from the University of Chicago, com-
prising of 228 patients undergoing immediate expander-based breast reconstruc-
tion (study and control groups of 45 and 183, respectively), it was concluded that 
the application of iNPWT significantly decreased the rate of major mastectomy f lap 
necrosis rate (requiring operative intervention), overall mastectomy f lap necrosis 
rates, and overall complication rates [39].
3.3.7 Lymphatic f low
An important supplement to the improved perfusion is increased lymphatic 
f low around the incision. Lymphatic f low increments aid in reducing hematoma 
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• Increase in local perfusion, oxygenation, and lymphatic f low.
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matory mediators and increase the concentration of local tissue growth factors, via 
microdeformation [30].
An immediate benefit of the iNPWT is the foam dressing that protects the 
incision/wound from external contamination as well as its ability to minimize the 
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required to pull apart a sutured incision, and 43% more force was required to pull 
apart a stapled incision than non-iNPWT-treated incisions. An interesting correla-
tion was the proportional association between the width of the foam dressing and 
the force required to pull the incision apart. The study concluded that a foam width 
of 60 mm is required to increase the tensile strength of the incision.
Studies on earlier techniques of NPWT discouraged the construction method 
(dressing of the incision by cutting foam into thin strips) as it likely decreased the 
positive effect of reduced lateral tension on the incision [1].
Early application of iNPWT on pig wound model demonstrated improved 
healing in terms of mechanical, histomorphometric, and gene expression proper-
ties. These incisions showed significantly improved mechanical properties (strain 
energy density, peak strain) and a narrower scar, extending in the deep dermis [31].
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mokine and cytokine signals in conventional dressing (sterile absorbent abdominal 
dressing)-treated incisions compared to iNPWT-treated incisions. Thus, the latter 
seemed superior in wound strength and wound maturity compared to conventional 
dressing-covered incisions [31].
Early application of iNPWT promotes f luid egress and continuous removal of 
exudates. This leads to reduction in local edema, reduced hematoma/seroma rates, 
improved time to hematoma resolution, decreased time to wound healing, and 
with split-thickness skin grafts (STSG), improved survival with NPWT [12]. When 
used with grafts and skin substitutes, the f luid egress with iNPWT minimizes 
sheer stress and provides tight apposition to the underlying recipient wound bed, 
which promotes incorporation of the graft or skin substitutes and reepithelializa-
tion of graft interstices [32–34]. Maruccia et al. described faster healing, fewer 
dressing changes, and quicker maturity of mesh skin grafts when combined with 
NPWT. This combined treatment provides higher integration, better immobiliza-
tion of the graft, expulsion of f luids, and a moist clean wound bed [35].
The reduction in local edema and removal of f luids in sites such as the abdomen 
and breast help in reducing the need for postoperative drainage. There is renewed 
interest in analyzing results to conclude reduced need and duration for postopera-
tive drains. Several studies in general surgery, plastic surgery, and orthopedic 
surgery have demonstrated reduced drainage with iNPWT-covered incisions. 
Raymund Horch and his team, in 2014, demonstrated the benefits of iNPWT in 
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a post-bariatric patient population undergoing dermolipectomy of the abdomen 
and who presented with reduced exudate formation, earlier drain removal, and 
decreased length of hospitalization [36].
3.3.4 Pain relief
Pain relief with iNPWT has been reported rarely, as very few studies have 
focused on reporting pain scores with this modality. Maruccia et al., in 2016, 
reported a statistically significant reduction in pain scores and wound area in skin 
graft patients. This could be explained by faster healing and improved uptake of the 
graft, along with less frequent need for dressing changes [35].
3.3.5 Scar appearance
Recent literature shows scar appearance improvement with the iNPWT sys-
tem, across various incision sites. Keeney et al., in 2018, reported a trend toward 
better outcomes and improved scar appearance in total knee arthroplasty (TKA) 
patients [22]. Similar improvements have been reported with breast, abdominal, 
and lower and upper extremity incisions too. This is explained by faster wound 
healing, decreased time-to-heal time, reduced wound area and lateral tension, 
and reduced scarring in the deep dermal layers. Optimization in wound heal-
ing and avoidance of complications, such as wound dehiscence and hematoma/
seroma formation, reduce secondary scarring and augurs well for improved scar 
appearance.
3.3.6 Perfusion and oxygen saturation
An important aspect of iNPWT is its ability to alter microcirculation and 
improve tissue perfusion and oxygen saturation, in the immediate, intermediate, and 
long-term analysis of surgical wounds. The purported mechanisms of action are 
microdeformation of wound and increased neo-angiogenesis via release of local 
growth factors [37]. Improved perfusion is demonstrated in the cutaneous arterioles 
(along the skin edges) as well as the deeper tissues, as evidenced by Atkins et al., 
in peri-sternal perfusion after cardiac surgery via median sternotomy. The iNPWT 
was also able to compensate for the reduced perfusion rendered by mammary artery 
harvesting in these patients. In a study published in 2014, Raymund Horch and 
his team demonstrated improved SaO2 and blood f low at all time intervals, over 
abdomen and thigh wounds in post-bariatric surgery patients undergoing dermoli-
pectomy. This was recorded by placing sensors and O2C probe over the abdominal 
skin and thighs [36].
Timmers et al. found a fivefold increase in perfusion, assessed with Doppler 
probes, after application of NPWT over the forearms of healthy volunteers [38].
In a study on iNPWT published in 2016 from the University of Chicago, com-
prising of 228 patients undergoing immediate expander-based breast reconstruc-
tion (study and control groups of 45 and 183, respectively), it was concluded that 
the application of iNPWT significantly decreased the rate of major mastectomy f lap 
necrosis rate (requiring operative intervention), overall mastectomy f lap necrosis 
rates, and overall complication rates [39].
3.3.7 Lymphatic f low
An important supplement to the improved perfusion is increased lymphatic 
f low around the incision. Lymphatic f low increments aid in reducing hematoma 
Wound Healing
114
and seroma rates, which are estimated to be reduced by 50–63% with the use 
of iNPWT. The importance of increased lymphatic f low on reducing seroma/
hematoma rates is evidenced by the porcine model study described by Kilpadi 
and Cunningham, in which significant reduction of hematoma and seroma occurs 
without f luid collection in the canister [40].
Kilpadi and Cunningham reported 63% reduced hematoma/seroma rates with 
iNPWT and injected isotope-labeled nanospheres in the subcutaneous tissue to 
discover their highest concentration in lymph nodes closest to, draining the incision 
site [40]. Recent literature is overwhelmingly in favor of reduced seroma/hematoma 
rates, across various surgical procedures covering different surgical specialties and 
incision sites. To name a few, iNPWT and reduced seroma/hematoma have been 
demonstrated at f lap donor sites, like scapular and latissimus dorsi free f lap harvest 
sites, total hip and knee arthroplasty, over abdominal (e.g., cesarean, laparotomy, 
and abdominoplasty), thoracic incisions (e.g., sternotomy), breast incisions 
(expander-based and autologous reconstruction), lower extremity (trauma and 
fractures), and groin incisions (vascular procedures involving femoral vessels) 
[40–43].
3.3.8 Hospital stay
Reduced hospital stay with iNPWT use has been demonstrated extensively, via 
reduced time-to-heal duration, as well as decreased SSI and wound dehiscence and 
complication rates. A recent systematic review on abdomen procedures estimates 
reduction of ICU stay but required more extensive clinical RCT and research [44]. 
Though, it’s difficult to quantify this reduction in hospital stay across various pro-
cedures, NPWT as an incision management tool has been demonstrated to optimize 
and accentuate the wound healing process.
3.3.9 Readmission and reoperation rates
These rates have been assessed in a recent meta-analysis comparing efficacy 
of NPWT in high-risk patients undergoing abdominal wall reconstruction. Both 
outcomes were low in the iNPWT group as compared to control [9 vs. 14% and 3 vs. 
14%, respectively; RR = 0.68 CI (0.46–0.99)].
3.3.10 Wound dehiscence and complication
Wound dehiscence and complications are lowered with the use of iNPWT and 
its aforementioned benefits. Recent literature estimates a reduction of ~50% reduc-
tion in wound dehiscence rates, across various surgical specialties [23, 45–50].
The proposed mechanism of improved wound healing, increased perfusion, 
decreased infection rates, decreased hematoma/seroma rates, decreased lateral and 
deep wound tension, improved wound maturity, and strength and obliteration of 
dead space augurs well for low wound dehiscence and complication rate.
Besides the cost-benefit analysis, an incision management tool with these 
benefits and improved scar appearance definitely requires further clinical trials and 
recommendations for use, especially in high-risk patients.
3.4 Complications and risks of iNPWT
Interest in the use of iNPWT has been peaking in the last few years as favor-
able outcomes seem promising and with easy adaptability and application of 
at-home single-use canister-based NPWT. This single-use NPWT can be used for 
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7 days and improves patient acceptability and compliance. A lot of research has 
been invested in the safety of these systems and to identify complications imped-
ing its widespread use.
The risk of hemorrhage, especially in patients on anticoagulants and with clot-
ting disorders, has been described with the use of iNPWT. Any evidence of fistulas 
or communication to visceral cavities needs further imaging and management 
before the application of negative pressure. Allergic reaction to the dressings is a 
contraindication to the use of iNPWT. Minor skin irritation and ecchymosis are the 
most frequently encountered complications.
4. Clinical applications of incisional NPWT
The earliest description of the use of negative pressure in wound healing was in 
the management of soft tissue injury associated with open fractures. The beneficial 
outcomes seen in various animal models spurred the development of a wide range 
of clinical indications including abdominal, breast, orthopedic, vascular, cardiac, 
and plastic surgeries (e.g., skin graft, burns, muscle f lap) [51].
4.1 Abdominal wounds
The use of incisional NPWT in high-risk patients undergoing abdominal 
surgeries decreased wound complications such as surgical site infections and wound 
healing complications. The primary goals of incisional NPWT wound management 
include active removal of exudates, estimation of third-space f luid loss, and avoid-
ance of mechanical contamination of the abdominal viscera [51].
With the help of the dressing, NPWT applies negative pressure uniformly, thus 
promoting healing by reducing edema, approximating the wound, and removing 
infectious material and exudates [52].
Some studies showed that NPWT improves the removal of abdominal f luid, 
which helps in early fascial closure. The removal of f luids is especially beneficial in 
reducing inf lammatory responses that may occur [53, 54]. This is supported by the 
septic/hemorrhagic shock porcine model, which showed that NPWT efficacy was 
partially due to a reduction in the anti-inf lammatory response [55].
On a recent comparative study on incisional NPWT and conventional dressing 
following abdominal wall reconstruction, the authors demonstrated a statically 
significant reduction in the incidence of skin dehiscence and overall wound com-
plications in the incisional NPWT group compared with the conventional dressing 
group [30].
In a study comparing the rates of SSI of patients who underwent surgery for 
pancreatic, colorectal, or peritoneal surface malignancies between incisional 
NPWT and conventional dressings, the incidence of SSI was significantly lower in 
the incisional NPWT group than the conventional group [56].
The use of incisional NPWT as an effective prophylactic tool has been exam-
ined in studies from various surgical specialties. The results show that its use 
facilitates healing of incisional wounds and reduces the incidence of wound heal-
ing disorders [57].
4.2 Breast surgery
Breast reconstruction using the expander-/implant-based breast reconstruction 
is usually performed after mastectomy and plays a crucial role in psychosocial and 
oncological outcomes in breast cancer patients.
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and seroma rates, which are estimated to be reduced by 50–63% with the use 
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7 days and improves patient acceptability and compliance. A lot of research has 
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One of the most common and significant complications in the immediate 
expander-based breast reconstruction is mastectomy f lap necrosis, which has 
been reported to occur in up to 30% of the patients [58]. Authors of a recent study 
evaluated the incidence of mastectomy f lap necrosis in patients with incisional 
NPWT after immediate expander-based breast reconstruction compared with the 
incidence in patients with conventional dressing.
The incisional NPWT group had a lower overall complication rate, overall 
mastectomy f lap necrosis rate, and major mastectomy f lap necrosis than the 
conventional dressing group [59].
Besides oncological breast surgery, the use of incisional NPWT was also assessed 
in a multicenter study on reduction mammoplasty. The results have shown that inci-
sional NPWT applied to closed incision appeared to be most effective on dehiscence 
in the higher BMI categories and benefit most in preventing complications in the 
higher tissue resection weight categories [60] (Figure 2). The results thus suggest 
applying incisional NPWT devices in reduction mammoplasty where the BMI is 
over 25 or resection weight is above 500 mg [60] (Figure 3).
The safety and efficacy of incisional NPWT in elderly patients undergoing 
breast surgery were studied previously. The results of the study suggest that the 
rates of infections and surgical site events (SSE) were lower with the use of inci-
sional NPWT. The use of incisional NPWT is thus highly recommended in elderly 
patients, who have significant increased risk of developing SSE when compared 
with younger patients [61]. Other studies have concluded that incisional NPWT 
applied to closed surgical incisions on healthy patients after breast reduction 
surgery prevented postsurgical wound complications significantly [62].
4.3 Orthopedics
Complications related to high-risk lower extremity fractures such as calcaneal, 
pilon, and tibial plateau are particularly common. Common complications include 
infection and wound healing problems. In a prospective randomized multicenter 
clinical trial evaluating the use of NPWT after calcaneus, pilon, or tibial fractures, 
the authors have found a significant reduction of infection in the NPWT group [48]. 
The beneficial effects of NPWT on wounds after total ankle replacement or calca-
neus fractures were recognized in a study that showed decreased total time required 
to achieve complete healing, decreased risk of infections, and decreased pain and 
swelling [63]. Several retrospective studies showed positive effects of incisional 
NPWT on wounds after open reduction and internal fixation of acetabular frac-
tures. The NPWT group showed reduced rates of wound dehiscence, deep wound 
infections, and infection rates [64, 65].
A prospective randomized clinical study examined the wounds of patients after 
total hip arthroplasty using ultrasound examination to evaluate for the develop-
ment of potential seroma, a possible risk factor for wound infections. The study 
showed a significant reduction in the seroma size when compared to standard 
wound dressing and positive effects on wound healing and complication rate [42].
4.4 Cardiac surgery
Despite the use of prophylactic antibiotics, the increasing incidence of post-
operative sternal wound infections continues to be a serious problem after surgi-
cal cardiac procedures. Sternal wound infections are associated with additional 
expenses, increased length of stay in the hospital, increased mortality during the 
first year, and a significant reduction in quality of life [66].
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Risk factors that increase the risk of sternal wound infections include smoking, 
diabetes, increasing number of grafts, peripheral vascular disease, chronic pulmo-
nary disease, obesity, increased duration of mechanical ventilation, preoperative 
malnutrition, and harvesting of bilateral internal mammary arteries [67].
The use of incisional NPWT on sternal surgical incisions in patients with 
multiple comorbidities and consequently a high risk for wound complications was 
evaluated. Results have shown no wound complications in this high-risk group of 
patients at least 30 days after surgery and complete wound and surrounding skin 
healing with the absence of skin lesion due to negative pressure after removal of the 
dressing [68]. Results from another study also concluded that applying incisional 
Figure 2. 
Progression of incisions in patient treated with iNPWT and standard wound care after bilateral reduction 
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NPWT over clean, closed incisions for the first 6–7 postoperative days reduced the 
likelihood of postoperative wound infections after median sternotomy not only in 
high-risk patients but also in a comprehensive patient population [45].
4.5 Vascular surgery
Vascular surgical site infections (SSI) occur as a result of perioperative events 
that lead to the colonization of the wound and underlying graft with bacterial spe-
cies. Patients undergoing vascular procedures are at an increased risk of developing 
an SSI of up to 5% of clean procedures and 30% of clean-contaminated procedures 
[69]. Severe complications that arise after vascular surgery including leg amputation 
and death prompted the use of incisional NPWT postoperatively to prevent com-
plications associated with such surgeries. Results of different studies have shown a 
potential reduction in wound complications and no observed increase in hemorrhage 
in high-risk patients with severe comorbidities undergoing vascular surgeries [70].
Recent retrospective study on lower leg fasciotomy supports faster wound clo-
sure and daily wound size reduction, fewer dressing changes, and shorter hospital 
stay with NPWT. These factors contribute to significant reduction in surgical site 
infections, from 30 per cent with standard wound care to 6 per cent with closed 
incisional NPWT [71].
4.6 Plastic surgery
In plastic surgery, the use of NPWT is particularly important in patients who 
experienced complications associated with skin graft rejection and its associated 
partial necrosis. It’s also used after excision of large scalp f laps due to injuries and 
lack of opportunities to cover it with the patient’s own skin. NPWT resulted in faster 
healing and granulation of wounds and a reduction of the overall size [72]. The use 
of NPWT in large wound surfaces with large amounts of mucus, observed in skin 
burns, resulted in a significant acceleration in the time taken for patients’ healing 
and rehabilitation. Additional outcomes included wounds that healed better, fewer 
Figure 3. 
Relation of body mass index (BMI) on wound dehiscence rates in patients undergoing reduction mammaplasty. 
The NPWT group shows lower wound dehiscence rates than standard wound care (reprinted with permission 
from Ref. [60]).
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infection rates, and more elastic tissue preservation [73]. Results from a multicenter, 
prospective randomized controlled, within-patient study involving our center and 
senior author (RDG) provided high-level evidence supporting significantly reduced 
wound complications following application of iNPWT in susceptible patients [60].
5. Conclusion
Advances in surgical and sterilization techniques have largely mitigated risk of 
wound complications and SSI rates; however, these complications till date pose a 
major physical, financial, and psychological challenge in the postoperative phase of 
treatment. Incisional NPWT presents a promising treatment modality for surgical 
wounds and incisions, with its proposed benefits in reducing infections, prevent-
ing wound dehiscence and optimizing wound healing and scarring. Randomized 
controlled trials and further clinical research are warranted to develop guidelines 
to the safe, effective, and routine use of iNPWT. However, in the present economic 
model of healthcare, efficacy of a treatment modality alone does not justify its use, 
and a large-scale cost-benefit analysis is warranted to rationalize its use in high-risk 
and low-risk postoperative patients.
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